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ABSTRACT. 
Hypothalamic neurotransmitter systems are likely to play an important role in 
bringing about the changes in neuroendocrine function which occur throughout 
development. In particular, the dopaminergic neurones intrinsic to the hypothalamus 
are widely implicated in the regulation of the reproductive and growth axes which 
exhibit clear ontogenetic changes in their endocrine profiles. Therefore, using foetal 
rat hypothalamic cells in primary culture, maintained in a serum-free defined 
medium, we have investigated the morphological and functional development of the 
intrahypothalamic dopaminergic systems. 
Immunocytochemical studies demonstrated the presence of three 
morphologically distinct sub-types of tyrosine hydroxylase-immunopositive (THIP) 
neurones. On day three in vitro unipolar, bipolar and multipolar cell types were 
apparent. The latter two sub-types persisted to later stages in culture and increased 
both in perikarya size and neurite length. All subtypes have been shown to have 
correlates in vivo. 
Biochemical studies employing tritiated dopamine ([3H]DA) demonstrated a 
time- and temperature- dependent uptake mechanism within the cultures which was 
significantly attenuated by uptake inhibitors such as benztropine and nomifensine in a 
dose - dependent manner. The degree of uptake into the hypothalamic cells in culture 
increased as a function with time reflecting a maturation of the uptake mechanism in 
play. Certain experiments suggest that the uptake may also be influenced by 
dopamine receptor modulation. 
[3H]DA was released under both basal and potassium (56mM) - stimulated 
conditions and the magnitude of the response was reduced by exclusion of calcium 
from the release medium. The ability of the cells to release pH]DA also increased 
with the age of the culture again indicating a functional maturation of the DA 
containing neurones within this preparation. 
Functional maturation of these systems was also reflected in studies involving 
the measurement of endogenous DA using high performance liquid chromatography 
coupled with electrochemical detection (HPLC - EC). The neurones displayed an 
inherent maturation as shown by an increase in the magnitude of release (basal and 
potassium - stimulated) of endogenous catecholamine with advancing cultivation 
time. Potassium - depolarization was seen to enhance the rate of 
development/improve the efficiency of the release mechanism. In addition, we found 
that cultures initiated from tissue collected at different gestational ages showed 
differential behaviour in terms of DA output. 
The role of 17 6 - oestradiol (E2) in regulating hypothalamic dopaminergic 
function was also investigated both indirectly with the use of pH]DA and by direct 
measurement of endogenous DA. Both uptake and release of [^HJDA and release of 
endogenous DA were significantly modulated by the concentration of the steroid in 
the defined medium. The optimal concentration for uptake ([^HJDA) and release 
(pH]DA and endogenous DA) were 10 and 10 respectively. These levels of 
oestrogen are likely to be within the physiological range. The parameters under 
investigation were also influenced by progesterone, but in a manner which was 
distinctly different from that of oestrogen. 
The effect of prolactin and gonadotrophin - hormone - releasing hormone on 
the release of endogenous DA was also studied to investigate whether 
intrahypothalamic dopaminergic systems might be involved in negative feedback 
regulation of hormone release. While prolactin was ineffective in modulating DA 
output GnRH was a potent secretagogue for the dopaminergic systems within the 
culture model. 
GABA-ergic neurones within the cultures were also studied in order to test 
a) the specificity of the results with the DA neurones and b) a functional interaction 
between hypothalamic GABA-ergic and dopaminergic neurones. Studies on the 
uptake and release of [ ^ H J G A B A in hypothalamic cells in culture highlighted marked 
differences in behaviour of GABA-ergic and dopaminergic systems both in terms of 
their pattern of maturation and their responsiveness to gonadal steroids. Bicuculline 
( G A B A A receptor antagonist) significantly (p < 0.005) enhanced the release of 
endogenous D A at concentrations ranging from to 10"^  M and both G A B A A and 
G A B A B agonists (muscimol and baclofen respectively) were also found to modulate 
the release of endogenous D A . Marked differences in the behaviour of [ ^ H ] D A 
release compared with that of the endogenous amine were noted and suggest caution 
when interpreting pharmacological studies using cells pre-loaded with [^H] - labelled 
neurotransmitters. 
In conclusion, these results demonstrate that hypothalamic dopaminergic 
neurones in primary culture undergo a pre-programmed morphological and functional 
maturation which have several correlates in vivo. At least one sub-population of these 
neurones is responsive to gonadal steroids and influenced by hypothalamic GABA-
ergic systems. As hypothalamic dopaminergic pathways are essential components in 
the regulation of neuroendocrine activity we propose that this model may serve as a 
valuable tool for the investigation of the ontogeny of DA systems intrinsic to the 
hypothalamus and also their interaction with other hypothalamic neurotransmitters 
and neuropeptides. 
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CHAPTER ONE: INTRODUCTION 
21 
1.1. Purpose of the Investigation. 
Up until the mid 1960s, interest in dopamine (DA) centred largely on its place in the 
biosynthetic pathway for the neurotransmitters noradrenaline (NA) and adrenaline 
(Adr), when it was regarded solely as a precursor in their synthesis. Since then, the 
acceptance of DA as a neurotransmitter in its own right has led to numerous 
investigations on the distribution and function of the dopaminergic systems of the 
CNS (Anden et al 1965, 1966a, 1966b, Bjorklund et al 1970, 1973a, 1973b, 1975 
1979). 
The majority of central DA containing systems are located within the midbrain and 
cortex. These pathways have been the subject of close scrutiny, mainly due to their 
involvement both in psychiatric and neurodegenerative diseases. The mesolimbic 
pathway has been associated with the development of schizophrenia (Hokfelt et al 
1974), while the nigrostriatal pathway is implicated in the aetiology of Parkinson's 
Disease (Homkiewicz; 1973, Fuxe & Ungerstedt 1976). Interest arising from the 
potential use of neural implants to alleviate the symptoms of Parkinson's Disease has 
resulted in numerous investigations into the function and development of the 
mesencephalic dopaminergic systems, under both in vivo and in vitro conditions 
(Prochiantz et al 1981, Barbin et al 1985). 
A significant concentration of dopaminergic neuronal systems is also located in the 
diencephalic brain region, namely, the hypothalamus. Hypothalamic areas such as 
the periventricular (PeVN) and arcuate nuclei (Arc) and the zona incerta (ZI), contain 
dopaminergic perikarya which project locally to innervate areas such as the anterior 
hypothalamus, preoptic area and median eminence (Bjorklund et al 1973a, 1975, 
1979). These anatomical divisions are associated with the control of the 
neuroendocrine system and their dopaminergic neuronal systems are strongly 
implicated in many aspects of the regulation of neuroendocrine function. However, 
despite their likely importance in the maintenance of the body's homeostatic 
processes, the development of these pathways has received relatively little attention 
compared with their mesencephalic counterparts. 
Throughout life the endocrine system exhibits significant and sometimes dramatic 
changes in function, which are likely to be pre - programmed to occur at critical 
stages of development. The late foetal, early neonatal period is one such critical time 
when the neuronal circuitry influencing adult patterns of endocrine function are 
established. The mechanisms underlying these events remain unknown, but most 
certainly include events at hypothalamic level, involving neurotransmitter systems. 
22 
Elsewhere in the brain, evidence suggests that the programming of adult behavioural 
patterns during embryonic development occurs via a process involving DA, (Arevalo 
et al 1987, Matte son 1988), but a similar role for DA in the neuroendocrine 
hypothalamus remains unexplored. 
The endocrine system, in conjunction with the autonomic nervous system, which is 
also controlled by the hypothalamus, constitutes the major route whereby the CNS 
regulates peripheral function and achieves homeostasis. Therefore obtaining further 
knowledge of the development of the intrahypothalamic neurotransmitter systems and 
the factors which influence their activity would greatly benefit our understanding of 
the neural control of endocrine function and ultimately, processes which are important 
to health and disease. 
Access to the hypothalamus is difficult in vivo. We have therefore adopted a primary 
cell culture model to investigate the dopaminergic neuronal systems intrinsic to the 
hypothalamus in terms of their in vitro development and the factors which influence 
their function. 
1.2. The Hypothalamus. 
1.2.1. Function. 
Amongst its numerous roles the hypothalamus controls both endocrine and autonomic 
regulatory processes. Growth and reproduction, events related to parturition and milk 
production in the female and the evolution of the stress response are all intimately 
associated with hypothalamic function. Furthermore, the ingestion of food and water, 
and control of respiration and body temperature are all governed at hypothalamic 
level. The ability of the hypothalamus to integrate the complex array of 
neurochemical and electrical inputs it receives contributes to its role as a central key 
to the function of the mammalian CNS. Its complexity has, for many years, 
hampered investigation into its structure and function, yet advances in technology 
have allowed the neuronal and neurochemical anatomy of the hypothalamus to be 
investigated and a considerable amount of detail concerning its neuropeptide and 
neurotransmitter systems and their receptors has now been elucidated. Despite this, 
much is yet to be discovered concerning the function and inter-relationships of the 
many neuronal pathway s intrinsic to the hypothalamus and the consequences of their 
interactions on the activity of the hypothalamo-pituitary (HP) - axis. 
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1.2.2. Structure and Development. 
The hypothalamus arises from the embryonic diencephalon, a division of the 
prosencephalon. During early developmental stages, the hypothalamus appears as the 
lowest of three swellings located laterally in the wall of the third ventricle. During 
the developmental process the hypothalamic swelling becomes detached from the 
other two portions, namely the epithalamus and the thalamus and a groove called the 
hypothalamic sulcus forms between them. The third ventricle forms from the central 
cavity between the hypothalamus and thalamus and continues to develop within the 
lateral walls of the diencephalon. The roof of the third ventricle is formed by a 
monolayer of ependymal cells covered by a layer of mesenchymal cells possessing an 
extensive capillary system. These capillaries form the choroid plexus of the third 
ventricle by invaginating locally and connecting with the ependymal cells beneath. 
The link between the hypothalamus and the pituitary gland is of special significance 
to neuroendocrine function and it is important to understand the relationship between 
these two structures both in terms of their neuroanatomomy and neurochemistry. The 
neurohypophysis is formed by the downward evagination of a portion of the 
diencephalon known as the infundibulum and remains in neuronal direct 
communication with the hypothalamus. By contrast, the adenohypophysis develops 
from the cavity known as Rathke's pouch, and does not have a neural origin. Instead, 
the hypophyseal stalk is formed by the infundibulum and the infundibular part of the 
adenohypophysis. The ependymal cells of the adenohypophysis extend to the 
pituitary stalk growing along and around it and forming the pars tuberalis. 
Communication between the hypothalamus and the anterior pituitary is via a highly 
vascular portal system originating from the internal carotid artery. This portal system 
consists of primary capillary systems within the median eminence (ME) at the base of 
the hypothalamus, and also the pituitary stalk and the posterior lobe of the pituitary 
gland. Blood flow to the ME is provided by the superior hypophysial artery while the 
pituitary stalk and the posterior lobe are served by the middle and anterior 
hypophysial arteries, respectively. The blood supply to the anterior pituitary gland 
originates at the level of the ME and enters the gland via long portal vessels which 
run along the pituitary stalk. In addition, a secondary portal system, comprising short 
vessels connects the posterior and anterior pituitary lobes, bridging the avascular cleft 
of the intermediate lobe (Daniels & Pritchard 1975). Blood drains from the anterior 
lobe via a secondary capillary plexus which is linked to the systemic venous 
circulation by Y - shaped pituitary veins. Likewise the blood supply to the posterior 
lobe re-enters the systemic circulation via venous drainage. A schematic 
representation of the neurovascular organization of the hypothalamo - pituitary 
complex is illustrated in Fig. 1.1. At the level of the ME regulatory factors which 
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influence anterior pituitary function are released into the portal circulation, and this 
represents the fundamental basis for hypothalamic regulation of neuroendocrine 
function (Green & Harris 1947). 
Fig. 1.1. The neurovascular arrangement of the hypothalamo - pituitary axis. 
MEDIAL BASAL HYPOTHALAMUS 
Capillary plexus 
Long portal vessels 
transport 
hypothalamic 
regulatory factors to 
the anterior lobe of 
the pituitary gland 
anterior lobe 
3rd Ventricle 
Arc 
ME 
euronal processes 
extend from the 
magnocellular division 
of the Arc to innervate 
he posterior lobe. 
OXY, AVP 
posterior lobe 
GnRH, PRL short portal vessels 
intermediate lobe 
The hypothalamus is commonly divided into three regions, namely the supraoptic 
region rostrally, the tuberal region located midway and the mammillary region 
caudally. The ventral surface of the hypothalamus has three "landmarks" the optic 
chiasm, tuber cinereum and mammillary bodies which define these three portions of 
the hypothalamus respectively. Alternatively, it may be considered as divided in a 
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longitudinal manner into medial and lateral areas. The medial zone has a high 
cellular content, the neurones forming nuclei of more or less well defined 
aggregations. In contrast to this, the lateral zone is not easily defined by nuclei, its 
neurones being more diffuse. The lateral zone is known chiefly for possessing a large 
bundle of ascending and descending axons which is known as the medial forebrain 
bundle (MFB) and it is this structure which forms the major input and output 
pathways of the medial hypothalamus (see below). 
1.2.3. Nuclei of the Hypothalamus. 
The neuronal cells of the hypothalamus which participate in neuroendocrine function 
may generally be placed into two categories in terms of their cell body size. The 
magnocellular division comprises large neurones the processes of which, with few 
exceptions, terminate on the capillaries of the neural lobe of the pituitary gland and 
release neurotransmitters and neuropeptides into the circulation. A subgroup of 
smaller cells, the parvocellular division, project fibres to the precapillary spaces of the 
hypophysial portal vessels and the neurohormones which they secrete are transported 
to the anterior pituitary gland where they regulate the release of anterior pituitary 
hormones. 
The cells of both divisions are organised in well defined aggregations (nuclei), 
situated in several regions of the hypothalamus. Within the supraoptic region of the 
hypothalamus lie the laterally paired supraoptic nuclei (SON) and the paraventricular 
nuclei (PVN). Both nuclei, contain magnocellular cells which project axons forming 
the hypothalamo - neurohypophysial tract, projecting to the posterior pituitary and 
the PVN has several distinctive parvocellular divisions, namely the anterior, medial, 
dorsal and lateral divisions as characterised by Van Den Pol (1982). 
The paired suprachiasmatic nuclei (SCN) are almost circular in shape and lie in close 
association at the midline of the basal hypothalamus. They are situated beneath and 
adjacent to the third ventricle rostrally, just above the optic chiasm. These nuclei are 
involved with the generation of circadian rhythms and also control daily rhythms of 
behaviour and hormone secretion (Meijer & Rieveld 1989). Also in the anterior zone, 
is the medial preoptic nucleus (MPON), a major target for the sex steroids, rich in 
oestrogen and testosterone receptors. Such receptors are also densely located in the 
septum with which the preoptic area merges. 
The ventromedial and dorsomedial nuclei (VMN and DMN respectively) are found in 
the medial region of the hypothalamus. Along with the arcuate nucleus (Arc) these 
cell groups surround the ventral part of the 3rd ventricle. Like the PVN, the VMN is 
26 
under the influence of a great number of afferent and efferent connections from and to 
other regions of the CNS such as the spinal cord and mesencephalic central grey 
matter (Swanson & Kuypers 1980). The neurones within the Arc project into the ME 
and their axons terminate in the pericapillary spaces of the portal capillary loops. 
Thus neurotransmitter pathways emerging from this nucleus have direct access to the 
portal circulation and from there to the anterior pituitary gland (Swanson & Kuypers 
1980). The projections contribute to the parvocellular neurosecretory systems 
originating from small neuronal cell bodies in the medial portion of the Arc. 
The periventricular nucleus, (PeVN), is located at the rostral extreme of the 3rd 
ventricle. Its function in neuroendocrine regulation is chiefly related to the control of 
gonadotrophin secretion since discrete lesioning of the nucleus disrupts the pulsatile 
release of luteinizing hormone (LH). The anteroventral portion of this nucleus 
exhibits sexual dimorphism regarding the distribution of tyrosine hydroxylase (TH) 
containing cells, with a 3 - fold greater number of TH immunoreactive neurones 
contained in the female PeVN than in the male (Simerly et al 1985). In addition, this 
nucleus is also the location of a population of somatostatin (SRIH) secreting neurones 
(Herbison et al 1991). The cell bodies of these neurones are large, but, unlike other 
cells of the magnocellular division, the processes of this cell population terminate at 
the level of the median eminence and SRIH reaches the anterior pituitary via the 
portal system. 
Finally, there are the mammillary bodies, which are visible on the ventral surface of 
the hypothalamus. The mammillary nuclei form a complex structure located caudally 
within the mesencephalic central grey. 
1.2.4. Pathways to and from the Hypothalamus. 
The medial forebrain bundle (MFB) is the structure through which both the ascending 
and descending projections of the hypothalamus pass and, in most cases, traverse the 
lateral portion of the hypothalamus. Immunocytochemical techniques show that a 
significant percentage of the monoaminergic neurones of the brainstem travel to the 
hypothalamus via the medial forebrain bundle. The hypothalamus receives a rich 
noradrenergic input, originating in the ventrolateral medulla oblongata and the 
nucleus of the tractus solitarius. From the hypothalamus this noradrenergic tract, 
which is known as the ventral noradrenergic bundle (VNAB), ascends to the MFB. A 
number of hypothalamic areas receive rich noradrenergic input including the anterior 
hypothalamic areas, the medial preoptic area and the periventricular zone and these 
connections are of great neuroendocrine importance and have been the subject of 
extensive investigation. Other regions innervated by fibres emerging from the 
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medial forebrain bundle include the PVN, SON Arc and SCN. Adrenergic neurones 
from the medulla also connect with the medial hypothalamus and like noradrenergic 
neurones heavily innervate the PVN, although their functional role within the 
hypothalamus is ill defined. 
The 5-HT containing neurones of the mesencephalic raphe nuclei pass through the 
medial hypothalamus, the mammillary complex, the SCN, the periventricular (PeV) 
zone and the Arc and also moderately innervate the internal layer of the ME. 
Noradrenergic, adrenergic and serotoninergic neurones form an extensive network of 
neurones called the periventricular system which connects the hypothalamus to the 
mesencephalon. In addition dopaminergic neurones pass through the hypothalamic 
periventricular and periaqueductal grey and they project to and within the 
hypothalamus rostrally. More detailed information of the dopaminergic neurones 
intrinsic to the hypothalamus will be discussed in subsequent paragraphs. 
The descending pathways within the hypothalamus also pass through the MFB 
emerging from the limbic system. This system includes the olfactory areas of the 
forebrain as well as the septal nuclei and the amygdaloid nuclear complex which are 
structures of the neocortex. Some of these structures project to the medial 
hypothalamus, while others terminate within lateral regions of the hypothalamus, 
innervating the medial hypothalamus via intemeurones. 
1.3. Anatomy of the Central Dopaminergic Systems. 
A summary of all the major dopaminergic tracts may be found in Table 1.0. 
Catecholamine containing neurones traverse the brainstem from the medulla 
oblongata to the diencephalon and are also found in the retina and olfactory bulb. 
The CA-containing systems were first described byDaMstrom & Fuxe (1964) who 
depicted 12 different cell groups which they designated A1 - 12. Further studies by 
these workers and Bjorklund et al (1973, 1975) led to the addition of further cell 
groups, an A13 located in the rostral zona incerta and the A14 in the anterior 
periventricular hypothalamus and the preoptic region. Tyrosine hydroxylase 
immunocytochemistry (see Table 1.0) has more recently led to the observation of a 
system of cells disseminated in the dorsal portion of the preoptic area, the 
ventrolateral area and the hypothalamus. These cells collectively form the A15 cell 
group and another cell group, located in the olfactory bulb have been designated to 
the A16 cell group. An additional cell group exists in the amacrine cells of 
mammalian retina as observed by Ehinger (1976). 
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Table. 1.0. Dopaminergic tracts of the CNS. 
Name of Tract Site of Orgin Innervation Area Method of visualisation/identification Reference 
Nigrostriatal A9: substantia nigra 1. dorsal striatum 
2. subthalamic nucleus 
3. globus pallidus 
4. ventral putamen 
a. Falck-Hillarp fluoresence 
b. Glyoxylic-histofluorescence 
c. Aluminium-formaldehyde 
histofluorescence 
d. Immunocytochemistry (ICC) for TH 
a. Anden et al 1965 
b. Bjorklund & LindvaU 1975 
c. Loren et al 1980 
d. Pearson et al 1983 
Mesolimbic AlO: ventral tegmental area 1. dorsal striatum 
2. ventral striatum 
3. nucleus accumbens 
4. tuberculum olfactorium 
5. bed nucleus of the stria terminalis 
a. Falck-Hillarp fluoresence 
b. Multiple fluorescence/retrograde 
trace studies 
a. Ungerstedt et al 1971 
b. Albanese et al 1983 
Periventricular, 
hypothalamic and 
preoptic 
Al l : mesencephalic 
peri - aqueducW grey; 
-periventricular gray of the 
caudal thalamus 
and 
A12-A14: periventricular 
hypothalamus and 
periventricular preoptic area 
1. periaqueductal gray 
2. medid thalamus 
and 
3. anterior hypothalamus 
4. medial preoptic area 
a. Glyoxylic histofluorescence a. Bjorklund & Lindvall 1975 
^Tuberohypophyseal A12-A14: arcuate and 
periventricular hypothalamic 
nuclei 
1. intermediate lobe of the pituitary 
gland 
2. neural lobe of the pituitary gland 
a. fluorescent histochemistry 
b. microspectrofluorometric mapping 
c. immunocytochemisty (ICC) 
d. ICC for TH 
a. Bjorklund et al 1973 
b. Bjorklund et al 1977 
c. Hokfelt et al 1977 
d. Daikoku etal 1986 
Wuberoinfundibular A12: arcuate nucleus and 
periarcuate nucleus 
1. All layers of the median eminence. 
2. Pituitary Stalk. 
a. fluorescent histochemistry 
b. microspectrofluorometric mapping 
c. ICC for TH 
d. ICC for TH 
a. Bjorklund et al 1973 
b. Bjorklund et al 1977 
c. Hokfelt et al 1977 
d. Ugramov et al 1989 
Incertohypothalamic A13: medial zona incerta 
A l l , A14: periventricular 
hypothalamus 
1. zona incerta 
2. medial preoptic periventricular 
hypothalamus 
3. septum 
a. fluorescent histochemistry 
b. microspectrofluorometric moping 
c. ICC 
d. ICC for TH 
a. Bjorklund et al 1973 
b. Bjorklund et al 1977 
c. Hokfelt et al 1977 
d. Ugramov et al 1989 
TH = tyrosine hydroxylase 
ICC = immunocytochemistry 
* See also: Smith & Fink (1972). 
13.1. The Mesencephalic DA Cell System. 
Dopamine - containing neurones are mostly distributed in the mesencephalon and 
diencephalon. Others are located in the A2 group situated in the medulla oblongata. 
By far the greatest population of dopaminergic neurones are found in the cell group 
known as the mesencephalic DA cell system, which includes the A8, 9 and 10 cell 
groups. From this cell system originate the neurones which form the extensive 
mesotelencephalic DA projection system with approximately 15, 000-20, 000 DA 
neurones emerging from each half on the mesencephalon. 
1.3.2. The Diencephalic DA Cell System. 
Within the A11-A14 cell groups lie the diencephalic DA cell systems. They give rise 
to the extensive intradiencephalic projections as well as the diencephalospinal 
pathway. These are considerably fewer in number than those of the mesencephalon 
with approximately 500 neurones on each side in the tuberal A12 group which gives 
rise to the tuberohypophyseal and tuberoinfundibular pathways. An almost equal 
amount occupies the remaining diencephalic cell groups thus, the diencephalic DA 
cell population is less than one tenth of that of the mesencephalon. 
1.4. Dopamine Containing Fibre Tracts of the Hypothalamus. 
In order to appreciate the possible inter-relationships of hypothalamic DA pathways 
and the likely neuroendocrine functions ascribed to them, it is important to describe 
briefly their main cy to architectural characteristics. The detail so far known 
concerning the exact location of these tracts has been found by making observations 
in the rat and primate CNS. Evidence does however suggest that these organisational 
features hold true for other species and man (Felten & Sladek, 1982, Nobin & 
Bjorklund, 1973). 
1.4.1. The Incertohypothalamic Dopaminergic Tract. 
The incertohypothalamic dopaminergic (ICHDA) projection system, (also known as 
the intradiencephalic system), is comprised of short, locally projecting neurones. The 
fibres of this tract undergo extensive bifurcation soon after leaving the cell bodies and 
if visualised by histofluorescent techniques (see Table 1.0) exhibit fine weak 
fluorescence with varicosities separating the only partially visible intervaricose 
segments (Bjorklund et al 1975). 
The pathway itself may be described in 2 components the caudal and the rostral as 
defined by Bjorklund et al (1975). The caudal component of the tract extends from 
an area of dopaminergic cell bodies located in the caudal thalamus, the posterior 
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hypothalamic area and the medial zona incerta, (groups A l l and A13) and pass 
upwards to the dorsal part of the DMN as well as the anterior and dorsal areas of the 
anterior hypothalamus. The rostral component of the incertohypothalamic fibre 
system originates in the rostral periventricular cell bodies of the A14 cell group and 
distributes itself in the PeVN of the anterior hypothalamus and in the PVN, SCN and 
MPON up to the level of the anterior commissure. From here this component of the 
fibre tract extends to the lateral septal nucleus at its most caudal part. 
1.4.2. The Tuberohypophyseal Dopaminergic Tract. 
The dopaminergic cell groups from which the tuberohypophyseal dopaminergic 
(THDA) neuronal system is derived may be divided into 2 groups on the basis of their 
mode of projection. One cell group within the rostral portion of the Arc projects to all 
levels of the ME in a diffuse manner, while a second group projects dorsoventrally 
to connect each portion of the Arc i.e. rostral, middle and caudal with the 
corresponding segment of the ME situated beneath it. Dopamine containing fibres 
have also been located around the endocrine cells of the pars intermedia and in the 
neural lobe (Bjorklund et al 1970). It is considered that the cell bodies of these fibres 
originate in the rostral portion of the Arc and the cells innervating the pars intermedia 
lie just rostral to those which impinge upon the neural lobe. The fibres are distributed 
extensively in the neural lobe, and form a dense network around the endocrine cells of 
the pars intermedia, some fibres ending as dopamine filled droplets or as a terminal 
swelling such as those found in peptidergic neurosecretory axons. 
1.4.3. The Tuberoinfundibular Dopaminergic Tract. 
The tuberoinfundibular (TIDA) neurones originate in the Arc and project to all layers 
of the ME and hypophysial stalk. In the external layer of the median eminence they 
form a dense network impinging on the precapillary spaces of the hypophyseal portal 
vessels. The fibres are varicose and when visualised by histofiuorescent techniques 
(see Table 1.0) fluoresce strongly (Bjorklund, 1973). Within the internal layer of the 
ME a portion of the fibres are considered to be pre-terminal, en route to the posterior 
lobe of the pituitary gland or to deeper layers of the median eminence and run parallel 
to one another in the sagittal and frontal planes. The dopaminergic fibres of the TIDA 
pathway are arranged in close association with non - catecholaminergic axons and 
perikarya. On the basis of these structural observations, it is considered that 
dopamine released at the level of the ME, either enters the portal blood to influence 
the anterior pituitary gland, or acts on neighbouring axonal terminals. This latter pre -
synaptic action may influence the release of hypothalamo - hypophyseal regulatory 
factors and thus also control anterior pituitary hormone secretion. 
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The entire dopaminergic input to the ME and to the posterior pituitary gland is 
considered to originate in the mediobasal hypothalamus (MBH) with additional 
noradrenergic input coming from the lower brainstem Al and A2 cell groups as well 
as from the sympathetic cervical ganglion as detailed by Swanson et al (1981). 
1.4.4. Additional Hypothalamic DA Neurone Cell Systems. 
Additional cell groups are also found within the hypothalamus. Cell groups are 
present in the DMN, the area which surrounds the PeVN and also the fornix (F), the 
supramammillary area, the ventral surface of the hypothalamus and at the border 
between the medial and lateral hypothalamus. 
To date the exact destinations (anatomical and neurochemical identity) of all the 
projections are unknown although hypothalamic DA projections are strongly believed 
to make local connections with other neuronal populations within the structure. 
However, the presence of these large numbers of DA cell groups within the 
hypothalamus serves to emphasise the important role played by dopamine in the 
regulation of hypothalamic and pituitary function. Evidence for a neuroendocrine 
role for DA will be considered in Section 8 of this chapter, but first the methods for 
establishing the dopaminergic nature of these pathways will be discussed. 
1.5. Techniques used for Visualising Dopaminergic Neuronal Pathways. 
The first microscopical visualization of catecholamines was within peripheral tissue 
of sheep and cows, using a chromaffin reaction (Falck et al 1959). With the 
development of the hot formaldehyde histofluorescence method the demonstration of 
catecholamine - containing neuronal cells was achieved (Falck et al 1962) and the 
technique was used subsequently to visualize amine containing neurones in the 
mesencephalon extending processes to the striatum (Bertler et al 1964) and to the 
limbic forebrain (Anden et al 1965). Since these early investigations, knowledge of 
the central dopaminergic systems has increased in line with the development of more 
sensitive and refined histochemical tracing techniques. 
One of the major shortcomings of the original Falck - Hillarp technique was its lack 
of sensitivity which prevented the visualization of the preterminal portions of 
catecholamine- containing neurones. Development of the glyoxylic acid 
histofluorescence method, a more sensitive technique, when used in conjunction with 
vibratome sections of neuronal tissue, allowed the visualizatton of fibre networks and 
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their sites of termination, thus enabling scientists to begin to construct a "map" of the 
central dopaminergic systems. 
A second shortcoming lay in the lack of specificity of the aldehyde histofluorescence 
methods. It was almost impossible to distinguish between the different types of 
catecholamine containing neuronal populations by microscopic studies, as a similar 
fluorescence colour was produced for all the amines. Often, distinction between 
noradrenergic and dopaminergic populations was made simply on the basis of 
differences in their morphology but such differences were not true for all 
catecholaminergic cells. To date, the major method for determining the exact identity 
of dopaminergic neurones is based to a large extent on the use of pharmacological 
agents such as a - methyl - p - tyrosine which selectively inhibits tyrosine hydroxylase, 
the rate - limiting enzyme in the synthesis of this catecholamine. Many of 
the principal dopaminergic systems of the CNS were accurately delineated by using 
this method. Furthermore, dopamine - 6 - hydroxylase inhibitors and depletion of 
catecholamine stores followed by restoration of intraneuronal DA levels by 
administration of L- dopa, has further allowed selective visualization of the central 
DA - containing neurones, although at this stage the "map" remained incomplete 
(Bjorklund et al 1975). 
The next important advancement in visualization methodology involved the 
introduction of retrograde tracer technology. Axonal tracers such as horseradish 
peroxidase or fluorescent dyes, when used in combination with histofluorescence 
provided a greater understanding of the organization of the DA projection systems, 
i.e. it was possible to identify the location of dopaminergic perikarya and the site of 
innervation of their processes in relation to other brain structures and 
autoradiography, involving the uptake of tritiated ([^H]), DA provided further 
information concerning the topography of central dopaminergic systems. The 
specificity of this method was provided by the use of uptake inhibitors such as 
desmethylimipramine which prevented the uptake of [^HJDA into noradrenergic 
nerve terminals while more recently the use of electrolytic or neurotoxin lesions 
allowing selective removal of the NA projection systems, have been used to map the 
cortical DA innervations, (Thierry et al 1973, Fallon et al 1978) and the DA 
innervations within the diencephalon (Bjorklund et al 1975). 
With the purification of TH, the rate limiting enzyme of DA synthesis and the 
production of antibodies to it, the development of increasingly more sensitive 
histochemical methods has been achieved. The greater sensitivity provided by 
immunocytochemistry has allowed the visualization of dopaminergic perikarya 
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and fibres in foetal tissue which has permitted studies on the embryonic origin and 
foetal and neonatal development of central dopaminergic systems as discussed below. 
1.6. The Development of the Dopaminergic Systems oftheHypothalamusira vivo. 
The ontogeny of the catecholaminergic systems in the CNS as a whole has been 
reported in numerous studies (Golden 1973; Specht et al 1981). However, the 
ontogeny of the catecholaminergic neurones of the hypothalamus per se has received 
much less attention with most authors looking either only at discrete regions of the 
structure (Daikoku et al 1986) or conversely at larger portions of the CNS which 
incorporates the hypothalamus i.e. the diencephalon which consists of the 
hypothalamus and its surrounding borders (Engele et al 1989). It was a study by 
Ugramov et al in 1989^^hich was the first to characterise, in terms of neurone 
morphology and location, the differentiation of the catecholamine containing 
neurones in the hypothalamus (and septal region) during a developmental period 
from the 12th foetal day (El2) to the 9th postnatal day (P9) in the rat. Using TH 
antiserum and failing to visualize the enzyme involved in NA synthesis i.e. 
dopamine 6 - hydroxylase, the authors concluded by elimination, that the tyrosine 
hydroxylase - immunopositive (THIP) neurones which were observed in their study 
were in fact dopaminergic rather than noradrenergic. 
1.6.1. Anatomical Ontogeny. 
Ugramov et al (1989a and b) reported that it is possible to detect THIP neurones in 
the foetal hypothalamus as early as E13 in gestation. In slices of the hypothalamus 
taken from rat pups, THIP neurones were visualised in the lateral region and anlages 
of the hypothalamus and septal region. Although initially scattered, the THIP 
neurones began to migrate during E14 and 15, aggregating in more dorsal regions of 
the hypothalamus. By E18 DA containing perikarya throughout the hypothalamus, 
formed dense accumulations which were partially differentiated and by P9, the cells 
had migrated from their site of origin to their final positions within the hypothalamus. 
Many THIP cell aggregations occurred forming nuclei in locations corresponding to 
the hypothalamic nuclei known to exist in the adult structure. 
THIP neurones were detected in the region of the SCN in both the foetus and the 
neonate. The neurones were characteristically bipolar and lay close to the ventral 
portion of the third ventricle. The cells accumulated in this region prior to spreading 
dorsally and dorsolaterally during development up to E20, after which time they 
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occupied positions in the periventricular and preoptic regions. Projections from these 
dopaminergic perikarya extended dors ally through the subependymal region 
spreading across the optic chiasma and descending to the medial segment of the optic 
tracts. 
The medial preoptic area was the location of an obvious accumulation of THIP 
neurones which were even more pronounced in the foetus than in the neonate. This 
cell cluster consisted of both bipolar and multipolar neurones which projected to the 
third ventricle and to the optic chiasma. The anterior hypothalamic nucleus had a 
dense accumulation of THIP neurones and again more were observed in the foetus 
than in the neonate. They projected in dorsomedial and ventrolateral directions, 
although the distribution only became obvious during postnatal periods of 
development. 
Still more THIP neurones accumulated from El8 in the dorsomedial, infundibular and 
postinfundibular regions. Within this area, the dopamine containing cell bodies 
formed nuclei occupying the PVN, the ZI and dorsomedial hypothalamus, which 
often overlapped. By P9 these cell clusters were clearly separated and occupied 
distinct positions which were easily distinguishable. 
Within the ventral portion of the developing hypothalamus, an accumulation of THIP 
neurones were demonstrable by El8 and persisted to P9. There were two notable 
nuclei in this region, one placed laterally in the ME and a smaller ceU cluster also 
lying laterally. The former nucleus consisted of between 10 THIP cells on E18 and 
22 on P9. They comprised both unipolar and bipolar neurones which were smaller 
than those found in the dorsal region of the hypothalamus. The two nuclei were 
connected by a chain of single THIP neurones. The nucleus located in the median 
eminence became displaced by P3 lying close to the Arc. By P9 this nucleus 
completely occupied the arcuate portion of the hypothalamus sending processes to the 
median eminence. 
The PeVN was first recognisable as a group of THIP neurones from E20. From the 
arcuate preoptic level, dopaminergic perikarya spread to the retrochiasmatic level. 
Postnatally, the nucleus became displaced further, to setde in the periventricular area 
between the infundibular and anterior hypothalamic levels. Characteristically, the 
neurones within this nucleus were bipolar and projected to the ventrodorsal region 
along the third ventricle, forming an intricate network along the subependymal layer. 
By P9 the periventricular accumulation of THIP neurones traversed to the SCN. 
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The THIP neurones of the SON were only detectable after birth defined as a few 
bipolar THIP neurones in the lateromedial hypothalamus. 
1.62. Morphological Ontogeny. 
Throughout a 20 day developmental period, in vivo, incorporating the latter days of 
foetal life and the first 9 days of postnatal life, the THIP neurones of the 
hypothalamus underwent extensive morphological changes which were considered to 
be a result of cell differentiation. The first THIP neurones to be detected (on El3) 
possessed either a single thick process or two processes one which was thick and 
unbranched, and one which was thin. However, by E14, the thick processes 
underwent extensive bifurcation, giving rise to between 2 and 3 additional processes. 
By El8, uni- , bi- and less frequently, multi-polar neurones were identified and the 
latter increased in number to become the predominant type by P9. All THIP 
subtypes increased in perikarya size and neuronal length during foetal and neonatal 
development, forming neuronal connections. 
1.6.3. Functional Ontogeny. 
The technique of high performance liquid chromatography with electrochemical 
detection (HPLC-EC), has recently been employed to investigate the functional 
ontogeny of the hypothalamic dopaminergic neurones (Pares - Herbute, 1989; 
Santana et al 1992). The DA content in the diencephalon followed a biphasic 
developmental pattern. Levels of DA were first measurable, as early as E13 and 
increased dramatically by the time of birth (15-fold), after which time there was a less 
pronounced rise (9-fold) to adult levels by P30. The physiological significance of the 
high levels of DA found in the developing hypothalamus is poorly understood. In 
other foetal brain regions, DA is considered to exert modulatory influences on 
neuronal development and behaviour. For instance, DA in the midbrain and cortical 
areas was reported to influence neuronal outgrowth (Matteson 1988) and also induces 
a permanent modification of adult behaviour (Arevalo et al 1987). However, there 
are relatively few studies which address other aspects of dopaminergic function and 
investigations into the release of DA from foetal hypothalamic dopaminergic systems 
and the factors which influence it, are yet to be performed. 
1.7. Dopaminergic Neuronal Function. 
The recognition of DA as a genuine neurotransmitter followed the isolation of 
neurones which contained TH but were deficient in dopamine - B - hydroxylase. Such 
neurones were unable to synthesise NA/Adr, and DA was proposed to be the end 
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product of their synthetic pathway. In later studies, DA was found to be located in 
high concentrations within nerve terminals and the identification of receptors 
displaying specificity for DA, further substantiated a neurotransmitter role for the 
amine (Vogt 1973). 
1.7.1 Synthesis and Metabolism. 
The enzymatic pathway involved in the synthesis and metabolism of DA is illustrated 
in Fig 1.2. The conversion of tyrosine to 3, 4 - dihdroxyphenylalanine (dopa), serves 
as the rate-limiting step in DA synthesis, presumably regulating the intraneuronal 
concentration of the amine. The metabolism of DA is restricted to the cytoplasmic 
pool of the transmitter,which may represent the storage site for newly synthesised 
readily releasable pools of DA while the vesicular bound storage site offers protection 
from intraneuronal enzymatic degradation. 
1.7.2 DA Uptake. 
Termination of dopaminergic activity is achieved by a combination of re-uptake and 
enzymatic degradation. The uptake of catecholamines was first perceived in 1932, 
when it was suggested that NA might be taken up by neuronal and non-neuronal 
tissue. Small doses of tritiated catecholamines were found to be rapidly removed 
from the circulation following injection (Axekod et al 1959; Whitby et al 1961) and 
the radiolabelled neurotransmitter was subsequently located, in concentrated amounts, 
in various peripheral tissues which received sympathetic innervation. From such 
observations, it was postulated that the amines were most likely to accumulate in 
sympathetic neurones. This theory was substantiated by the observation that physical 
or chemical destruction of sympathetic neurones totally abolished the uptake of NA 
into peripheral organs (Iversen et al 1975). Autoradiographic and histochemical 
studies provided more evidence for this hypothesis and it is now estimated that 
between 70-80% of released NA may be recaptured under normal conditions. Uptake 
is now generally considered to be a major mechanism for the termination of activity 
of aminergic neurotransmitters such as NA, Adr, 5-HT and DA, both centrally and 
peripherally. 
The uptake of DA is inhibited by ouabain an inhibitor of the Na+/K+ ATPase pump, 
suggesting that the uptake mechanism is dependent on the transport of ions across the 
cell membrane and more specifically the transport of Na+. The existence of a DA 
transporter complex was proposed which acts as a mobile carrier with a DA binding 
site that shuttles from one side of the membrane to the other, transporting molecules 
of DA and Na+ with it. The co - transport system is not unique to DA and high 
affinity uptake mechanisms displaying selectivity for other neurotransmitters and 
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neurotransmitter candidates such as NA, 5-HT, Glu, Asp, GAB A, Gly, TAU, Pro and 
adenosine are also present in the CNS (Amara 1993). 
Fig 1.2. Synthesis and Metabolism of DA. 
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Within the last few years molecular biological techniques have provided us with 
further information concerning the transporter molecule. Usdin et al (1991), isolated 
the cDNA clones encoding the rat and bovine DA transporter as did Shimada et al 
(1991). Degeneration oligonucleotides corresponding to regions of high sequence 
identity between NA and GAB A transporter molecules served as probes or were the 
basis of polymerase chain reactions (PGR) to generate probes for screening DNA 
libraries. The common structural motifs reflect the important generic functions of the 
protein such as Na+/Gl" co - transport which is a vital function to all members of the 
CO-transporter family. The specificity of each transporter, in relation to its affinity to 
ligands and inhibitors, is provided by the regions of divergence where amino acid 
sequences between the co-transporters differ. 
The DA transporter protein is a potential site for drug action. Inhibitors of the DA 
uptake mechanism i.e. nomifensine, benztropine, diclofensine, cocaine and manzidol 
appear to interact with specific membrane sites in a stereospecific and highly selective 
manner and either inhibit binding of the substrate or prevent translocation of the 
transporter protein across the membrane. This is considered to be the main 
mechanism of action of certain anti-depressant drugs which, by increasing the 
synaptic concentration of DA, augment synaptic transmission. In addition, cocaine 
and other drugs of abuse act on the transporter complex to mediate their psychotic 
effects (Ritz et al 1989; Trendelburg et al 1991). All uptake inhibitors have 
physiological effects which correlate strongly with their ability to block DA uptake 
and thus they continue to be the subject of much interest to the drug industry as 
potential therapeutic agents. 
1.7.3 DA Release. 
The release of DA in rat brain has been studied using in vitro preparations such as 
brain slices (Reisine et al 1982), and synaptosomes (Gregerson & Salmanoff, 1987) 
and brain homogenates (Plantje et al 1982) either pre-loaded with radiolabelled DA or 
precursors of DA synthesis (Baldessarini et al 1975). In addition, the release of 
endogenous DA from brain slices has been investigated by use of radioenzymatic 
assays (Kant & Meyerhoff 1978) and HPLC-ECD (Sharp et al 1986). The release of 
DA in vivo has also been studied, using the push-pull perfusion technique in both 
anaesthetised (Gonon et al 1980) and freely moving (Chen et al 1984) animals. A 
combination of brain dialysis with HPLC-ECD has also been employed to measure 
extracellular levels of DA and its metabolites and also to monitor drug-induced 
effects on transmitter release and metabolism (Zetterstrom et al 1983). 
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It is generally agreed that the release of DA, like that of most transmitters, is 
dependent on the entry of Ca^+, through voltage dependent Ca^+ channels, into the 
nerve terminals (recent reviews, Szerb et al 1981; Zucker & Lando 1986). The 
channels are activated by the arrival of a depolarising current which elevates the 
potential of the presynaptic membrane, a phenomenon known as depolarization. The 
resulting channel opening allows the influx of Ca^+, which promotes a transient 
fusion of neurotransmitter-packed vesicles with the presynaptic membrane. DA is 
thus released into the synaptic cleft, which it traverses to elicit a postsynaptic effect 
on adjacent neurones. Depolarization of the membrane by electrical stimulation or 
elevation of the extraneuronal concentration of K+ also induces DA release, the 
magnitude of release usually being greater than during spontaneous efflux. 
From the results of certain investigations of the activity of dopaminergic systems, it 
appears that DA may be stored in and released from dendritic nerve terminals as well 
as axonal nerve terminals (Ni e oullon et al 1977). Dendritic release of DA may 
provide tonic inhibition of dopaminergic neurones themselves, with the firing rate of 
dopaminergic cells being inhibited by the activation of DA receptors on their cell 
bodies. Furthermore, the synthesis of DA is reported to be inhibited by the activation 
of DA receptors found either on the dopaminergic cell soma or on the dendrites 
(Demarest et al 1979b), whilst release is inhibited by activation of DA receptors on 
dopaminergic nerve terminals (Arbilla et al 1981). 
1.7.4 DA Receptor Subtypes. 
Spano et al (1978) first proposed a classification for DA receptors based upon their 
linkage to adenylate cyclase. Activation of the Dj receptor caused stimulation of 
adenylate cyclase, whereas D2 activation either inhibited or was not related to 
adenylate cyclase activity. Both receptors exist in high and low affinity states with 
Kd values for DA of 0.8 and 400 nM respectively for Di and 8nM and 4, OOOnM 
respectively for D2 receptors. Pharmacological and molecular biological evidence 
however, suggests the existence of other Di and D2 - like receptors sub-types and a 
list of these receptors, their distribution and their respective ligands, may be found in 
Table 2.0. It is the D2 receptor, in a high affinity state, which mediates the inhibition 
of prolactin from the anterior pituitary gland, located on lactotrophs (see below). 
Furthermore the D2 receptors located within the mediobasal hypothalamus and the 
neurointermediate lobe of the pituitary are believed to modulate DA release from 
TIDA and THDA neurones (Plantje et al 1987; Sarkar et al 1983). 
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Table 2.0. DA receptors: classification and subtypes. 
Receptor Subtype High Affinity Ligands Low Affinity Ligands 2nd Messenger Coupling Site of Distribution 
D l / D l A Benzazepine - type 
drugs e.g. SKF 38393, 
SCH 23390 
Butryophenone - type drugs 
e.g. haloperidol 
Stimulation of adenylate 
cyclase 
Caudate putamen, nucleus accumbens, olfactory 
tuberculum, cerebral cortex, limbic systems, 
hypothalamus and thalamus. 
DIB/5 As for Di As for Di As forDi Mamillary nuclei, parafasicular nuclei of the 
thalamus and the hippocampus. 
D2S/2L butryophenones benzazepines Inhibition of adenylate 
cyclase, activation of K+ 
channels. 
A9 and A10 regions i.e. substantia nigra and 
ventral temental area, the mediobasal 
hypothalamus, the anterior and neurointermediate 
lobes of the pituitary gland. 
D3 benzamides, e.g. 
raclopride 
Not well defined Olfactory tubercle, nucleus accumbens, substantia 
nigra and ventral tegmental area and the 
hypothalamus. 
D4 clozapine (atypical 
neuroleptic) 
all types of DA antagonists 
except clozapine. 
Not well defined Frontal cortex, amygdala, medulla and midbrain 
regions. 
1.8. DA and Neuroendocrine Control. 
1.8.1 Prolactin. 
If the normal connections between the hypothalamus and the pituitary gland are 
disrupted, whether by lesions to the hypothalamus, sectioning of the pituitary stalk, or 
in vitro incubation of pituitary tissue, there is a significant rise in the release of 
prolactin, while the release of other pituitary hormones e.g. luteinizing hormone, 
declines. From such observations it was postulated that the brain, and more 
specifically, the hypothalamus was the site of synthesis and storage of a prolactin-
inhibitory factor (PIF), exerting a tonic inhibition on prolactin release at the level of 
the pituitary. 
It was initially assumed that the PIF, like other hypothalamic regulatory factors 
identified at that time, was a neuropeptide, but investigations directed at isolating a 
peptidergic PIF were unfruitful. However, the high concentration of DA located in 
the mediobasal hypothalamus led scientists to investigate its potential role as a 
neuroendocrine regulator. It was demonstrated that high concentrations of DA were 
present in portal blood and that such concentrations of DA were sufficient to inhibit 
prolactin release from lactotrophs in vzYro,(MacLeod et al 1970; Shaar & Clemens 
1974; Ben-Jonathon et al 1977, Gibbs & Niell 1978). Further evidence was 
subsequently provided establishing DA as major physiological PIF and, to date, its 
role has not been successfully challenged. However, the regulation of prolactin 
release is not determined by the action of a sole factor as the alterations in plasma 
prolactin levels which are observed during changes in endocrine status, e.g. 
pregnancy, suckling and the oestrous cycle, could not reasonably be attributed to the 
activity of a single neurohormone. Gamma-amino butyric acid (GABA), 
gonadotrophin associated peptide (GAP) and a - MSH have also been implicated in 
the inhibition of prolactin release. In addition, a whole range of prolactin releasing 
factors including 5-HT, vasointestinal peptide (VIP), thyrotrophin releasing hormone 
(TRH) and 6 - endorphin, have more recently been reported (Leong et al 1983). 
Both the TIDA and THDA neuronal systems are considered to be directly involved in 
the regulation of prolactin release. A detailed description of these pathways may be 
found in Sections 1.4.2, 1.4.3 and Table 1.0. It is considered that much of the DA 
released from the TIDA and THDA hypothalamic systems serves as a 
neuromodulator rather than as a neurotransmitter. Thus, once released from the 
dopaminergic nerve terminals at the level of the ME, DA enters the hypophyseal 
portal system and is transported to the pituitary gland. From here it acts on D2 
receptors located on the lactotrophs of the anterior pituitary gland as shown by 
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immunocytochemical investigations (DeLean 1982). There is a strong correlation 
between the potency of 0% receptor agonists and their effectiveness in suppressing 
prolactin release. The actual mechanism by which D2 receptor activation results in 
suppression of prolactin release is, to date, poorly defined although several theories 
have been suggested (Barns et al 1978; Gudelesky et al 1980; Heiman & Ben -
Jonathon 1982; De La Escalera & Weiner 1988; De La Escalera et al 1988, Murai 
et al 1989a and 1989b; Mogg & Samson 1990). 
Regulation of the levels of DA reaching the anterior pituitary gland is mediated partly 
by the state of vasoconstriction in the various vascular beds, which determines the 
blood flow in the portal vessels. Blood flow may be shunted in various directions and 
such versatility of flow is a vital feature for the necessary exchange of hormonal 
"signals" between the hypothalamus and pituitary. Furthermore, the activity of the 
DA nerve terminals at the level of the median eminence may be regulated by pituitary 
factors, such as prolactin, transported back to the hypothalamus by retrograde blood 
flow. 
A reciprocal relationship exists between the portal blood DA concentration and the 
plasma prolactin levels during the rat oestrous cycle (de Greef et al 1984), but there 
are certain instances where the correlation is not maintained. For example, both the 
peripheral levels of prolactin and the concentration of DA in the portal circulation is 
higher in female rats that in males and there is no detectable DA in the portal blood of 
conscious sheep as shown by Thomas et al (1989) suggesting that a direct relationship 
between portal DA and plasma prolactin is an oversimplification. There are a number 
of reasons why the direct correlation fails. DA released from the median eminence 
regulates the release of a number of pituitary hormones, not only prolactin and thus, 
the level of DA in the portal blood is not influencing plasma prolactin levels alone but 
the concentration of other plasma hormones as well. Furthermore, as previously 
mentioned, there are a whole range of PIFs and PRFs, which act in concert to regulate 
prolactin release, and hence portal blood DA levels alone do not determine plasma 
prolactin levels. Moreover, the number of lactotrophs which actually express 
prolactin at any given time will also play a key role in determining the levels of the 
circulating hormone. 
Certain reports state that only between 15-20% of the DA synthesised and transported 
to the median eminence is actually released into the portal blood (Reymond & Porter 
1982). This suggests that the TIDA and THDA tracts are not exclusively involved in 
the regulation of prolactin secretion and that DA at the level of the median eminence 
is likely to regulate the release of a number of other hypothalamic and pituitary 
hormones. 
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1.8.2. Gonadotrophin - Hormone - Releasing Hormone. 
The hypothalamic decapeptide, gonadotrophin-hormone-releasing-hormone, (GnRH), is the 
major hypothalamic regulator of gonadotrophin secretion from the anterior pituitary gland. 
Much is known concerning the regulation of the surge in plasma LH levels which is a 
prerequisite to ovulation, but the neural factors which regulate GnRH release at the level of 
the hypothalamus are complex and not fully understood. 
At present DA is generally believed to inhibit GnRH release and the TIDA neuronal system 
has been implicated. Histochemical evidence reveals that GnRH and DA nerve terminal 
networks in the external layer of the median eminence extensively overlap and possibly form 
synaptic connections (Simerly et al 1987). Furthermore, the DA agonist, apomorphine, 
reduces plasma LH levels in addition to abolishing the oscillatory release of LH observed in 
normal cycling rats and selective 6-OHDA lesioning of dopaminergic neurones potentiates 
LH release (Sarkar et al 1981). Thus, DA released from the TIDA nerve terminals appears to 
exert an inhibitory influence on GnRH especially at the level of the median eminence, 
preventing its release into the portal circulation and its subsequent stimulatory effect on 
gonadotrophin secretion. The fall in DA turnover in the medial pre-optic area observed 
around the time of the preovulatory LH surge suggests the removal of the inhibitory tone on 
GnRH allowing its secretion. 
DA has also been reported to stimulate GnRH secretion (James et al 1987) as a positive 
correlation exists between LH levels and hypothalamic DA turnover in the mPOA of rats 
following steroid priming. This observation implies an involvement of the neurotransmitter 
in the positive feedback of sex steroids on LH secretion. The stimulatory influence of DA on 
GnRH release is believed to be exerted by the ICHDA neuronal systems as the activity of 
dopaminergic neurones at the level of the ZI fluctuates throughout the course of the oestrous 
cycle in rats (MacKenzie et al 1988) with turnover rising over the second day of dioestrous 
and the morning of proestrous, being optimal on the evening of that day. This rise coincides 
with the preovulatory LH surge and there is a strong correlation between the rise in DA levels 
and the rise in plasma oestradiol levels noted at that time in the cycle. Furthermore, ablation 
of the ICHDA with the neurotoxin 6 - OHDA induces constant dioestrous in normal cycling 
rats (MacKenzie et al 1988). It has, however, been reported that differential effects of DA on 
GnRH release may be demonstrated by modulating the activity of different DA receptor 
subtypes (Sarkar & Fink, 1981) and this may account for the apparent contradictory role 
ascribed to the neurotransmitter as found in the literature. 
It is also likely that other neurotransmitter/neuropeptide systems are involved in 
controlling GnRH release such as GAB A (see below). Furthermore, the role of the 
peripheral sex steroids in the regulation of gonadotrophin release is almost certainly directed 
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albeit not exclusively, at hypothalamic level and several neurotransmitter systems 
within the hypothalamus are steroid responsive adding yet another factor to the 
complex regulatory pathway for GnRH secretion. 
1.83. Growth Hormone. 
A number of reports have linked DA with the regulation of growth hormone (GH) 
release (MacLeod et al 1970, Meister et al 1985). If given i.p. DA, which is unable to 
cross the blood brain barrier, has no effect on circulating levels of GH, however if 
given i.e.v., levels of GH in the plasma are elevated. Furthermore, DA agonists, such 
as apomorphine, which does have central actions, increase circulating levels of GH by 
either i.p. or i.c.v. routes. Hence the action of DA in regulating GH release is 
considered to be mediated via a central mechanism. 
1.8.4. Somatostatin. 
Somatostatin (SRIH) is found in several regions of the hypothalamus as well as 
elsewhere in the CNS and the periphery. It serves both as a neurotransmitter and 
neuromodulator and apart from its well established role as an inhibitor of GH release 
(Brownstein et al 1975) it also inhibits the release of thyrotropin and prolactin 
(Enjalbert et al 1982) secretion from the anterior pituitary gland. A significant 
fraction of SRIH nerve terminals within the hypothalamus project to the median 
eminence and secrete the neuropeptide into the portal circulation and it is this 
population of SRIH secreting cells which is believed to be influenced by DA. 
DA has been ascribed both an inhibitory (Bennet et al 1979) and stimulatory (Negro-
Vilar 1978) role in the regulation of SRIH. DA administration was found to stimulate 
SRIH secretion and cause an increase in the concentration of SRIH in the hypophysial 
portal blood (Chiara et al 1979) which accords with its reported stimulatory effects on 
GH secretion. However, DA exerts a stimulatory role on both GHRH and SRIH 
secretion in a perfusion system of isolated hypothalamic slices (Kitajima et al 1989). 
The effect on SRIH exerted by this amine may be restricted to a distinct population of 
SRIH containing neurones within the hypothalamus but it could also act at SRIH 
nerve terminals rather than cell bodies, as DA stimulates the release of the 
neuropeptide from ME, but not from mediobasal hypothalamic fragments (Negro -
Vilar et al 1979; Maeda et al 1980; Lengyel et al 1985). 
As with prolactin, DA is considered to regulate SRIH release via a D2 receptor 
mediated process. The D2 agonists, bromocriptine and LY 171555, increase 
hypophysial levels of SRIH, an effect which is reversed by D2 antagonists and a 
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report suggests that D2 agonists increase levels of pre-pro mRNA for SRIH (Zorrilla 
et al 1990). 
/ .85. Other Neuropeptides. 
DA has also been implicated in the regulation of other neuropeptides including 
vasopressin and oxytocin (Lightman et al 1982, Moos & Richard 1982) and 
corticotrophin-releasing hormone (Fehm et al 1980), although to date, much of the 
evidence proposed is contradictory and the exact nature of the amines' involvement of 
their regulation is yet to be clearly defined. 
1.8.6. Interactions with Hypothalamic GAB A - ergic Systems. 
GABA is the major inhibitory neurotransmitter of the CNS and, like DA, is found in 
high concentrations within the hypothalamus, the highest levels being observed in the 
preoptic, anterior and dorsomedial nuclei (Tappaz et al 1986). 
Within the hypothalamus, GABA and DA neurones interact both anatomically and 
functionally. Immunocytochemical studies (Oertel et al 1982) show that neurones 
which are immunoreactive for GAD and TH lie in close proximity within the region 
of the 71. GABA-ergic terminals within this area impinge on dopaminergic neurones 
and also on other GABA-ergic neurones in addition to neurones considered to contain 
neuropeptides (Leranth et al 1985). Other studies using electron microscopy and ICC 
to visualize GAD and TH (Horvath et al 1993), provide ultrastructural evidence that 
GAD-immunoreactive terminals form synaptic connections with TH-immunoreactive 
neurones in the Arc and evidence exists for the co-localization of the two 
neurotransmitters within this nucleus, from which both the tuberoinfundibular 
dopaminergic and GABA-ergic systems are known to arise. Furthermore, electron 
microscopic studies indicate the presence of axoaxonic and dendrodendritic synapses 
in the Arc, the PeV zone and within the ME between GABA and DA neurones. 
Measurements of GABA levels, DA turnover rates and the effects of administered 
G A B A A agonists such as muscimol, suggest that G A B A may exert an inhibitory 
influence on DA release and especially the activity of TIDA neurones. In addition, 
GABA is considered to influence dopaminergic activity in a number of other brain 
regions, including the vertebrate retina (Wulle & Wagner 1990) and the substantia 
nigra (Smith & Bolam 1990; Lacey et al 1988). 
Evidence also exists for a functional interaction between these two systems in terms 
of their regulatory influence on neuropeptide release. For instance, ICC studies 
indicate synaptic connections between GABA, GnRH and DA containing neurones 
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both in the preoptic area and the Arc/ME complex (Van den Pol 1986; Sakaeu et al 
1988). A technique combining anterograde tracing coupled with acute 
neurodegeneration of DA neurones with 6 -hydroxy-dopamine, demonstrate that DA 
containing cells originating in the ZI terminate on both GnRH and GABA 
immunoreactive neurones. All three neurochemicals are considered to act in concert 
to control the episodic release and the pre-ovulatory surge of LH (Fuchs et al, 1984) 
in a complex manner which is not fully defined. DA and GABA exert opposing 
effects on GnRH release performing contrasting roles at the same hypothalamic site. 
GABA inhibits GnRH at the levels of the MPOA (Demling et al 1985), while DA, in 
contrast, stimulates GnRH secretion in this area (MacKenzie et al 1988). However, in 
other regions of the hypothalamus, including the Arc/ME complex, GABA stimulates 
GnRH release while DA exerts an inhibitory influence (McCann et al 1986; Jarry et al 
1990). Thus, the two neurotransmitters act either in concert or in opposition to 
directiy or indirectly regulate GnRH secretion and regulate circulating levels of LH. 
As both neurotransmitter systems are influenced by the activity of gonadal steroids, it 
is likely that they are also involved in the steroid feedback processes occurring at the 
level of the hypothalamus, as discussed below. 
1.8.7. Interaction with Gonadal Steroids. 
Considerable evidence suggests that gonadal steroids influence the release of 
hypothalamic regulatory peptides. For instance, the regulation of SRIH and GnRH is 
influenced by the prevailing levels of gonadal steroids which differ between the sexes 
and during the oestrous cycle. However, oestrogen receptors are not found either in 
GnRH neurones (Shivers et al 1983) or on the SRIH containing neurones within the 
PeVN (Herbison et al 1993) and this suggests the existence of an additional, steroid 
responsive, intermediary neuronal pathway. Hypothalamic dopaminergic neurones 
have been reported to be directly oestrogen responsive (see below) and DA is thus a 
likely candidate for these steroid actions. 
The activity of the TIDA systems is regulated by circulating levels of oestrogens as 
well as by prolactin. Oestrogen has been reported to have both stimulatory (Gunnet et 
al 1986) and inhibitory (Arita et al 1989, 1990; Tong & Pelletier 1991; Pasqualini et 
al 1993) effects on the activity of the TIDA neuronal systems as assessed by changes 
in the rate of DA turnover. Furthermore, autoradiographical studies linked with ICC 
have shown that this population of DA containing neurones accumulate [^H] 
oestradiol (Sar, 1984). Nevertheless, recent research suggests that oestrogen's role in 
modulating the activity of TIDA neurones may be mediated via a pituitary factor. 
Hypophysectomy significantly attenuates the stimulatory effect of E2 on 
dopaminergic activity (Eikenburg et al 1987) and in vivo and in vitro studies have 
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implicated prolactin as a likely mediator of these actions of E2 (Labrie et al 1980; 
Lookingland & Moore 1984a, Gunnet et al 1986). Alternatively, an as yet 
uncharacterized cytotropic factor isolated from the pituitary gland has been shown to 
increase tyrosine hydroxylase expression in cultured brain cells, (Gonzalez et al 1989; 
Porter et al 1990) and may also possibly mediate the modulatory effect of oestrogen 
on TDDA activity. 
A number of reports have also documented a modulatory effect on ICHDA turnover 
by oestrogens both in vivo (Gunnet et al 1986) and in vitro (Sanghera et al 1991) and 
the DA containing neurones within this tract also accumulate [^H] oestradiol (Sar 
1984). In addition, the rostral and caudal portions of the ICHDA tract have been 
demonstrated to be differentially but directly modulated by oestrogens (Gunnet et al 
1986; Lookingland and Moore 1984b), although to date, the consequence of this on 
neuroendocrine function is poorly understood. 
In the studies to be reported in this thesis we have aimed to investigate both the 
morphological and functional development of the intrahypothalamic dopaminergic 
systems, employing a primary cell culture model. Previous studies within this 
laboratory have shown that this experimental preparation is useful for the 
investigation of hypothalamic neuropeptide systems both in terms of their 
development (Davidson & Gillies 1993) and their function (Gillies & Davidson 
1992). The culture model is advantageous in that it allows the observation of changes 
in dopaminergic activity occuring at the perinatal period, a time at which many of the 
homeostatic and behavioural patterns expressed in the adult are established. 
Furthermore, accurately controlling the environment to which the cultures are 
exposed, may allow us to elucidate the role played by a range of physiological factors 
on the behaviour of these dopaminergic neuronal populations. As DA neurones are 
so prevalent in the hypothalamus and have been ascribed a number of regulatory roles 
in the control of hypothalamo - hypophyseal hormone secretion, we believe that an 
investigation into the ontogeny of these pathways, the identity of substances which 
modulate their function and the relationship existing between DA and other 
hypothalamic factors, will enhance our understanding of the importance of this 
neurotransmitter to both the developing and the adult neuroendocrine system. 
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CHAPTER TWO: METHODOLOGY 
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2.1. Initiation of Primary Hypothalamic Cell Cultures. 
In the present study we have employed a primary cell culture model to investigate the 
morphological and functional ontogeny of the dopaminergic neurones intrinsic to the 
hypothalamus, as well as their interactions with other hypothalamic neurotransmitter 
and neuropeptide systems and gonadal steroids. 
2.1.1. Dissection. 
Female Wistar rats, which were timed 18 days pregnant, were anaesthetised under 
diethyl ether and the uterus was removed, aseptically, by Caesarean section, into a 10 
ml sterile petri dish containing saline, supplemented with penicillin (lOOlL^ml) and 
streptomycin (O.lmg/ml). The foetuses were excised using sterile dissection scissors 
and forceps which were heat sterilized prior to use. The pups were decapitated and 
the heads placed on filter paper soaked in saline. Curved forceps were used to hold 
the foetal head in position while an incision was made from the base of the skull to 
the tip of the snout with iridectomy scissors, exposing the dorsal surface of the brain. 
Curved forceps were placed under the frontal lobe and the brain was inverted to 
expose its ventral side. The hypothalamus of the foetal brain is a prominent structure, 
2-3mm across, and using the curved forceps, the hypothalamus was removed as a 
"pinch" and transferred to collection buffer (Table 3.0). The foetal hypothalamic 
tissue gathered from a number of pregnant rats (usually 10) was pooled for each set of 
investigations. 
Table. 3.0. Collection Buffer. The following constituents were added to lOOmIs of 
Hanks Balanced Salt Solution (Ca^+/Mg^+ free). 
CONSTITUENT CONCENTRATION 
PENICILLIN lOOIU/ml 
STREPTOMYCIN O.lmg/ml 
BOVINE SERUM ALBUMIN 0.4% w/y 
HEPES 4.8mg/ml 
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2.1.2. Cell Dispersal. 
The cells were dissociated using a combination of mechanical agitation and 
enzymatic disruption of the hypothalamic tissue as described by Clarke et al (1987). 
Essentially, hypothalamic tissue was pooled (approximately 100 hypothalami per 
experiment) and suspended in collection buffer in a 30ml universal container. Gentle 
trituration was performed using a fire - polished, siliconized pasteur pipette with an 
internal diameter of approximately 1.5mm. The tips of the pasteur pipettes were 
"flamed" using a bunsen burner to produce pipettes with varying bore sizes. As the 
dissociation procedure proceeded, pipettes with progressively smaller internal 
diameters (< 0.5mm), were used to aid the dispersal process. After the first trituration 
the tissue fragments were collected by centrifugation (using a bench top centrifuge) at 
900 r.p.m. for 3 mdn. The supernatant was discarded, and the pellet re-suspended in 
the enzyme solution (Table 4.0) before transferal to the dispersal pot (Fig 2.1) which 
was placed in a water bath at 370C. The dispersal paddle was attached to an electric 
motor and gently rotated for 30 min to aid cell dispersal. After the initial incubation 
the large tissue fragments were allowed to settle and the cell suspension was decanted 
to a universal container. The larger fragments were re-suspended in 2-3mls of 
enzyme solution and gently triturated using a pasteur pipette with a smaller bore size 
(< 1.0mm internal diameter). 
A further 18mls of enzyme solution was then added to the dispersal pot which was 
returned to the water bath for a further 15 min incubation. After a final trituration 
virtually no tissue fragments remained and the cell suspensions derived from both the 
15 and 30 min incubations were centrifuged at 1000 r.p.m. for 10 min. The 
supernatant of each was discarded and the pellets were re-suspended and pooled in 2 
mis DNA -ase solution (Table 5.0) using minimal trituration. After the addition of a 
further ISmls of DNA- ase solution, the cell suspension was allowed to stand for 15 
min at 37°C. Following a further pelleting the cells were re-suspended in a small 
volume of collection buffer, triturated a final time and layered onto 20 mis of debris 
removal buffer (Table 6.0). Centrifugation was again performed at 1000 r.p.m. for 10 
min and the resulting pellet was re-suspended in defined medium (Table 7.0). After 
checking the cell yield, the final volume was adjusted to give a plating density which 
was consistent for all batches of cultures (see below). 
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Fig. 2.1. Apparatus for the dispersal of hypothalamic cells. 
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2.1.3. Plating and Maintenance. 
This method of culture preparation consistently produced a yield of 0.7 - 0.8 x 10^ 
cells per hypothalamus with a viability in excess of 90% (Clarke et al 1987). The 
final cell suspension was, if necessary, adjusted to the equivalent of 3 hypothalami 
per ml of defined medium and in all instances the cells were plated at an equal 
density. Depending on the nature of the experiment (see later) 1ml of cell suspension 
was plated in each 35mm well or ISO i^l per 15mm well to achieve equal plating 
density, i.e 2.5 x 10^ cells per mm^. Cultures were maintained in a humidified 
incubator at 37°C in an atmosphere of 5% CO2. The incubation medium was first 
changed on day five (unless an experiment was performed on day 3) and thereafter on 
alternate days throughout the experimental period with the day of initiation of the 
cultures being designated as day 0. Under these conditions the cells remained viable 
for several weeks (Clarke & Gillies 1988). 
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Table. 4.0. Enzyme solution. The following constituents were added to lOOmls of 
Hanks Balanced Salt Solution (Ca^+/Mg2+ free). 
CONSTITUENT 
PENICILLIN 
STREPTOMYCIN 
BOVINE SERUM ALBUMIN 
HEPES 
CONCENTRATION 
lOOIO/raL 
O.lmg/ml 
0.4% w/y 
4.8mg/ml 
Dispase, (0.2mg/ml) and Deoxyribonuclease I (DNA-ase I, 0.5mg/ml) was added to 40inls of the 
above solution and filter sterilized to give the final enzyme solution used for cell dispersal. 
Table. 5.0. DNA -ase Solution. The following constituents were added to lOOmls of 
Hanks Balanced Salt Solution 
CONSTITUENT CONCENTRATION 
PENICILLIN 
STREPTOMYCIN 
BOVINE SERUM ALBUMIN 
HEPES 
lOOIiyml 
O.lmg/ml 
0.4 % w/y 
4.8mg/ml 
Deoxyribonuclease - 1 (0.5mg/ml) was added to 20mls of the above and filter sterilized to give the 
final DNA -ase solution used for cell dispersal. 
Table. 6.0. Debris Removal Buffer. The following constituents were added to 
20mls of Collection Buffer. 
CONSTITUENT 
BOVINE SERUM ALBUMIN 
CONCENTRATION 
0.8 % w/y 
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Table 7.0. Constituents of the defined medium (DM). The following constituents 
were added to a 1:1 mixture ( final volume, lOOmls) of Dulbeccos Modified Eagles 
Medium (DMEM) and Ham's F12. 
CONSTITUENTS FINAL CONCENTRATION 
PENICILLIN lOOIU/ml 
STREPTOMYCIN lOOng/ml 
HUMAN TRANSFERRIN l(X)|lg/ml 
FUNGIZONE 0.5n.g/ml 
INSULIN 5|j,g/ml 
PUTRESCINE O.lmM 
SODIUM SELENITE 30nM 
17B - OESTRADIOL * l.OpM 
PROGESTERONE * 20nM 
TRIIODOTHYRONINE * l.OnM 
Sterile aliquots of the supplements were stored at -lOPC. The medium was pre-warmed to 37°C prior 
to use. * Stock solutions of these constituents were dissolved and stored in ethanol. 
2.1.4. Preparation of Tissue Culture Plastics. 
Poly - L - Lysine (10|ig/ml in sterile water) was added to the tissue culture wells (15 
or 35mm in diameter, as stated), for 30 min. After rinsing three times with sterile 
distilled water, the wells were incubated in a medium containing 10% foetal calf 
serum (PCS Table 8.0) for at least one hour and then removed before seeding of the 
cells. These procedures improved the attachment of the cells to the plates and 
provided a suitable matrix on which the cells could establish themselves and grow. 
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Table. 8.0 Coating medium. The following constituents were added to 50mls of 
Dulbecco's Modified Eagles Medium. 
CONSTITUENT CONCENTRATION 
PENICILLIN lOOIU/ml 
STREPTOMYCIN O.lmg/ml 
FUNGIZONE O-Sp-g/ml 
FOETAL CALF SERUM 5mls 
HORSE SERUM 5mls 
2.15. Preparation of Glass Coverslips. 
For the immunocytochemical studies the cells were grown on 15mm coverslips 
placed in multiwells so that they might be easily manipulated through subsequent 
procedures. The coverslips were first washed in a mild antibacterial detergent and 
rinsed thoroughly. Following this, they were rinsed in high grade methanol and 
placed individually on fluff - free gauze sheets to dry. Sterilisation of the coverslips 
was performed by placing them (typically in groups of 30), in glass bottles, sealed 
with aluminium foil and placed in an hot oven at 180°C for three hours. Prior to use, 
the coverslips were soaked overnight in a sterile solution of poly -L- lysine 
(100|ig/ml) then rinsed extensively in the sterile atmosphere of the microbiological 
safety cabinet, in sterile water. The coverslips were propped vertically against the 
side of the multiwells and allowed to dry and then laid flat on the bottom of the weU 
and left in the coating medium for 1 hour prior to cell seeding. 
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2.2. Immunocytochemical Studies. 
Immunocytochemistry (ICC) was employed in the present study to visualize specific 
neuronal systems within the hypothalamic preparation. Both dopaminergic and 
GABA-ergic systems were visualized using ICC according to the following 
procedures. 
2.2.1. ICC for Tyrosine Hydroxylase. Fluorescence Method. 
Indirect fluorescent immunocytochemical studies were performed on hypothalamic 
cells grown on glass coverslips as outlined above (Section 2.1.5) and all stages prior 
to mounting the cells were carried out in the multiwells. Cells were initially washed 
three times with a 400^1 volume of Earles' Balanced Salt Solution (for constituents 
see Table 9.0), prior to a 30 min fixation period in a modified Zamboni fixative (a 4% 
w/v paraformaldehye, 1% (v/v) picric acid solution in phosphate buffered saline, pH 
7.6). The cells were incubated overnight, at 4^C, with an anti-tyrosine hydroxylase 
(aTH) mouse monoclonal antibody (ascites fluid). The specificity of the antibody 
was confirmed by immunoprecipitation of the phosphorylated enzyme (Semenenko et 
al 1986). The antibody has been reported to react with TH immunoreactive sites in 
the known catecholaminergic neuronal systems of the rat brain, visualized using 
fluorescence and PAP/DAB immunocytochemistry (Semenenko et al 1986; 
MacMillan et al 1986; Melander et al 1986). Following three sequential washes in 
phosphate bufferered saline (PBS) containing 2% Triton - X - 100 (PBS + TX, pH 
7.6), to remove excess primary antibody, the cells were incubated in a 10% solution 
of normal goat serum (NGqS), made up in PBS, for 30 min, which provided a 
blocking stage reducing non-specific signal. The antigen was then visualized by 
exposing the cells (for 90 min) to a Lissamine - rhodamine - conjugated second 
antibody directed against mouse IgG and diluted in PBS containing 2 % N G q S . 
Thereafter the processed coverslips were mounted on ethanol washed glass 
microscope slides in a commercially available mountant (Citifluor) and the tyrosine 
hydroxylase immunopositive (THIP) neurones were viewed by fluorescent 
microscopy. Controls involved the omission of the primary antibody. Optimisation 
of the conditions are discussed in 3.1.1.1. 
2.2.2 ICC form. PAP IDAB Method. 
In addition to the fluorescence visualization system, the peroxidase - antiperoxidase 
(PAP) technique was also used in the present study with certain modifications of the 
procedure as follows. 
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The cells were washed, fixed and rinsed as outlined in section 2.2.1. Following 
rinsing the cells underwent 10 min washes in 100% ethanol, 50% ethanol and 100% 
ethanol again, in order to remove endogenous peroxidase which would otherwise 
interfere with the visualization system. The cells were then processed as outlined 
above in terms of the treatment with the primary antibody and blocking stage. 
However, following the blocking stage the cells were exposed to an unlabelled second 
antibody (raised in a goat against mouse IgG) for an incubation period of 90 min. 
After three washes in PBS the cells were incubated with a third antibody layer, the 
PAP complex, for a further 90 min (Fig 2.2). All excess antibody was removed by 
three sequential washes in Tris HCl, (0.78G of Tris hydrochloride in 100 mis of 
distilled water, pH 7.4), for 10 min. Visualization was achieved by incubating the 
cells in 200|il of a solution consisting of 5mg of diaminobenzidine (DAB free base), 
and 3.3|il of 20% hydrogen peroxide (H2O2) in a 10ml volume of Tris HCl. 
Development of the colour reaction was observed under light microscope and as the 
brown stain began to appear (typically between 7 and 10 min), the reaction was 
terminated by rinsing the cells in fresh Tris HCl. It was necessary to dehydrate the 
cells by passing them through an ethanol gradient from 70% to 100% before dipping 
the cover slips in xylene and mounting them on ethanol washed glass microscope 
slides in a commercially available mountant (Ralmount). THIP neurones were 
visualized by light microscopy. 
2.2.3. ICCforGABA. 
For GAB A ICC cells were processed as detailed in Section 1. The fixative consisted 
of the modified Zamboni fixative supplemented with 1% glutaraldehyde. The anti -
GABA polyclonal antibody was generated to recognise GABA conjugated to a 
glutaraldehyde moiety (Somogyi et al 1985) and tested negative for cross reactivity 
with L-glutamate, L-aspartate, D-aspartate, glycine, taurine, L-glutamine, L-Lysine, 
L-threonine, L-alanine, a-aminobutyrate, putrescine, 5-aminolevulinate, and positive 
for cross reactivity with y-amino-p-hydroxybutyrate, p-alanine,5-aminovaterate, e-
aminocaproate. The primary antiserum was used at a dilution of 1:3000 and the cells 
were incubated overnight at 4oC. Normal goat serum (10%), was again used as the 
blocking stage. The second antibody was a fluoroscein (FITC), conjugated antibody 
raised against rabbit IgG, to which the cells were exposed for 90 min at a dilution of 
1:100. Mounting was performed as described above (section 2.2.1.) and controls 
included the replacement of the primary antibody with normal rabbit serum. 
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2.2.4. DualImmunocytochemical Studies. 
In order to investigate the possible interactions between the dopaminergic and 
GABA-ergic systems within the cultures, double staining experiments were 
performed. Cells were processed initially for TH immunocytochemistry followed 
immediately by visualization of GABA - immunoreactivity. As different fluorescent 
labels were employed i.e. rhodamine (red) for DA and fluoroscein (green) for GABA, 
it was possible to distinguish the immunofluorescence by observing the mounted cells 
through filters providing different wavelengths (400 - 490nm for FTTC; 550 - 650 for 
rhodamine). 
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Fig. 2.2 Principle of ICC Reactions. 
a). Indirect (Fluorescent) Method of ICC 
Fluorescent tag (e.g. rhodamine) 
20 antibody, directed against the IgG of the 
species in which the 1° antibody is raised. 
1° antibody, directed against the antigen to be 
visualized. 
The antigen e.g. an enzyme, protein, 
neurotransmitter, locatW in me tissue 
preparation e.g. brain slice, cell 
culture. 
b). Third Layer Antigen Method of ICC (peroxidase antiperoxidase). 
PAP complex, consisting of an antiperoxidase 
antibody raised in the same species as the 1° 
antibody, conjugated to peroxidase 
in the ratio: 2 antibody molecules to 3 
peroxidase molecules. 
2° unlabelled antibody, directed against the 
IgG of the species in which the 1 antibody 
is raised. 
1° antibody, directed against the antigen to be 
visualized. 
The antigen e.g. an enzyme, protein, 
neurotransmitter, locat&i in the tissue 
preparation e.g. brain slice, cell culture. 
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2.3. Studies with Radiolabelled DA and GAB A. 
Cells grown in 15mm diameter, 4 x 4 multiwell plates were used to investigate the 
uptake and release of [3H]DA and [^HJGABA into the hypothalamic cells in primary 
culture and the levels of tritium labelled neurotransmitters accumulated and released 
were measured using liquid scintillation spectrophotometry. 
2.3.1. The Principle of Liquid Scintillation Spectrophotometry for detection of 
[3H]DA and [3H]GABA. 
Liquid scintillation spectrophotometry relies on the conversion of kinetic energy into 
light energy. When a molecule of tritium [^H] decays a 6 - particle is emitted from its 
nucleus, which collides with the aromatic solvent molecules within the scintillation 
fluid (e.g. toluene, benzene or xylene). The kinetic energy produced by the collision 
is not readily detectable and is rapidly dissipated. However, the scintillation fluid 
also contains solutes known as scintillators, the molecules of which become excited 
and when their orbital electrons return to their ground state, energy emission occurs as 
a photon of light. 
There is, to a first approximation, a linear conversion of energy generated to photon 
light emitted and hence the intensity of the light produced by scintillation is directly 
proportional to the initial energy of the 6 - particle. The generated photons of light 
are detected by the photomultiplier tube (PMT), and a small electrical current is 
produced, with an amplitude directly proportional to the number of electrons detected 
by the cathode. The electrical pulse is in turn analysed by means of integrated 
electronic circuits and recorded as discrete counts or as a count rate. Absolute values 
of radioactivity are attained by the construction of an internal quench curve, which 
corrects for the efficiency of the analyser (in this instance 40%) and converts the 
subsequent counts per minute (c.p.m.), to disintegrations per minute (d.p.m.). 
2.3.1.1. Calibration. 
In order to investigate the linear relationship between the concentration of the 
radiolabel in the sample and the resulting electrical impulses generated following 
scintillation, a standard curve was constructed. To produce this a range of 
concentrations of radiolabel (i.e. [^H]DA) from 5 to 150|i,Ci/ml) were added to lOmls 
of the scintillation cocktail and counted (each standard was counted in triplicate). 
When a graph was plotted depicting concentration of radiolabel v's d.p.m. (Fig 2.3), a 
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linear relationship was observed which was conserved over the range being 
investigated hence proving that d.p.m. was a reliable indicator of radioactivity. 
2.3.1.2. Counting Ejficiency. 
A portion of radioactivity decayed in a liquid scintillation solution is always lost in 
the system. This is due to interferences with the production or transmission of light 
emitted by the scintillators and different sample preparations will affect the efficiency 
of the counting procedure, i.e. causing quench. The degree of quenching in the 
system was thus determined by repeating the procedure above by preparing [^HJDA 
standards (over the same concentration range) containing the tissue solubilizer, Triton 
- X- 100 and/or solubilized cells, in amounts comparable to those used in the 
investigation procedure. Standard curves were again plotted and the degree of quench 
produced by the presence of the solubilizer and cells was represented by a change in 
the gradient of the standard curves (Fig 2.4). The percentage difference in the 
gradients of the curves achieved by counting in the absence versus the presence of the 
solubilized cells reflects the degree of quench in the sampling system and was 
accounted for in subsequent data analysis. 
2.3.2. pHJDA Uptake Studies. 
The method of the uptake studies followed a method similar to that reported 
elsewhere (Prochiantz et al 1979). The culture medium was discarded and the cells 
were rinsed three times with a 200|il volume of pre-warmed Earles' Balanced Salt 
Solution (BBSS - Table 9). Following this, the cells were pre-incubated for 15 min in 
200^1 of supplemented BBSS (sBBSS, Table 10.0) containing the monoamine 
oxidase inhibitor, pargyline, (lO'^M). The cells were exposed to pH]DA at a 
concentration of 2|iCi per well, (3.3 x 10"^M) initially diluted in sBBSS plus 
pargyline as detailed above. The specific activity for the radiolabelled DA altered 
from batch to batch and ranged from 43 - 60Ci/mmol. 
The cells were exposed to [3H]DA for 1 hour at 37°C (or a time and temperature 
specified by the experimental design). Uptake of [3H]DA was terminated by rinsing 
the cells in ice-cold sBBSS prior to a further three washes to remove excess and non-
specific, extracellularly bound label. Cells were solubilized in a 50% solution of 
Triton - X - 100 and the "cell suspension" collected into scintillation vials containing 
5ml of NB 260, a scintillation cocktail. The accumulated radiolabelled 
neurotransmitter was estimated by liquid scintillation spectrophotometry. In those 
investigations employing pharmacological agents, such as uptake inhibitors or 
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receptor antagonists, the drugs were added to the [3H]DA prior to incubation to 
produce the desired final concentration. 
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Fig. 2.3. Illustration of the linear relationship between the concentration of the radiolabelled 
neurotransmitter [^HJDA and d.p.m.. The linear relationship was conserved over a range of 
concentrations of pH]DA from 5 to 150(j.Ci/ml. (S.A. = 60Ci/mmol). 
2.3.2.1. Kinetic Analysis. 
Kinetic analysis of [^H]DA uptake was performed by loading the cells with one of a 
range of concentrations of [^HJDA from 0.3nM to 30.0|iM. The cultures were then 
treated as outlined in section 2.3.2. In order to determine the Michaelis - Menten 
constant (Km) and the maximum velocity for uptake (Vmax) a double reciprocal plot 
was constructed of V(in pmoles/min/well of cells) and the concentration of [3h]DA 
(in |iM). The rate of uptake was expressed as "per well of cells" rather than as "per 
mg of protein", as protein estimation studies (performed using the method of 
Bradford 1976) revealed increases in protein content within the cultures between DIV 
3 and 7 followed by a decline in content on DIV 14 (0.175 ± 0.015 on DIV3, 0.215 ± 
0.003 on DIV 7 and 0.05 ± 0.005 on DIV 14). The rise in protein content is widely 
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considered to be the result of glial proliferation within the cultures, whereas the 
decline is considered to be due to both neuronal and non - neuronal cell death. Thus 
relating the data derived from kinetic analysis to protein content may give misleading 
Km and Vmax values, especially when attempting to relate these values to increasing 
culture age. This argument is in agreement with issues which have been discussed 
elsewhere (Ahnert - Hilger et al 1986) and other workers have expressed affinities 
and rates of [^H]DA uptake in terms of amount per well of cells (Valchar & Hanbauer 
1993). We therefore adopted this method for our analysis. Each concentration was 
measured in quadruplet and the reciprocal of each concentration was plotted against 
the reciprocal of the corresponding value for the rate of uptake expressed as [imoles 
of DA/min/well of cells. Each point was plotted to give a line of best fit using a 
computerized least square method and linear regression analysis. The value of Km 
was determined from the intercept in the x - axis (i.e when y = 0), whereas the value 
for Vmax was measured by the intercept on the y - axis (when x = 0). A schematic 
representation of the plot is illustrated in Fig.2.5. 
2000000 1 
1500000 
E 
4 1000000 
73 
500000 -
50 100 
Concentration [3H] DA(p,Ci/ml) 
Fig. 2.4. Effect of the tissue solubilizer Triton - X - 100 and solubilized cells on the counting 
efficiency of the system. The phenomenon of quench was not observed either when standards were 
prepared and counted in the presence of by Triton - X -100 ( - # - ) , in the presence of the solubilized 
cells (—•—) or in their absence (—•—). There was no significant difference in the gradients of the 
standard curves constructed under the three conditions and hence the characteristics of the sample did 
not alter the efficiency of the counting system. (SA = 60Ci/mmol) 
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Fig. 2.5. A diagramatic representation of the double linear regression plot used to 
determine the Km and Vmax values for [^HJDA and [^HJGABA uptake into 
hypothalamic cells in primary cell culture. 
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2.3.3. [%]DA Release Studies. 
For release studies, the cells were loaded with [^HJDA in the manner outlined in 
Section 2.3.2 above. However, instead of terminating the uptake by rinsing the cells 
in ice-cold buffer, the cultures were washed sequentially (3 x 200|il), in sEBSS, pre-
warmed to 37°C, to remove excess label and attain a steady state (Fig. 2.6). The cells 
were then subjected to 7 min incubation in sEBSS under basal conditions or in the 
presence of 200|il BBSS containing 56mM potassium (56mM K+, Table 9.0). The 
sEBSS was removed to scintillation vials containing 5ml of scintillation cocktail and 
the amount of radiolabelled DA releasedwas estimated using liquid scintillation 
spectrometry. Additional investigations were performed to verify the Ca^+ -
dependency of the observed release by repeating the experiments omitting Ca^+ from 
the incubation medium. 
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Fig. 2.6. The attainment of steady state levels of [^H]DA release by rinsing of the hypothalamic cells. 
After loading the cells as described in Section 2.3.2 the excess label was removed ( ^ 0 ) and the cells 
were rinsed with sEBSS either at 37°C ( H ) or at 4°C ( I I) and all washes were counted by liquid 
scintillation spectrophotometry. After the third wash the release of [^H]DA became stable depicting 
that all excess label had been removed and that a steady state of basal release had been attained. When 
the cells were rinsed at 4°C, release followed a similar pattern but at a significantly (* p < 0.02, ** p < 
0.005) lower level. This was considered to represent non-specific release. 
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Table. 9.0. The constituents of Earles' Balanced Salt Solution (EBSS). The 
following constituents were added to lOOmIs of distilled water and filter sterilized. 
BASAL RELEASE EBSS STIMULATED RELEASE EBSS 
CONSTITUENTS WEIGHT 
(mg) 
FINAL CONC 
(mM) 
WEIGHT 
(mg) 
FINAL CONC 
(mM) 
NaCl 680 120 370 65 
KCl 4L7 5.6 417 56 
CaCl2 36 2.0 36 2.0 
MgS04 20 0.8 20 0.8 
Na2H2P04.7H20 15.8 1.0 15.8 1.0 
NaHCOs 220 26 220 26 
D - GLUCOSE 100 5.4 100 5.4 
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Table. 10.0. Supplements to the Earles's Balanced Salt Solution. (sEBSS). The 
following constituents were added to lOOmls of BBSS. 
CONSTITUENTS CONCENTRATION 
PENICILLIN 100 lU/ml 
STREPTOMYCIN 100)J,g/ml 
BACITRACIN 30ng/ml 
ASCORBIC ACID 30p.g/ml 
HEPES lOmM 
APROTININ 80KIU/ml 
Studies with [^HJGABA. 
Uptake and release studies were performed to investigate these properties in the 
GAB A-ergic systems within the cultures using a method which was similar to that for 
[3H]DA. 
2.3.1. PHIGABA Uptake Studies. 
In uptake studies the GABA - transaminase (GABA-T) inhibitor, amino-oxyacetic 
acid (AOAA), at a concentration of 1 x lO'^M, was included in the sEBSS throughout 
the experimental procedure. AOAA prevents intraneuronal degradation of GABA 
(Drejer et al , 1987) by inhibiting pyridoxal phosphate (Kruk & Pycock 1991), which 
acts as a co-factor for GABA-T. The cultures were rinsed and pre-incubated as 
outlined in the [^H]DA studies before being exposed to [^H]GABA at a concentration 
of 0.1|iCi (2.5 X 10"^ M; specific activity 91 Ci/mmol), for 10 min. The remainder of 
the procedure was identical to that outlined in Section 2.3.2. 
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2.3.4.1. Kinetic Analysis. 
Kinetic analysis of [3H]GABA uptake was performed by loading the cells with one of 
a range of concentrations of [^HJGABA from 0.54nM to 0.54|iM. The cultures were 
then treated as outlined in section 2.3.1. Values for and Vmax were calculated as 
outlined in Section 2.3.2.1. 
2.3.5. pHJGABA Release Studies. 
The release studies for [^HJGABA followed the protocol described for [^HJDA as 
described in Section 2.3.3. 
2.4. Investigations with Gonadal Steroids. 
2.4.1. 17fi' oestradiol. 
Investigations were performed to determine the effect of the gonadal steroid 17 6 -
oestradiol (E2) on dopaminergic neurone function. Batches of cells, prepared as 
outlined in Section 1 were divided into groups and maintained in defined medium 
(Table 7.0), containing one of a range of concentrations of E2 from 10 to lO'^M, 
from the time of plating i.e. DIV 0. All other components of the defined medium 
remained unchanged. On specified days uptake and release studies for [3H]DA and 
[3H]GABA were performed as described above (Section 2.3). 
2.4.2. Progesterone. 
Experiments were performed to determine the effect of the gonadal steroid, 
progesterone (Prog), on the uptake and release mechanisms displayed by the 
dopaminergic neurones within the culture model. Cultures were divided into groups 
and maintained in DM containing one of a range of concentrations of Prog from 10"12 
to lO'^M, from DIV 0. All other components of the DM, including E2, remained 
unchanged. Uptake and release studies for [^HJDA were performed as detailed in 
Section 2.3. 
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2.5. Studies with Endogenous DA. 
The release and content of endogenous DA in the hypothalamic cultures was 
measured using high performance liquid chromatography coupled to electrochemical 
detection. 
2.5.1. Principle of High Performance Liquid Chromatography with 
Electrochemical Detection. 
The technique of High Performance Liquid Chromatography (HPLC) is based upon 
the separation of a mixture of compounds (analytes) in solution on the basis of their 
hydrophobic or lipophilic properties. This method was first introduced by Refshauge 
et al (1974) and, although initially of limited use due to the high cost of the 
equipment, it is now the method of choice for the analysis of catecholamines, other 
related amines and a host of other related and non-related compounds in a range of 
biological fluids including plasma, CSF and urine. Refinements of the technique rely 
partly on the development of more efficient hardware, such as pumps, autosamplers 
and detectors, and partly due to the development of more refined columns and 
packing materials which allow efficient through-put of samples while retaining high 
specificity and sensitivity. The principles which aided in the improvement of HPLC-
ECD may be found in a review by Kilpatrick (1986). 
Widely speaking there are two methods by which separation may be achieved, either 
using ion-exchange chromatography or reverse phase chromatography. The former 
is employed for the measurement of ionised material and the stationary phase i.e. the 
column has a more polar nature than the mobile phase. In the latter case the situation 
is reversed in that the solid phase of the system is less polar than the mobile phase. In 
fact under normal conditions of reverse phase chromatography the material which 
forms the column usually consists of a non-polar compound such as Cig silica or 
ODS. Such material provides a lipophilic phase which serves to attract analytes 
within the solution which are of a non-polar nature and, combined with other factors 
such as adsorption, will influence the degree to which the constituents within a 
solution are separated. Rapid mass transfer of substances in solution between the 
stationary phase and the mobile phase is provided by the structural characteristics of 
the packing material. ODS columns available commercially consist of very small 
diameter, spherical particles (usually between 3 and 5|im diameter) which by nature 
of their size and spacial arrangement provide a large surface area over which the 
mobile phase will flow. This mass transfer determines the degree of resolution 
achieved i.e. the smaller the particles of the packing material, the greater the 
resolution between the analytes. 
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It follows that analytes with very differing pKa values (i.e. that at which 50% of the 
compound is in an ionized form), will be separated with a greater degree of 
resolution. However, other factors such as the width of the peaks (as shown on the 
resulting chromatogram) and the capacity factor (retention time) of the analyte on the 
column also play a major role in determining the separation power of the 
chromatography system. 
The separation of catecholamines cannot be based solely on the degree of ionization 
as all catecholamines are ionized at a range of pHs from 1 - 7 . Instead, separation is 
dependent on differences in the lipophilicity of the amines. DA is the most lipophilic 
(or hydrophobic) catecholamine due to a lack of an hydroxyl (OH) moiety on its 
catechol ring. The next most hydrophobic catecholamine is Adr due to the presence 
of an alkyl group in its structure and the least hydrophobic amine is NA. It is for this 
reason that the retention time for NA is often very low and this amine elutes rapidly 
from the column and is lost in the solvent front making its detection and 
quantification very difficult and unreliable. Ion pair reagents such as the aryl and 
alkyl sulphonates and sulphates (e.g. octyl sulphonate) are often added to the mobile 
phase and attach themselves to the column. They attract the ionized analytes which 
then become more firmly held by the stationary phase thus increasing the retention 
time. Conversely, the addition of organic modifiers such as methanol or acetonitrile -
shorten the length of time that analytes are retained on the column by competing with 
the column for the non-polar moieties of the analytes, the result of which is that they 
are attracted away from the column and are thus more rapidly eluted. 
Kissinger (1977) was the first to introduce the method of electrochemical detection, a 
technique by which the oxidation of a compound leads to the generation of electrons 
and hence a small but detectable current. This current may then be amplified to a 
level which may be recorded. The current generated by oxidation is considered to be 
directly proportional to the number of molecules which have passed over the 
electrode and thus the method allows quantitative as well as qualitative analysis to be 
carried out. The relationship between the analyte concentration and the generated 
potential is affected by such external factors as the temperature, pH and ionic strength 
of the mobile phase and these parameters must be kept constant if quantitative 
determinations are to remain reliable. 
Detection of the generated current is produced by a carbon working electrode which 
supplies the current for the oxidation of the electro-active analytes as well as 
measuring the extent of the oxidative process. The potential is applied via an 
auxilliary electrode made of platinum or steel. This potential causes oxidation of the 
70 
analytes and is kept at a steady, workable level by a reference electrode which is 
usually composed of Silver/Silver Chloride (Ag/AgCl) The measured potential is 
then transferred to an external recorder where it is displayed by pen deflection as a 
peak. The concentration of the analyte in the original sample may thus be expressed 
either as peak height, area or width. 
2.5.2 The HPLC - System. 
A description of the HPLC -BCD hardware used in the investigation may be found in 
Table 11.0 and Fig. 2.7. 
2.5.2.1. The Mobile Phase. 
The mobile phase into which the analytes were dissolved and delivered to the system 
was prepared from HPLC grade reagents and only acid washed glassware was used in 
the preparation procedure. It was important to eliminate any risk of contamination to 
the mobile phase as this would have been severely detrimental to both the 
chromatography and detection apparatus. Hence all water used in preparation of the 
mobile phase and rinsing of glassware was at least double glass distilled, de-ionized 
and underwent purification by reverse osmosis prior to filtration in a Milli - Q water 
purification system. 
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Table. 11.0. The HPLC - EC hardware. 
COMPONENT SPECIFICATION COMMENTS MAINTENANCE 
Solvent delivery system PM-48 pump, operated 
at 0.8ml/min 
Gives reproducible flow 
rate, minimal noise due 
to incorporated pulse 
dampner. 
Frequent cleaning of 
pump head and 
replacement of piston 
seal to increase pump 
life and prevent leakage 
of mobile phase. 
Sample loop injector Rheodyne 7125 
50|j1 capacity. 
Ensures delivery of 
constant volume of 
sample to the system 
with good 
reproducibility. 
Replacement of rotor 
sed every 6 - 1 2 
months, removal of all 
abrasive particles from 
the sample to prevent 
scratching of the rotor 
seal surface. 
The Guard Column MF - 6026, pellicular 
particles of CDS -
53 nm diameter. 
Protects analaytical 
column by removing 
insoluble contaminants 
from samples and/or 
mobile phase. 
Replacement after every 
200-500 samples, 
dependent on their prior 
preparation. 
Analytical Column MF - 6213 Phase II, 
CDS 3p. diameter 
spherical particles, 
15cm X 46mm external 
diameter. 
Allows separation of 
analytes with good 
resolution and 
reproducibility. 
Cartridge seal 
replacement prevents 
leakage from the 
column, peak splitting is 
often due to a void in the 
column requiring 
repacking or replacing. 
The Detector LCB - 4 amperometric 
detector, set at a 
potential of 0.7mV in 
relation to the reference 
electrode (see below). 
a. Working Electrode MF -1000, glassy 
carbon. 
Composed of chemically 
resistant, highly 
conductive material, 
provides the surface for 
electrolysis. 
Loss of efficiency due to 
build-up of oxidised 
material on the surface. 
Frequent cleaning with 
alumina polish removes 
deposits and increases 
the sensitivity of the 
cell. 
b. Reference Electrode Model TL 5A, Ag/AgCl Provides a stable, 
reproducible voltage to 
which the working 
potential may be 
referenced. 
Stored in 3M KCl, in 
light proof container, 
when not in use, to 
increase life expectancy. 
c. Teflon Cell Gasket MF-1046 Determines the dead 
space volume within the 
thin-layer cell and thus 
determines the speed 
with which the sample 
passes through it. 
Chart Recorder HP 3396 A Illustrates the generated 
current as a peak which 
is directly proportional 
to the amount of analyte 
detected at the electrode. 
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Fig. 2.7. SCHEMATIC DIAGRAM OF THE HPLC-ECD SYSTEM 
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Table 12.0. Mobile phase was prepared 1 litre at a time by dissolving the following 
amounts of each reagent in 900mls of H2O. 
REAGENT WEIGHT (G) 
CITRIC ACID 21.01 
SODIUM HYDROXIDE 0.25 
ETHYLENEDIAMINE-TETRA - 0.37 
ACETIC ACID (EDTA) 
OCTYL SULPHONATE 0.216 
The pH of the buffer was then measured and, if necessary, adjusted to 2.55. The 
organic modifier was then added (40mls of acetonitrile) and the mobile phase was 
made up to volume. 
It was vital to remove all air and any possible insoluble contaminants from the mobile 
phase by de-gassing and filtration using the apparatus illustrated in Fig 2.8. A glass 
scinter covered with a 0.2|j,m filter was attached to a vacuum flask connected to a gas 
jar which prevented "suck -back" of the water from the vacuum system and hence 
contamination of the mobile phase. The mobile phase was then transferred to a glass 
bottle wrapped in aluminium foil (as the mobile phase is light sensitive) and kept at 
ambient temperature surrounded by foam chips for insulation against temperature 
fluctuations. An inlet tube was placed in the mobile phase which was connected to 
the solvent delivery system and thus pumped the mobile phase into the apparatus. 
When not measuring samples, the solvent was recycled over short periods of time. 
The mobile phase was typically replenished every week, but was occasionally 
changed more frequently depending on the nature of the investigation being carried 
out. 
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Fig 2.8. Apparatus for the De-gassing of the Mobile Phase. 
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2.52.2 Sample Injection. 
The sample/standard (at least 100|il) was injected (using a flat needled Hamilton 
syringe), via the needle port, into the loop while the injector valve was in the "load" 
position. In this position the mobile phase which flows through the system 
continuously, was redirected to bypass the injector loop. Once the loop was filled, the 
injector valve was turned to the "inject" position thus bringing the loop into series 
with the column, resulting in the sample being flushed onto the column as the mobile 
phase passed through the sample loop. This ensured that the volume of sample 
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introduced to the system was constant for each injection and thus improved the 
reproducibility of the resulting chromatograms. 
2.5.2.3. Calibration!Standardization. 
In the present investigation the internal standard used was dihydroxybenzylamine 
(DHBA). This was chosen as it behaves like the catecholamines, eluting within the 
same time frame but not at the same time as other amines. It is however, resistant to 
enzymatic breakdown and is therefore stable. A known concentration of the internal 
standard, which would produce a peak of a pre-calculated height, was added to each 
sample (or standard), prior to extraction, and served as an indicator of amine 
recovery. From this it was possible to estimate absolute recovery and correct the 
values of the other amines accordingly. 
In order to calibrate the system and to determine the limit of detection, standards of 
the catecholamines, NA, Adr, DA, DOPAC and the internal standard DHBA, were 
made up in O.IM PCA. A stock solution of each amine (Img/ml) was made in the 
first instance, which was subsequently diluted in O.IM PCA to give a top standard of 
5ng/ml, (equivalent to 250pg per 50^1 injected onto the column). Serial dilutions 
were made to the top standard and the lowest standard used was 0.3ng/ml (equivalent 
to 15.625pg per 50}il injected onto the column). Each catecholamine was first 
injected individually, starting with the lowest concentration to construct a standard 
curve and also to determine the retention time for the amine. Each standard was 
measured in triplicate. Finally, all five amines were made up together in a single 
solution (from here on referred to as an amine mix) and injected in order to determine 
whether each individual retention time was conserved or whether they interacted. 
Standard curves were thus plotted of amount of amine versus peak height for each 
analyte and these were linear over a range from 10 - 250pg. Figs 2.9, 2.10 and 2.11 
illustrate standard curves for DA, DHBA and DOPAC respectively. The limit of 
detection for the HPLC system was defined by a signahnoise ratio of greater than 3:1. 
For DA, DOPAC and DHBA, the limit of detection was 0.2ng/ml (lOpg), O.lng/ml 
(5pg) and 0.3ng/ml (15pg), respectively. 
2.5.2.4. The Chromatogram. 
Examples of typical chromatograms for the amine mix are shown in Fig 2.12. The 
top chromatogram (A), illustrates the blank i.e. injection 50fil of O.IM PCA alone 
onto the column, thus the vehicle for the amines was not in itself significantly electro-
active. Chromatogram B depicts injection of the lowest concentration of the amine 
mix (0.3ng/ml) and chromatograms C and D illustrate the amine mix concentrations 
of 2.5 and 5.0ng/ml respectively. NA, Adr, DHBA, DOPAC and DA had retention 
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times of 1.95, 2.5, 3.0, 3.9 and 4.66, respectively. The integrator recognized the 
peaks by their respective retention times allowing for 0.5 time units on either side of 
the "standard" time. The detector current was set at InA. 
Fig 2.13. shows examples of chromatograms for samples collected from the 
hypothalamic cultures. Chromatograms A and B illustrate the injection of release 
medium from basal and stimulated incubations respectively (see below). 
Chromatogram C (with the detector current set at 0.5nA) illustrates the injection of a 
purified homogenate of hypothalamic cells in order to determine amine content. Such 
samples contained a number of uncharacterized substances which could not be 
removed by the extraction procedure. 
On occasions the amines, when injected as an amine mix, co - eluted or eluted with 
retention times which were very close resulting in partially merged peaks. This 
naturally hampered quantitative analysis and the mobile phase was subsequently 
modified by use of either an ion pair reagent such as octyl sulphonate, or an organic 
modifier such as acetonitrile, to increase or decrease the retention times and this was 
sufficient to alter the retention time and thus separate individual analytes. In some 
instances the peaks were only just merging and at such times, merely altering the flow 
rate slightly was sufficient to separate two peaks and allow their individual detection. 
For quantitative analysis the chromatograms were recorded by an on - line integrator 
(HP 3396 A, Hewlett Packard) and the height of the peak was taken as a measure of 
the quantity of analyte oxidised at the working electrode. This served as a 
quantitative indicator of the amount of the analyte present in the injected standard (or 
sample) as the amount of current generated is directly proportional to the pen 
deflection. 
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The peaks obtained on injection of the sample were identified by comparing the 
retention times with those of the standard amine mix. 
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Fig. 2.9. Linear relationship between the amount of DA and the peak height as measured from the 
chromatogram. Linearity was conserved over a range of DA levels from 15 - 250pg injected onto the 
column. Each amount was measured in triplicate and a calibration curve was constructed prior to 
measurement of each batch of samples and also after maintenance of the HPLC hardware. 
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Fig. 2 .10. Linear releationship between the amount of the internal standard, DHBA and peak height 
as measured from the chromatogram. 
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Fig. 2.11. Linear relationship between the amount of DOPAC and the corresponding peak height as 
measured from the chromatogram. 
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Fig. 2.12. Chromatographic analysis of the amine mix. 
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Fig. 2.13. Chromatographic analysis of different sample types. 
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2.5.3. Release Studies. 
Cells maintained in 35mm diameter culture dishes were used to investigate the release 
of endogenous DA. On the day of experimentation, the cells were washed (2 x 1ml) 
in sEBSS containing pargyline at a concentration of lO'^M and underwent a 15 min 
preincubation period. They were then incubated in sEBSS (0.5ml) containing basal 
(5.6mM) or elevated (56mM) levels of K+ for periods of 1 hour (or times and 
conditions specified by the experimental design). The samples were then collected 
onto lOpl of 5.0 M perchloric acid (PCA), to give a final concentration of O.IM PCA 
and stored at -80°C until the time of amine determination using reverse phase, high 
performance liquid chromatography with electrochemical detection (HPLC-ECD). 
To investigate the effect of E2 on endogenous DA, release cells were grown from the 
time of plating, in a defined medium containing one of a range of concentrations of 
E2 from 10"14 to lO'^M. They were subjected to release studies as outlined above and 
the DA output under different steroidal environments was again measured by HPLC -
ECD. 
2.5.4. Sample Preparation for HPLC-ECD. 
2.5.4.1. Adjustment of pH. On the day of assay, 0.5ml samples were thawed on ice 
and spiked with 3,4, dihydroxybenzylamine (DHBA, Sigma) at a concentration of 
2.5ng/ml, which acted as an internal standard (see Section 2.5.2.3). The samples were 
originally stored in O.IM PCA which lowered the pH to approximately 2.5. However 
it is reported that alumina absorbs amines more efficiendy when the sample is 
adjusted to an alkaline pH (Bouloux et al 1985). The pH of the samples was 
therefore raised to approximately 8.4 by adding 0.5ml of 0.5M Tris - EDTA (pH 8.6) 
buffer prior to extraction, (sample pH was typically in the range 8.40 - 8.42, mean ± 
s.e.m. = 8.41 ± 0.004, n=5). 
2.5.4.2. Extraction. DA was removed from the samples using commercially 
produced alumina cartridges, in conjunction with a vacuum system (Speed-mate 30) 
which allowed accurate regulation of the rate at which the samples passed through the 
alumina. Prior to extraction the cartridges were "primed" by rinsing through 0.5ml 
aliquots of the following solutions: 
i. 3 X 50% methanol. 
ii. 2 X 50% acetonitrile 
iii. 3 X HPLC grade H2O 
iv. 3 x Tris- EDTA buffer (pH 8.5). 
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This procedure significantly enhanced the recovery of the amines. Samples were 
loaded onto the primed cartridges in 1ml volumes and passed through the alumina at a 
rate of 1ml per min which was determined to be the optimal speed (Table 13.0). The 
cartridges were then washed with 2 x 0.5ml aliquots of HPLC grade H2O before 
elution of the amines in 200)il of 0.1 M PCA. Recovery was typically in the region of 
60% although there was batch-to-batch variation in the efficiency of the alumina 
cartridges. The percentage recovery was established for each batch prior to use and 
the variation in recovery was subsequently accounted for in the calculation of the 
results. As an example, for one batch of cartridges employed, the mean percentage 
recovery ± s.e.m. was 66.4% ± 6.0, n=6. 
2.5.4.3. Optimization of the Extraction Procedure for DA. The procedure for the 
extraction of the DA and the other catecholamines was optimized by modification of 
both samples and cartridges as described above. Other modifications included 
altering the rate at which the sample was passed through the cartridge and changing 
the volume of O.IM PCA used to elute the amines. Details of the optimization of the 
extraction procedure may be found in Table 13.0. Row 1 outlines the initial 
conditions and row 11 gives the optimal conditions which were subsequently used in 
the present study. 
2.5.5. Content Studies. 
In certain experiments the amount of DA held in intracellular storage sites within the 
hypothalamic cultures was also measured. The cells were scraped from the base of 
the culture dish in 0.5mls of O.IMPCA and homogenized using mild sonication. The 
resulting "cell solution" was stored at -SO^C until the time of assay. Sample 
preparation and measurement followed the procedures as detailed in Sections 2.5.2 
and 2.5.4. 
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Table. 13.0. Optimization of the Procedure for DA extraction. 
00 
Modification Approx. pH 
of sample 
Volume of 
H2O used 
to wash 
cartridges 
(ml) 
Volume of 
MeOH used 
to wash 
cartridges 
(ml) 
Volume of 
acetonitrile 
used to wash 
cartridges 
(ml) 
Volume of 
Tris/EDTA 
buffer used to 
wash 
cartridges 
(ml) 
Flow rate for 
sample 
through 
cartridge 
(ml/min) 
Volume of 
O.IMPCA 
used to elute 
the amines # 
Improvement 
of % recovery 
+ = slight 
++ = moderate 
+++ = good 
1 2.5 1.0 5.0 1x200 Recovery 
<15% 
2 8.4 1.0 5.0 I x 200 +++ 
3 8.4 1.5 5.0 I x 200 ++ 
4 8.4 1.5 0.5 5.0 I x 200 + 
5 8.4 1.5 1.5 5.0 I x 200 ++ 
6 8.4 1.5 1.5 0.5 5.0 I x 200 ++ 
7 8.4 1.5 1.5 1.0 5.0 I x 200 ++ 
8 8.4 1.5 1.5 1.0 1.5 5.0 I x 200 + 
9 8.4 1.5 1.5 1.0 1.5 1.0 I x 200 +++ 
10 8.4 1.5 1.5 1.0 1.5 1.0 2 x 100 ++ 
11 8.4 1.5 1.5 1.0 1.5 1.0 4 x 5 0 +++ 
2.6. Statistical Analysis. 
The data obtained are presented as the mean ± s.e.m. (n=4). Significant differences 
compared with each control group were determined by use of Student's t - and Mann 
Whitney - U- tests. 
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CHAPTER THREE: RESULTS 
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3.1. Immunocytochemistry. 
3.1.1. Tyrosine Hydroxylase ICC. 
Using immunocytochemistry (ICC), it was possible to identify the presence of 
tyrosine hydroxylase immunopositive (TfflP) neurones within the cell cultures. 
3.1.1.1. Optimization. The technique of ICC involves a number of stages, each of 
which must be individually optimized in order to achieve specific and successful 
staining. It was important to arrive at optimal concentrations for both the primary and 
secondary antibodies and this was achieved by titration of the two antibodies, while 
keeping all other components of the procedure i.e. fixative, fixation time, incubation 
periods etc constant (Table 14.0). This allowed us to arrive at a satisfactory stain 
intensity whilst minimising non-specific binding of the antibodies to sites within the 
cultures. Low dilutions of the primary AB resulted in positive staining although 
background staining was significant and generally obscured the clarity of the 
neurones as shown in Plate. l.O.c, as did low dilutions of the secondary antibody 
(Plate l.O.b). When optimal concentrations of the two antibodies were employed 
background staining was minimal and did not significantly interfere with THIP 
neurone detection (Plate l.O.a). Results of the optimization study are described in 
Table 14.0 and the primary and secondary antibodies were used subsequently at 
dilutions of 1:10 and 1: 100 respectively. When the DAB/PAP visualization method 
was used the PAP complex (tertiary layer) was employed at a dilution of 1:1(K). 
Background staining was further reduced by an incubation stage after the primary 
antibody stage with NGoS, used at a dilution of 1:10. The serum saturated any sites 
to which the secondary antibody might bind non-specifically as it was raised in a goat 
and directed against mouse IgG. Higher concentrations had no further beneficial 
effect in reducing background staining, although the background signal was lower if 
the incubation period was 30 min as opposed to 10 min. 
3.1.1.2. Peroxidase - antiperoxidase vs. Fluorescence ICC. 
Initially the peroxidase - antiperoxidase/diaminobenzidine (PAP/DAB) method was 
employed to visuaHze the THIP neurones. The reaction product, due to its crystalline 
appearance provided a good degree of resolution and the processes (axons and 
dendrites) of THIP cells were easily distinguishable, bifurcating and extending 
over large distances of the culture plates. (Plate 2.0. A - D). 
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Table. 14.0. Optimization of TH ICC. Titration of the primary and secondary 
antibodies. 
DILUTION 
PRIMARY SECONDARY 
ANTIBODY ANTIBODY 
COMMENTS 
1:5 1:50 High background, obscuring any positive staining 
which may be present. 
1:5 1:100 Good staining, obvious THIP neurones seen, but 
still high background 
1:5 1:200 Good staining, low levels of background signal 
1:10 1:50 
More prominent staining, obvious large bipolar 
and multipolar neurones seen, but still high 
background signal 
1:10 1:100 Good staining, backgound signal markedly 
reduced 
1.10 1:200 No obvious THIP neurones seen 
1:20 1:50 Excessive background with no THIP neurones 
observed 
1:20 1:100 Faint staining, fluorescent signal only just 
detectable above background 
1:20 1:200 No THIP neurones observed 
As the primary antibody was expensive and in limited supply it was subsequently used at the highest 
dilution, which gave acceptable visualization (1:10), and the second antibody which was more readily 
available was used at a higher concentration (1:100), to further enhance the fluorescent signal. 
However, although the PAP/DAB method was effective and allowed clear detection 
of the TH containing cells, its use was confined to single label studies and the 
technique employing the use of a fluorescent labelled second antibody was used to 
perform dual label studies allowing the detection of multiple antigens for co-
localization studies. 
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Nevertheless, regardless of the visualization technique employed, it was possible to 
visualize THIP neurones with distinctly different morphologies. 
3.1.1.3. Morphological Description. 
Immunocytochemical studies revealed the presence of three morphologically distinct 
populations of THIP neurones. These were best characterised by the shape of their 
cell bodies and the number of processes. A unipolar neuronal type with an oval 
shaped cell body (Plate 3.0.a), was visualised as early as DIV 3, which was the 
earliest day studied. This neuronal cell type was however seen only during the initial 
stages of in vitro development and was considered either to mature into bipolar and/or 
multipolar neurones (see below) or to die as the culture aged. 
The second type of neuronal morphology was characterised by an oval cell body and 
two processes extending from either pole of the cell body and hence were considered 
to be bipolar neurones. This cell type was prevalent during the early stages of 
development i.e. DIV3 (Plate. 3.0.b) to DIV7 (Plate 3.0.d) and increased in size (both 
in terms of perikarya size and neurite length) throughout the period of investigation, 
up to DIV 14 (Plate 3.0.f). It was frequently possible to observe a large opaque 
nucleus, surrounded by immunoreactive perikarya (Plate 3.0.d). 
The third THIP neuronal cell type had characteristic fusiform or pyramidal shaped 
cell bodies with at least three processes (Plate 3.0.C, e and g for DIV 3, 7 and 14 
respectively). As with the bipolar neurones, this sub-type increased in size as a 
function of culture age. By DIV 14 this sub-population of THIP neurones became the 
most prevalent of the three sub-types observed within this experimental model. 
Whether this depicts an increase in the number of multipolar cells which could 
possibly develop from the other morphological types, or the poor survival of the uni-
and bipolar neuronal types is yet to be established. Varicosities were present on all 
three THIP neuronal populations and were more prominent during the initial stages of 
the investigation. 
3.1.2. GABA ICC. 
Immunocytochemical localization of GABA-ergic neurones within the hypothalamus 
was also performed using an antibody raised against the neurotransmitter itself. The 
majority of the GABA - immunopositive (GABA-IP) neurones had large, bipolar cell 
bodies with processes which underwent extensive bifurcation resulting in a complex 
dendritic/axonal network. Varicosities were clearly visible along the processes and 
growth cones were frequently observed at the nerve terminals. 
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3.2.3. Co-localization of TH and GAB A Immunoreactivity. 
Certain GABA-IP neurones were also found to contain TH immunoreactivity and the 
processes of this neuronal population could be traced over a greater distance when 
viewing the GABA fluorescence as compared with TH (Fig Plate 4.0. A - F). 
90 
Description of Plate. 1.0. Immunocytochemical visualization of tyrosine 
hydroxylase immunopostive (THIP) neurones in primary culture. The technique was 
optimized by titration of the primary and secondary antibodies as outlined in Section 
3.1.1.1. Optimal staining, with minimal non-specific signal, was achieved using the 
primary and secondary antibodies at dilutions of 1:10 and 1:100 respectively (A). 
Higher concentrations of the antibodies produced marked background signal which 
obscured the visualization of the THIP neurones as shown in Figs. C and B for the 
primary and secondary antibodies respectively. 
PLATE 1.0 
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PLATE 2.0 
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Description of Plate. 2.0. Peroxidase-antiperoxidase immunocytochemical 
visualization of THIP neurones in primary cultures of foetal rat hypothalamic cells. 
Bar = 10|im. 
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PLATE 3.0. 
> 
Description of Plate. 3.0. Immunocytochemical localization of THIP neurones in 
primary culture of foetal rat hypothalamic cells. Three distinct sub-types were seen 
on DIV 3, namely (a) a unipolar neurone seen only on the initial days in culture, (b) a 
bipolar type and (c) a multipolar type. The latter two sub-types persisted to later 
stages in culture. The bipolar type are shown for DIV 7 (d) and DIV 14 (f) and the 
multipolar type shown on DIV 7 (e) and DIV 14 (g). Bar = 20|im. 
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Description of Plate. 4.0. Co-localization of TH and GABA immunoreactivity in a 
single neurone. Figs A and D show two distinct neurones under light microscopy. 
Figs B and E show the same neurones displaying GABA immunoreactivity. Fig C 
shows the same neurone as shown in Figs A and B which was also stained for TH and 
fluorescence detected following this procedure was not markedly greater than the 
background signal and the neurones were thus considered to be TH immunonegative. 
Fig F shows the same neurone as shown in Figs D and E and when this neurone was 
co-stained for TH the neurone was found to be immunopositive. Bar = 10}im. 
PLATE 4.0. 
A 
% ? 
•* "• • • • . n ^ - V * - / , 
," ^***S ' V'-i mmm 
94 
3.1.4. Discussion. 
Using indirect ICC, it was possible to identify both TH and GABA immunopositive 
neurones within the hypothalamic cell culture preparation. Furthermore, neurones 
within each of these transmitter populations could be further subdivided on the basis 
of their morphology. 
Regardless of the visualization system employed, we were able to locate three 
morphologically distinct subtypes of THIP neurones, which are known to have 
correlates in vivo. The uni- and bi- polar neuronal types reported in this in vitro 
investigation are similar to those observed under in vivo conditions (Daikokn et al 
1986; Ugramov et al 1989a and b). A detailed study of the in vivo development of the 
dopaminergic systems of the hypothalamus, reported the presence of uni- and bi-
polar THIP cells, detectable as early as E13, situated in the vicinity of the arcuate 
nucleus. The processes of these cells projected to the presumptive median eminence 
at a later gestational age (Ugramov et al 1989a). The authors concluded that the uni-
and bi- polar neurones which they observed, constitute the TIDA neuronal system of 
the hypothalamus and on the basis of the morphological similarity, we propose that 
these subtvpes as identified in vitro mav belong to the same neuronal pathwav. 
In addition, the multipolar subtype is similar in morphology to a subset of THIP 
neurones reported by the same workers developing from as early as E15 in the area of 
the hypothalamus which would later form the zona incerta. It is thus reasonable to 
suggest that the multipolar THIP cells that we have identified belong to the rostral 
component of the ICHDA tract in vivo. 
A strong correlation with in vivo observations also exists in relation to the 
morphological maturation of the THIP neurones. We noted a distinct increase in 
perikarya size and neurite length of TH containing cells over the 11 day period of 
investigation. On DIV 3, all three subtypes identified were "immature" looking, in 
terms of cell body size, and the short, varicose nature of their processes. By DIV 7, a 
striking increase in perikarya size was observed, in addition to extensive elongation 
and bifurcation of the neurites, a trend which continued up to DIV 14. A similar 
pattern for morphological development of dopaminergic neurones has been reported 
for the hypothalamus (Daikoku et al 1986; Ugramov et al 1989a)as well as for other 
dopaminergic systems of the CNS (Specht et al 1981). Within the hypothalamus, the 
in vivo development of THIP neurones is associated with an increase in TH 
expression, perikarya size and neurite length. Cell body growth is reported to begin 
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as early as E13, with neurite formation and elongation occuring slightly later (E15 -
16, Daikoku et al 1986). 
For mesencephalic dopaminergic systems a similar pattern has been reported, 
although it is initiated at earlier gestational ages (E12.5 - 13.5) (Hemendinger 1980, 
Specht et al 1981). At this gestational age, TH - containing cells within the 
mesencephalon already possess at least one and frequently two processes, one of 
which may have undergone bifurcation. In contrast, by E12 hypothalamic 
dopaminergic neurones, if visible at all, possess very short weakly stained neurites 
and this suggests that the morphological development of hypothalamic dopaminergic 
systems "lag" behind that of mesencephalic dopaminergic pathways. We cannot, with 
our present findings, provide conclusive evidence for this, but in terms of functional 
development, evidence suggests that the diencephalic dopaminergic systems are 
retarded in relation to those of the mesencephalon (Engele et al 1989). A direct long-
term comparison of the morphological development of mesencephalic and 
diencephalic dopaminergic systems in vitro remains to be performed. 
ICC visualization of hypothalamic GABA- ergic systems highlighted a difference in 
the pattern of morphological maturation between these two neurotransmitter systems. 
GABA -IP neurones as visualized by fluoresence ICC appeared to develop rapidly 
and as early as DIV 3, GABA -IP cells were large with neurites which, although 
generally short, bifurcated extensively forming complex neuronal networks. We 
failed to see any obvious increase in cell size over the period of the investigation. It 
is interesting to speculate that, unlike the hypothalamic dopaminergic svstems. the 
hypothalamic GABA-ergic systems within this model undergo the maior part of their 
morphological development during earlier stages and that once re-established in 
culture conditions these cells initially grow at a much more rapid rate than their 
dopaminergic counterparts. This may constitute an important developmental 
difference between hypothalamic DA and GABA systems and it is possible that such 
a phenomenon may influence both the activity of these neurotransmitter systems and 
the role they play at later stages of postnatal development and in the regulation of 
neuroendocrine function. Furthermore, these observations suggest that certain aspects 
of pre-programmed developmental patterns are conserved under in vitro conditions. 
Neuro-neuronal interactions are widely believed to influence cell development. This 
concept, however, does not exclude the possible influence of glial cells on neuronal 
development and a number of studies have associated glial cells with the 
morphological maturation of DA containing cells. A recent investigation reported 
that the type of glial cells with which foetal dopaminergic neurones were co-cultured. 
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influenced the final morphology of the cells (Denis Donini et al 1984). If cells from 
the mesencephalon were cultured on glial cells derived from striatal tissue, the 
neurones exhibited a bipolar morphology projecting long, linear processes, with 
occasionally shorter processes around the cell body. In contrast, those cells grown on 
glial cells from a mesencephalic origin demonstrated a markedly different 
morphology with larger THIP neurones possessing numerous long and extensively 
bifurcating neurites. From these observations the authors suggested that the DA 
neurones, when allowed to grow on top of glial cell monolayers, exhibited a 
morphology dictated by the glial cell type underneath. A molecular basis for such an 
influence is suggested by the work of Lieth et al (1989) who proposed that different 
glial cell populations exhibit differential cell surface characteristics with respect to the 
composition of proteins and glycoproteins. Thus, the influence of cell -to- cell 
contacts is likely to operate in addition to the effect of soluble CSF borne factors. To 
our knowledge, an investigation of glial influences on the development of 
hypothalamic dopaminergic systems has not been performed but, as most of them 
project locally i.e. they innervate other regions within the hypothalamus, it is likely 
that if glial cells are associated with their development, they will be present within the 
culture preparation used and will be able to exert their regulatory effect. Also, as the 
hypothalamus contains a heterogeneous population of dopaminergic neurones, it is 
reasonable to suggests that different glia types may differentially regulate the 
development of each distinct dopamine containing neuronal population. 
The co-existence of DA and GABA in a single neurone has been reported in vivo for 
several brain regions including the hypothalamus. Wulle and Wagner (1990) reported 
localisation of GABA and tyrosine hydroxylase in a "simple" neurone model, i.e. the 
vertebrate retina. In addition, co-localisation of the two neurotransmitters has also 
been reported within cells occupying the region of the arcuate nucleus (Leranth et al 
1985). Our dual staining ICC studies highlighted the fact that TH and GABA were 
localized in the same cell although they were not co-localized in all the processes, i.e. 
some processes of the same cell were immunopositive for both TH and GABA while 
others were positive only for GABA (Plate. 4.0). This may reflect differential storage 
or release of the transmitters within the same neuronal pathway and may provide a 
means by which DA released from a cell which produces both DA and GABA, may 
feed back on the same cell either to augment or inhibit GABA release and vice-versa. 
Alternatively, it is interesting to speculate that during these early stages of 
development, differentiation is incomplete and that these double labelled neurones 
represent precursor cells which have not fully adopted a single, distinct phenotype. 
We cannot of course ignore the most obvious possibility that the sensitivity of the 
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ICC technique used to detect TH is not as great as that of GAB A and hence fails to 
highlight the enzyme located in the more distal segments of the processes. 
The functional significance of these findings is not clearly understood, but as DA and 
GABA are considered to be intimately associated with neuroendocrine regulation, 
their localisation within a single neurone/neuronal population may go some way to 
explaining the interrelationship shared by these two neurotransmitter subtypes. The 
present results emphasise the need for further investigation of certain aspects of 
neuronal interaction, including the extra - and intra- hypothalamic factors involved in 
the regulation of the morphological development of the neurotransmitter systems 
involved in neuroendocrine function. 
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3.2. Investigations with pH]DA. 
[3H]DA was used to investigate parameters of uptake and release in the dopaminergic 
neurones in our experimental preparation. Similar studies were performed with 
[^HJGABA to monitor the activity of the GABA-ergic systems intrinsic to the 
hypothalamus the results of which are detailed in Section 3.3. The results of these 
studies will be discussed together in section 3.3.3. 
32.1. Uptake Studies. 
Fig 3.1 demonstrates that the hypothalamic cultures accumulated [^ EQDA in a time 
and temperature dependent manner. Uptake increased with incubation time from 10 
to 60 min, after which time it began to plateau. The cells, when incubated at 4°C, 
failed to take up the radiolabelled neurotransmitter to any appreciable extent (less 
than 5% of uptake at 370C) and may represent non - specific accumulation. 
Subsequently, the value for uptake at 4°C was subtracted from the values for uptake 
at 37°C to give a measure of active uptake processes. As uptake was at a high yet 
submaximal level at 60 min, this incubation period was subsequently chosen for 
loading the DA neurones with radiolabelled neurotransmitter. 
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Fig. 3.1. Time course for the accumulation of pHJDA into foetal rat hypothalamic cells maintained 
in primary culture at 37°C ( • ) and 4°C d H. Cells were exposed to [^H]DA (2p,Ci/well of cells 
3.3 X lO'^M), for increasing periods of time before terminating the reaction and measuring the amount 
of label taken up as described in Section 2.3.2. 
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Uptake studies were performed at different time points in culture flTom DIV 3 to DIV 
14 (Fig 3.2). On early days in culture, viz. DIV 3, specific uptake was relatively low. 
A slight but significant increase in uptake occurred by DIV 5. Thereafter, uptake 
increased dramatically up to DIV 11 after which time it began to plateau. 
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Fig. 3.2. Ontogenesis of [^HJDA uptake into foetal rat hypothalamic cells in primary culture. Results 
represent the mean ± s.e.m., n=4. * p < 0.005, ** p < 0.002 compared with DIV3. 
Kinetic analysis of the uptake of [^HJDA revealed marked changes as the cultures 
matured (Table 15.0.). The value of Km decreased progressively on DIV 3 and 7 and 
14 (p< 0.005) and there was a conco mitant increase in the value of Vmax-
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Table 15.0. Apparent kinetic parameters for the uptake of [^ EQDA into hypothalamic 
cells in primary culture on different days in culture. 
DIV Km(|lM) Vmax (pmoles/min/well 
of cells) 
3 56.23+ 3.01 3.2 ± 0.075 
7 7.0 ± 1.3 4.27 ± 0.09 
14 3.98 ± 0.87 6.6 + 0.54 
The specificity of uptake i.e. whether the [^HJDA was being taken up into 
dopaminergic neurones, was investigated using two DA uptake inhibitors, 
benztropine and nomifensine (Fig. 3.3). Both drugs reduced uptake in a dose-
dependent fashion, with the highest concentration tested (10"^M), significantly 
attenuating uptake by 58.6% ± 6.7 and 69.5% ± 0.5, for nomifensine and benztropine, 
respectively. We were not able, however, to abolish uptake totally with the range of 
concentrations used in the present study. 
The activity of the uptake inhibitor nomifensine (lO'^M), increased with advancing 
culture age (Fig. 3.4). On DIV 3 and DIV 5, the inhibitor was relatively ineffective in 
blocking uptake but by DIV 7, nomifensine blocked uptake by 16.5 ± 1.1% and 
percentage inhibition rose to 44.5 ± 2.4 % by DIV 11. 
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Fig. 3.3. Dose-dependent relationships for nomifensine ( — • — ) and benztropine ( - * - ) in inhibiting 
uptake of [^H]DA into foetal rat hypothalamic cells in primary culture (DIV 10). Results represent the 
mean ± s.e.m. n=4. * p < 0.05, ** p< 0.002 compared with the control value. 
102 
50-1 
< 
1 
Q 
i 
o 
z. 
2 
S 
a 10 
% 
40 -
3 0 -
2 0 -
OJ 
** 
7 9 11 
DAYS IN CULTURE 
14 
Fig. 3.4. Ontogenetic pattern for inhibition of uptake of [^HJDA into cultured foetal rat hypothalamic 
cells. Uptake experiments were performed on different days in culture as detailed in Section 2.3.2, 
both in the absence or presence of the specific uptake inhibitor nomifensine at a concentration of 10" 
^M. Results represent the mean ± s.e.m., n=4. * p < 0.05, * * p < 0.02, compared with the percentage 
inhibition on D1V3. 
The ability of the natural ligand of the uptake process to block [^H]DA uptake was 
also investigated. Thus graded concentrations of unlabelled DA were added to the 
labelled DA (3.3 x lO'^M) during the 60 min loading period and produced a dose -
dependent inhibition of uptake, with the highest concentration of "cold" DA (IQ-^M) 
inhibiting uptake by 45% (p < 0.005, Fig. 3.5., solid bars). 
This observation was expected if the unlabelled DA was in competition with [^HJDA 
for the uptake sites, but the degree of inhibition was not as great as with the uptake 
inhibitors. A number of reports have suggested that the uptake of DA is regulated via 
a DA autoreceptor pathway whereby high levels of DA activate receptors (probably 
D2), in order to promote its own removal from the synaptic cleft (Demarest & Moore, 
1979a). To investigate this possibility, we studied the ability of a single concentration 
(10"9 M) of the D2 receptor antagonist, sulpiride, to influence uptake in the presence 
and absence of "cold" DA (Fig. 3.5). Whereas sulpiride alone and DA alone at a 
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concentration of 10"^M had no overall effect on uptake, in combination 
uptake was markedly reduced by approximately 60% (p < 0.001). This inhibition was 
reversed in a dose - dependent manner by increasing the concentration of the "cold" 
DA. These results suggest that DA promotes [^H]DA accumulation via a DA -
receptor mediated mechanism which is reversed by sulpiride. 
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Fig 3.5. Effect on the uptake of [^H]DA into foetal rat hypothalamic cells in primary culture by co -
incubation with "cold" DA alone ( B i ) , or "cold" DA in the presence of the D2 antagonist, sulpiride, 
at a concentration of 10"^ M, ( ^ ) . Results represent the mean ± sem. n = 4. t P < 0.05, f t < 0.005 
for [3h]DA uptake in the presence of "cold" DA compared with [^HJDA uptake in the absence of 
"cold DA". * p < 0.05, ** p , 0.001, for [^H]DA uptake in the presence of sulpiride compared with in its absence. 
Fig. 3.6 shows that increasing concentrations of "cold" DA may also reverse the 
inhibitory effects of nomifensine (IQ-^M) on [^H]DA accumulation, suggesting that 
DA itself regulates the uptake process and may overcome the effect of DA transporter 
blockade. 
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Fig. 3.6. Effect on the uptake of [^H]DA into foetal rat hypothalamic cells in primary culture by co-
incubation with "cold" DA alone ( H ) , or "cold" DA in the presence of the uptake inhibitor, 
nomifensine at a concentration of Results represent the mean ± sem. n = 4. t p < 0.05, 
t t < 0.005 for [3h]DA uptake in the presence of "cold" DA compared with [^HJDA uptake in the 
absence of "cold DA". * p < 0.05, ** p < 0.001, for [^HJOA uptake in the presence of nomifensine 
compared with uptake in its absence. 
3.2.2. Release Studies. 
The release of accumulated [^HjDA from the hypothalamic cell cultures was 
investigated under both basal and stimulated (56mM K+), conditions (Fig. 3.8) and 
both were significantly reduced by the exclusion of Ca^+ from the release medium, (* 
p < 0.01, ** p < 0.002, Fig. 3.7). Over a 7 min incubation period depolarization 
produced a threefold increase in the amount of [^HjDA released when compared with 
basal levels (** p < 0.002). On repeated stimulation [^HJDA release declined rapidly 
(p < 0.01). After a third stimulation, extraction of the cells indicated the presence of 
an appreciable intracellular pool of [^H]DA which was not releasable even by 
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depolarization. As levels of [^H]DA tended to decline after the initial stimulation, 
subsequent experiments used a single 56mM K+ stimulation only. 
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Fig. 3.7. The effect of exclusion of Ca^+ from the release medium on basal ( H ) and 56mM K+ -
stimulated ( r e l e a s e of [^HJDA from foetal rat hypothalamic cells maintained in primary culture. 
(DIV 9). Results represent the mean ± s.e.m., n=4. * p < 0.05, * * p < 0.002 for basal vs K+ induced 
release, t P < 0.05, t t p < 0.002, for basal and K"*" induced release in the presence vs absence of Ca 
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Fig. 3.8 The release profile for [^HjDA on day 7 in vitro. The hypothalamic cell cultures were 
preincubated with [^H]DA as outlined in 2.3.2 Once a steady state was attained three successive 7 min 
incubations were performed either under basal conditions ( H ) or in the presence of 56mM 
potassium f BSSST). The final column ( ^ 0 ) represents the non-releasable pool of [^HjDA as indicated 
by the [^HJDA content of the cells at the end of the release experiments. Results represent the mean ± 
s.e.m. n=4. *p < 0.01, ** p< 0.002 for basal v's 56mM K""" - induced release. 
When the release experiment was repeated, employing a 20 min incubation period, a 
different response was observed (Fig 3.9). Depolarization induced release was only 2 
fold greater than basal release and the decline incurred by repeated stimulation 
occurred more rapidly. Indeed on the second and third incubation, 56mM K+ -
stimulated release was significantly lower than basal release and similar results were 
found with 60 min incubation periods (data not shown). As these observations 
suggested that longer incubation periods results in rapid depletion of available 
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radiolabelled neurotransmitter stores, we adopted a 7 min incubation period for all 
subsequent release studies. 
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Fig. 3.9. The release of [^H]DA during a 20 min incubation period. * p < 0.05 for basal vs K"*" 
induced release, ** p < 0.01 for K+ induced release during the 1st incubation compared with that 
during the 2nd and 3rd incubation periods. 
Both basal and 56mM K+ - induced release of radiolabelled DA increased as a 
function of culture age. The greatest increase occurred between DIV 7 and DIV 9, 
(Fig. 3.10) with a further, less dramatic, increase at DIV 14. In the present 
investigation, release experiments were not performed on DIV 3 and DTV 5 as the 
uptake was low on these days and adequate label was not accumulated to make 
subsequent release experiments viable. 
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Fig 3.10. Basal ( • ) and 56mM K+ - stimulated ( R9SS!) release of [^HJDA from a single batch of 
hypothalamic cells in primary culture during a 7 min incubation period. Release experiments were 
performed on different days in culture. Results represent the mean ± s.e.m. n=4. *p < 0.005, basal vs 
56mM K+ - induced release, f p < 0.025, t t P < 0.01 [^HIDA release on DIV 7 vs DIV 9. 
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3.3. Investigations with pH]GABA. 
3.3.1. Uptake Studies. 
Uptake of [^HjGABA was time - dependent and began to plateau after only a 10 min 
exposure to the radiolabeled neurotransmitter (Fig. 3.11). There was an overall 
increase in the uptake of [^HJGABA over the investigational period, which followed a 
pattern distinctly different to that observed for [^HJDA (Fig. 3.12). On DIV 3 uptake 
was relatively high and a significant increase in uptake occurred between DIV 3 and 
DIV 7 in culture with levels of radiolabel increasing from approximately 7, 000 to 
14, 000 d.p.m./well of cells over a 4 day period. However between DIV 9 and DIV 
15 there was no significant change in the level of uptake while on DIV 18 a further, 
significant rise in the accumulation of the [%]GABA was observed. 
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Fig. 3.11. Time course for the accumulation of [^H]GABA by cultured hypothalamic cells at 37®C 
( I H ) and 4°C ("I I). Cells were exposed to [^H]GABA (0.1|iCi/well of cells - 2.5 x lO'^M), for 
increasing periods of time before terminating the reaction and measuring the amount of label taken up 
as described in 2.3.4. Results represent the mean ± s.e.m. n = 4. 
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Fig. 3.12. Ontogenesis of the uptake of [^H]GABA into foetal rat hypothalamic cells maintained in 
primary culture. Results represent the mean ± s.e.m. n = 4. * p < 0.05, ** p.< 0.01, compared with 
uptake on DIV 3. 
Analysis of the kinetics of [^H]GABA uptake revealed that there were significant 
changes in the values of both the Km and Vmax- The value for the Michaelis - Menten 
Constant decreased from 2.29 ± 0.4 to 1.0 ± 0.14 uM from DIV 3 to DIV 7 and 
remained constant between DIV 7 and DIV 14. Furthermore the value for Vmax 
increased from 6.622 ± 0.213 to 10.85 ± 2.9 nmoles/min/well of cells between DIV 3 
and DIV7 but there was no significant difference in the rate of uptake between DIV 7 
and DIV 14 (Table 16.0). 
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Table. 16.0. Apparent kinetic parameters for the uptake of [^H]GABA into 
hypothalamic cells in primary culture on different days in culture. 
DIV Km (HM) Vmax (nmoles/min/well 
of cells) 
3 2.3 ± 0.4 6.622 ± 0.213 
7 1.0 ±014 10.85+ 2.9 
14 0.9 ± 0.19 11.64+ 2.1 
T, 
The selective inhibitor of GABA uptake into neurones, SKF 89976 A inhibited uptake 
in a dose - dependent fashion with a 95% inhibition at lO'^M (Fig. 3.13), suggesting 
the presence of a specific uptake process. 
A single concentration of SKF 89976 A (lO'^M) was employed to investigate the 
ontogeny of the inhibition of the [^HJGABA mechanism. On early days in culture 
(DIV 3) inhibition of uptake was as great as 52 ± 3.9%, but percentage inhibition 
decreased on DIV 8 to 38.5 ± 1.9% and declined further on DIV 15 to 21± 3.6% 
(Fig. 3.14). 
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Fig. 3.13. Dose-dependent relationship for the specific inhibitor of GABA uptake into neuronal cells, 
SKF 89976 A in inhibiting uptake of [^HIGABA into foetal rat hypothalamic cells in culture, (DIV 3). 
Results represent the mean ± s.e.m. n = 4. * p < 0.05, ** p < 0.01, *** p < 0.001, compared with the 
control. 
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Fig. 3.14. Ontogenetic pattern for the inhibition of uptake of [^HIGABA into foetal rat hypothalamic 
cells in primary culture. Uptake experiments were performed on DIV 3, 8 and 15 as detailed in Section 
2.3.4., either in the absence or presence of the specific GABA uptake inhibitor, SKF 89976 A, at a 
concentration of lO'^M. Results represent the mean ± s.e.m. n=4. * p < 0.05, ** p.< 0.02 compared 
with the inhibition observed on DIV 3. 
Repeating the uptake experiments for [3H]GABA in the absence of extracellular Na+ 
revealed a transience in the Na+ dependency of the uptake mechanism. The uptake 
mechanism displayed only slight Na+ - dependency during initial stages of cultivation 
but the degree of dependence increased with extending periods in vitro as shown by 
the changes in the percentage uptake in the absence of Na+ (Fig 3.15). 
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Fig. 3.15. The effect of omitting Na+ from the loading medium on the uptake of [^H]GABA into 
hypothalamic cells maintained in primary culture. Results represent the mean ± s.e.m. n = 4. *p < 
0.05, ** p < 0.02 *** p < 0.001, compared with uptake in the presence of Na"*"-
33.2. Release Studies. 
The 56mM K+ induced release of [^H]GABA was 5 to 6 fold greater than that 
induced under basal conditions and was significantly reduced when Ca^+ was omitted 
from the release medium, (Fig. 3.16., * p < 0.05, **p < 0.002), although this 
reduction was not as profound as that observed for [%]DA. 
Fig 3.17 illustrates the effect of repetitive stimulation on the release of [3H]GABA. 
In contrast to the release of [^HJDA, the amount of [%]GABA released during the 
second and third stimulation was significantly greater than during the first stimulation 
although there was no significant difference between the two. 
[^HJGABA release experiments did not demonstrate an increase in the amount of 
neurotransmitter released with increasing culture age at any time point studied during 
the period of investigation from DIV 5 to DIV 18 (data not shown). 
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Fig 3.16. The effect of exclusion of from the release medium on the basal ( H i ) and 56mM K+ 
induced ( ^ 3 ) release of [^H]GAB A from foetal rat hypothalamic cells in primary culture. Results 
represent the mean ± s.e.m. n = 4. * p < 0.05, ** p < 0.002 for basal vs depolarization induced release, 
t p < 0.05 for release in the presence vs the absence of Ca^+. 
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Fig. 3.17. Release profile for [^HIGABA from foetal hypothalamic cells in primary culture. The cells 
were pre-incubated with [^H]GABA before being subjected to three consecutive 7 min incubations 
either under basal ( H ) or 56mM K+ induced ) conditions. Results represent the mean ± s.e.m. n 
= 4. * p < 0.05, ** p < 0.005 for depolarization induced release compared with basal. 
3.3.3. Discussion. 
These results show that hypothalamic cells in primary culture retain certain neuronal 
functions, the maturation of which may be investigated within this experimental 
model. The uptake of [^H]DA into hypothalamic cells in this culture system 
displayed both time and temperature dependency and a similar finding was made for 
[3H]GABA uptake. However, the [%]GABA uptake mechanism appeared to work 
with greater avidity than the mechanism for the uptake of [^HJDA, with saturation of 
the mechanism occuring after only 10 min, whereas the DA mechanism took 6 times 
longer to attain the same state (Figs. 3.1 and 3.11). Furthermore, analysis of the 
kinetic parameters of uptake revealed that the value for Km was more than one order 
of magnitude lower for [^H]GABA than [^HJDA uptake on all experimental days 
investigated, suggesting that the transporter protein involved in the removal of GABA 
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from the pre-synaptic cleft has a greater affinity and avidity for its ligand than the 
transporter protein involved in DA uptake. In addition, the value for Vmax was 
consistently higher for GABA than DA, suggesting that there are a greater number of 
uptake sites for GABA than DA within our culture preparation. Thus, it is possible 
that uptake plays a greater role in GABA-ergic function than in dopaminergic 
function within the hypothalamus. The anatomical arrangement of certain 
intrahypothalamic dopaminergic tracts, especially the TIDA pathway, with its nerve 
terminals impinging upon the precapillary spaces of the hypophyseal portal vessels 
makes any requirement for rapid DA re-uptake less important as it may be "flushed 
away" to the anterior pituitary gland. However, it is generally accepted that 
termination of GABA-ergic transmission depends almost solely on re-uptake. This 
could represent a functional basis for the profound differences in the uptake 
parameters as exhibited for the two transmitters within our culture model. 
Alternatively, the highly active uptake for [^HJGABA may reflect the greater 
maturity of these cells at this developmental stage relative to the dopaminergic 
neuronal populations. This view is in accord with the conclusions of our ICC studies 
and other results discussed below. 
The characteristics of the uptake process for both [3H]DA and GABA changed with 
age of the cultured cells suggesting that a pre-programmed maturation proceeds over 
extending periods in vitro. For pH]DA, the value of the Michaelis - Menten Constant 
(Km; expressed as |iM) decreased dramatically during in vitro development (viz. 56.2 
+ 3.01, 7.0 ± 1.3 and 3.98 ± 0.87, on DIV 3, 7 and 14 respectively), suggesting an 
increase in the affinity of the transporter protein for DA. In addition, the value of 
Vmax increased significantly with cultivation time, which is indicative of an increase 
in the expression of the transporter protein on the nerve terminals and co-incided with 
the increase in [3H]DA uptake, which was greatest between DIV 3 and 7 (Fig 3.2). 
We propose that the observed increase is partly due to neurite growth, as 
demonstrated in Plate 3.0, which would allow for an increase in the number of DA 
uptake sites being expressed and similar results have been reported for mesencephalic 
dopaminergic neurones in culture (di Porzio 1980). In essence, these results suggest 
that in the perinatal period the apparatus for termination of DA neurotransmission in 
the hypothalamus is not fuUv developed but that their maturation continues in vitro. 
Our finding of a change in the value of the Km contrasts with the observation made in 
the in vivo study of Coyle & Henry (1973), using hypothalamic fragments at different 
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stages of development, who reported that the apparent Km value remained constant 
during the postnatal period, although the studies are in agreement over the increase in 
Vmax- However, as the hypothalamic tissue used in our study is taken at an earlier 
stage in neuronal development, the transporter complex may require a longer time 
interval to attain a maximal functional level. If the kinetic analysis were extended 
beyond DIV 14 it is likely that the value of Km would have reached a steady level, as 
after DIV 14 the actual magnitude of uptake did in fact begin to plateau (Fig. 3.2). It 
is therefore possible that when hypothalamic dopaminergic neurones are removed 
from their in vivo environment and re-established in culture their rate of development, 
as measured by the ontogeny of certain biochemical parameters, is slower than in 
vivo. 
The Km values for [3H]DA uptake in the present investigation are, in general, greater 
than those reported in studies using other hypothalamic preparations. Demarest & 
Moore (1979a) reported that the uptake of [3H]DA into synaptosomal preparations of 
median eminence tissue had an apparent Km value of 1.5|iM, whereas Sarker et al 
(1983), using median eminence fragments, reported a Km value of 0.56|iM. 
However, as those values were derived from experiments on adult hypothalamic 
tissue and may exclude DA perikarya it is likely that the transporter mechanism in 
play functions differently to that in intact foetal neurones. It is known that changes in 
the DA transporter protein occur with aging (Bannon et al 1992) and our results 
support the hypothesis that similar changes in the transporter complex occur prior to 
birth and up to adulthood. 
The uptake of [^HJGABA also increased with advancing culture age, although the 
pattern of this increase was markedly different from that exhibited by the [^HJDA 
uptake mechanism. Thus, while there was a rapid rise in the uptake of the 
radiolabelled GAB A between DIV 3 and 7, similar to that displayed for [^HJDA 
uptake, the amount of [^HJGABA being accumulated (in terms of absolute levels of 
transmitter) was much greater even at the earliest time-point tested. Thereafter, 
[^HJGABA uptake did not change again until DIV 15, after which time there was a 
second sharp rise at DIV 18. In agreement with these observations, the kinetic data 
showed an increase in the apparent Vmax for [%]GABA uptake over a 14 day period, 
although we were unable to continue these studies beyond this time-point. There was 
also a significant decline in the apparent Km value for GABA uptake between DIV 3 
and 7 (2.3 ± 0.4 ,1.0 ± 0.14, respectively), reflecting an increase in the affinity of the 
transporter protein with advancing culture age. Both of these observations may 
account for the ready increase in [3H]GABA uptake on initial experimental days. 
Between DIV 8 and DIV 14 there was no significant increase in the uptake of 
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[^HjGABA and the maximal rate of uptake and the Km value remained constant 
suggesting no change in either the expression or the affinity of the transporter protein. 
The values for Km observed for [^HJGABA in this investigation, are similar to those 
reported in the literature for [^H]GABA uptake into foetal/neonatal cerebral cortex 
tissue both in primary culture (Borg et al 1980) and slice preparations (Johnson & 
Davies 1973) where the value for the Michaelis Menten Constant ranged from 2.0 to 
5.0jJ.M. Furthermore the Km value for [^HJGABA uptake into adult hypothalamic 
preparations is also within this range (Anderson & Mitchell 1986) suggesting that 
unlike the uptake mechanism for [^EQDA, the [^H]GABA uptake system does not 
undergo a great degree of maturation postnatally. To our knowledge, no kinetic data 
has been published for foetal hypothalamic GABA-ergic systems in culture. 
The specificity of uptake of both [^HJDA and [^H]GABA was investigated by use of 
their respective uptake inhibitors. In the case of [3H]DA, uptake was significantly 
attenuated in a dose - dependent fashion by benztropine and nomifensine which at the 
highest concentrations tested (lO'^M), produced a maximal inhibition of [^HJDA 
uptake of 60 and 70% respectively. These drugs are reported to be highly specific 
inhibitors of neuronal DA uptake mechanisms by interacting with the DA transporter 
protein (Dubochovitch & Zahniser 1985). We cannot eliminate the possiblity that the 
degree of inhibition which we have observed was not maximal as Sarkar et al (1983) 
using fragments of the median eminence and Puymirat et al (1987), employing mouse 
hypothalamic cells in culture have reported an inhibition of 70 and 90% respectively 
using the same inhibitors and it is likely that higher concentrations of the inhibitor 
would have resulted in a greater degree of inhibition. However, the ability of a single, 
sub-maximal dose of nomifensine to attenuate [^H]DA uptake into the hypothalamic 
neurones increased approximately three-fold with advancing culture age (Fig. 3.4). 
This may reflect a maturation of the DA transporter molecule and possibly an 
increase in the number of functional [^H]DA uptake sites in accord with the kinetic 
analysis data and reports by Engele et al (1989) and Fizman (1991). This distinct 
ontogenetic pattern for the ability of these compounds to inhibit [^HjDA 
accumulation may thus account for the sub-maximal level of inhibition demonstrated 
in this study and we propose that the uptake mechanism had not reached maturity at 
the time of these experiments. It is possible that performing the experiments at later 
stages of in vitro development may have produced a greater maximum degree of 
inhibition. 
119 
Alternatively, glial cells, known to be present in this culture model (Davidson & 
Gillies, 1993) may account for a proportion of [^HJDA accumulation although it has 
been reported that glial cells possess a considerably reduced ability to take up DA 
compared with neurones of the same developmental age (Barachovsky & Bradford 
1987). Therefore, we propose that the uptake of [^HJDA observed in our study was 
principally neuronal. Further investigations would require the use of specific 
inhibitors of DA uptake into glial cells which to our knowledge were not available at 
the time of carrying out this series of experiments. 
The uptake of [^HJGABA was very effectively inhibited by the specific inhibitor of 
GABA uptake into neuronal cells, SKF 89976 A, with the block being virtually 
complete at lO'^M. Furthermore, uptake of [^HJGABA was not affected by B-alanine 
which is considered to be a specific inhibitor of GABA uptake into glial cells. 
Therefore, we conclude that the uptake of [^HJGABA is exclusively into neuronal 
cells within this hypothalamic culture preparation. SKF 89976 A, in contrast to the 
[3H]DA uptake inhibitor nomifensine, became less effective in blocking [^H]GABA 
uptake as the cultures matured. The loss of effectiveness of the uptake inhibitor, the 
change in the Na+ - dependency of uptake (Fig. 3.15) and the second sharp rise in the 
amount of [^HJGABA accumulated (Fig. 3.12) all suggest some fundamental change 
in the behaviour of the transporter protein although the connection between these 
phenomena and their physiological relevance in the ontogeny of hypothalamic GABA 
- ergic systems, are yet to be elucidated. 
These results suggest that, in contrast to dopaminergic neurones, which display 
considerable functional and morphological immaturity at early in vitro ages up to 
DIV 7, the GABA-ergic neurones in primary culture gain functional competence at a 
very early stage in development. It is thus likely that once established in vitro, 
GABA-ergic neurones rapidly re-develop processes and begin to express uptake sites 
on their newly formed axons and dendrites. This proposal is further substantiated by 
our ICC studies, as during early stages of cultivation GABA-ergic neurones were 
already exhibiting well developed processes which do not appear to undergo further 
growth at later time-points in culture. We conclude that the apparatus for transport is 
in place early on in the developmental process of GABA-ergic cells and that this 
degree of maturity is retained and continued under in vitro conditions. 
Attempts to totally abolish [^HJDA uptake by direct competition with unlabelled DA 
failed, producing no greater than a 45% inhibition at the highest concentration of 
"cold" DA employed. This contrasts with some studies on murine hypothalamic cell 
cultures where lO'^M DA produced a 75% inhibition of pH]DA uptake (Puymirat et 
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al 1987). We therefore considered the possibility that the uptake of [^HJDA within 
our culture model was under some form of receptor mediated regulation by DA itself, 
as suggested by (Ross 1991). The D2 receptor antagonist sulpiride, displayed little 
inherent activity in affecting the magnitude of [^HJDA uptake but was highly 
effective in reducing [^HjDA accumulation in the presence of "cold" DA. Thus we 
have constructed a theoretical model for the regulation of DA uptake at the site of the 
nerve terminal (Fig. 3.18). 
Fig. 3.18. Theoretical model for the autoregulation of DA uptake into dopaminergic 
nerve terminals in the hypothalamic culture preparation. 
D2-like receptor 
(functionally coupled to 
the DA transporter) 
Nerve Terminal 
Na^ DA 
DA Transporter Protein 
(labelled and unlabeUed DA compete for 
transport into the nerve terminal at this site. 
Blocked by nomifensine and benztropine). 
In this model, it is proposed that presynaptically located DA transporters are 
functionally coupled to a DA receptor which exhibits pharmacological similarities to 
the D2-like receptor sub-type. At equilibrium, the net uptake of DA is determined by 
the amount of the neurotransmitter in the synaptic cleft, uptake occuring only when 
the concentration of DA approximates the Michaelis - Menten Constant for the uptake 
mechanism in play. D2-like receptor activation by high concentrations of DA results 
in facilitation of uptake, ensuring that excessive levels of DA are not allowed to flood 
the synaptic cleft. Thus, [^HJDA is readily taken up into the nerve terminal via the 
transporter molecule as it bears a structural resemblance to the endogenous ligand. 
121 
However, as sulpiride alone had a negligible effect on [^HjDA upake, it follows that 
the tritium labelled DA has minimal activity at the D2-like receptor proposed to be 
involved in regulating its uptake. Introduction of unlabelled and therefore 
pharmacologically active DA to the system, serves to disrupt the equilibrium and we 
propose that "cold" DA at a concentration of lO'^M DA has two potential actions. 
Firsdy, there is direct competition between labelled and unlabelled ligand at the DA 
transporter complex, which would normally result in the reduction of [^HJDA 
accumulation. This is, however, counteracted by the second action of the exogenous 
DA at the D2-like receptor, to facilitate [^HJDA uptake, the net result being no 
apparent change in uptake. When the secondary action is blocked by the introduction 
of the D2 antagonist sulpiride, [^H]DA uptake was inhibited by approximately 50%. 
As the concentration of "cold" DA is increased it would compete more effectively 
with [3H]DA at the transporter molecule and thus reduce accumulation. 
Simultaneously, however, it would compete with sulpiride at the D2-like receptor 
which would have the opposite effect of facilitating uptake. This interpretation merits 
further study as it implies that the net effect of raising DA levels depends critically on 
the prevailing DA concentration which could be influenced by the efficacy of a 
number of DA agonists which are used clinically. 
An alternative explanation for these resultsought also to be considered. Our uptake 
studies were performed with a 60min incubation period for [^H]DA accumulation. 
Net accumulation of [^H]DA will therefore depend on a balance between uptake and 
basal release processes over that hour. Thus, differences in net accumulation in the 
presence of varying concentrations of "cold" DA could also be influenced by a D2-
receptor mediated inhibition of [^H]DA release (Sarkar et al 1983). In view of the 
low levels of basal release, this latter explanation seems less likely. The correct 
interpretation of these results would be aided by molecular biological methods for 
measuring expression of the DA transporter protein and by a series of Km estimations, 
employing shorter incubation periods for [^HJDA accumulation, under different 
prevailing levels of "cold" DA and in the presence and absence of specific uptake 
inhibitors. 
Whatever the explanation, however, these findings suggest that the concentration of 
DA within the synaptic cleft influences DA accumulation. By inference, 
autoregulation of DA uptake has been reported previously, especially for the TIDA 
neuronal population (Demarest & Moore 1979a) where the uptake mechanism for DA 
operates at a lower affinity than in other populations (Km for dopaminergic neurones 
in the corpus striatum being 0.6|i.M compared with 1.5|iM in the TIDA neurones 
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Annunziato 1979). The uptake mechanism in the TIDA pathway is not however 
dysfunctional but is activated only when DA concentrations in the hypophyseal portal 
blood perfusing the nerve terminals reach a particular level. This in itself suggests 
some form of DA (receptor?) mediated modulation of uptake, as the presence of DA 
at the site of the nerve terminal is vital to its activation. 
The magnitude of the release of both [3H]DA and [3H]GABA in response to elevated 
K+ was Ca2+ - dependent and typically 2-5 times greater than that achieved under 
basal conditions, which suggests that the release mechanism displayed in this culture 
model possess a degree of functional integrity. However, [3H]GABA release 
appeared to be less dependent on extracellular Ca^+ and it has been reported that 
certain GABA-ergic systems within the CNS, like cholinergic systems may release 
their transmitter via a Ca^+ - independent mechanism (Arias & Tapia 1986). Such a 
mechanism may therefore account for a portion of release observed here. 
The ability of the hypothalamic cells to release pre-accumulated [3H]DA increased 
with age in culture, the most marked increase occuring between DIV 7 and DIV 9. 
Whether the increase in the total release of [3H]DA represents a maturation of the 
release mechanism displayed within this experimental model or whether it is partially 
a consequence of maturation of the uptake system is difficult to determine from this 
data, but several arguments suggest the former. Firstly, in a number of situations we 
have found that changes in uptake are not closely paralleled by changes in release 
(Section 3.5). Secondly, we have observed a similar increase in the release of 
endogenous DA over the same culture period (following section). Finally, 
synaptogenesis, which is thought to co-incide with the development of Ca^+-
dependent neurotransmitter release (Zurgil (1981), occurs extensively at DIV 7 in 
whole brain cultures (Bradford & Barachovsky 1987) which is the stage at which 
[3H]DA release increased most dramatically in our study (Fig 3.10). Furthermore, the 
increase in release of neurotransmitter with advancing cultivation time may be due to 
the development of growth cones and varicosities as demonstrated by our ICC studies 
which results in increased transmitter output. 
In contrast to the situation with dopaminergic neurones, the release of [^IflGABA 
remained unchanged over the period of investigation and was high even at DIV 5, 
when [3H]DA release studies were not viable. This difference suggests a degree of 
plasticitv for the F^HIDA release mechanism in vitro which is absent within the 
GABA-ergic population and mav indicate that GABA-ergic svstems mature more 
rapidlv. 
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The significant decline in [^HJDA release observed when the cells were subjected to a 
rapid train of depolarizing stimuli was considered to be indicative of a depletion of 
pre-accumulated [^H]DA stores. However, the significant amount of [^H]DA 
remaining in the cells following extraction shows that this is not so and suggests 
additional storage sites for the radiolabelled neurotransmitter, from which it cannot be 
readily released. This phenomenon has been suggested by other authors 
(Barachovsky & Bradford 1987). In contrast, a rapid train of depolarizing stimuli 
elicited an increase in [^HJGABA release, with the second and third responses being 
significantly greater than the first. These observations point to marked differences in 
the dynamics of storage and/or release of [^HJDA and [^HJGABA in our culture 
model, and may reflect fundamental differences in the dynamics of secretion of the 
two neurotransmitters in vivo. 
In conclusion we have demonstrated that foetal rat hypothalamic cells maintained in 
primary culture retain certain parameters of neuronal function, including the ability to 
accumulate and release exogenous radiolabelled neurotransmitters and that these 
markers of neuronal activity undergo a degree of maturation with advancing time in 
culture. Differences in the patterns of expression and development of these 
parameters between the dopaminergic and GABA-ergic systems indicate that 
different hypothalamic neuronal populations carry through distinct pre-programmed 
developmental profiles in vitro. Furthermore, the differences suggest that in late 
foetal life hypothalamic GAB A - ergic neuronal systems have reached a greater level 
of maturity than their dopaminergic counterparts and that the advanced developmental 
potential of the former is preserved and continued under in vitro conditions. 
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3.4. Studies with Endogenous DA. 
Using HPLC -EC for the measurement of endogenous DA we wished to determine to 
what extent the release of pre-accumulated [^HJDA was a measure of the behaviour 
of endogenously synthesised DA. 
3.4.1. Time dependency of DA release. 
Fig 3.19 illustrates a time course study for the release of endogenous DA. During a 
7-min period DA output was barely above our limits of detection (Section 2.5.2.3). 
Increasing the incubation period led to a significant increase in the amount of DA 
released under both basal and 56mM K+ - stimulated conditions. In view of these 
results it was decided that the release of endogenous DA would be investigated over 
incubation periods of 60 min, so that the levels of the amine could be detected with 
greater accuracy. 
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Fig. 3.19. The effect of incubation time on the basal ( ^ 0 ) and 56mM K+ induced CKSM') release of 
endogenous DA from cultures of hypothalamic cells on DIV 7 as measured by HPLC-EC. Results 
represent the mean ± s.e.m. n = 4. * p < 0.05, ** p < 0.001 for 56 mM K+ induced release compared 
with basal release. For basal and 56mM K+ - induced release p < 0.05 and p < 0.02 respectively for 7 
min compared with 20 min incubations. For basal and 56mMK+ induced release, p < 0.02 and p < 
0.001 respectively for 20 min compared with 60 min incubations. 
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3.4.2. Maturation of DA release from the hypothalamic cultures. 
Basal and K+ - stimulated release of DA from naive cultures (i.e. which had not been 
previously treated) was studied between days 3 and 21 in vitro (Fig. 3.20). On DIV 3 
release was low but detectable under basal conditions. There was a slight, but 
significant increase in the basal release of DA on DIV 7 followed by a slight fall on 
DIV 11. Thereafter basal release increased with culture age throughout the period of 
the investigation. Potassium - induced release increased throughout the time of the 
study not only in terms of absolute output but also when expressed as the percentage 
above basal. As none of these cells had received any prior stimulus these responses 
represent an inherent maturation of the dopaminergic neurones within our culture 
preparation. 
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Fig. 3.20. Release of endogenous DA from foetal rat hypothalamic cells maintained in primary culture 
during 1 hour incubations under either basal ( H ) or 56mM K+ - stimulated ( B 3 ) conditions. 
Experiments were performed on DIV 3, 7,11,14, and 21. Results represent the mean ± s.e.m. n=4. t 
p < 0.05, t t p < 0.025 for basal release as compared with the release on DIV 3, * p < 0.05, * * p < 
0.025 for 56mM K+ induced release as compared with the release on DIV 3 . 
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3.4.3. The Ontogeny of DA content in hypothalamic cultures. 
At certain time-points equivalent to those in Fig 3.20 the DA content was measured in 
naive cultures and in cultures which had just received a 1 hour depolarizing stimulus. 
There was no significant increase in DA content between DIV 7 and 14. 
Furthermore, on DIV 7, there was no significant difference in DA content between 
those cells which experienced a single 1 hour incubation with 56mM K+ prior to 
extraction and those which had not been pre-stimulated. However, on DIV 11 and 14 
DA content in those cells which were subjected to a depolarizing stimulus, was 
significantly higher (by approximately 30%) than that in naive cells. 
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Fig. 3.21. DA content in hypothalamic cells in primary culture immediately following a single 1 hour 
incubation in the presence of 56mM K+ ( ® ) or without pre - stimulation ( • ), on DIV 7, 11 and 
14. Results represent the mean ± s.e.m. n = 4. * p < 0.05 for unstimulated vs pre-stimulated cultures. 
3.4.4. Depolarization induced maturation of DA release and content. 
Previous work demonstrated that prior exposure of the cultures to elevated levels of 
potassium enhanced the response of peptidergic neuronal cells to depolarizing stimuli 
during later stages in culture (Gillies; 1989). We therefore investigated whether this 
phenomenon occurred for hypothalamic dopaminergic neurones. A single batch of 
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cells was cultured as outlined in Section 1.1, and divided into five groups (n=4). 
Group 1 was exposed to 56mM K+ for 1 hour on DIV 3 and continued to receive a 
depolarizing stimulus on DIV 7,11,14 and 21. Group 2 was first exposed to elevated 
levels of K+ on DIV 7 and received similar treatment to group 1 on subsequent 
experimental days. Groups 3, 4 and 5 did not receive their first depolarizing stimulus 
until DIV 11, 14 or 21, respectively. Thus in total group 1 received five potassium 
stimulations and groups 2 , 3 , 4 and 5 received four, three, two or one stimulation(s) 
respectively. 
Basal levels of DA release were not influenced by a prior depolarizing stimulus (data 
not shown) and Fig. 3.22 illustrates the response to K+ depolarization. The inherent 
maturation described earlier (Fig 3.20) is once again apparent in the increasing 
magnitude of the first response of successive groups. In addition, a depolarization -
dependent maturation of stimulated release is evident. Thus, on DIV 7 and 11 those 
cells which had been exposed to 56mM K+ on DIV 3 (group 1), released greater 
amounts of dopamine than those cells which were stimulated only once previously or 
not at all (groups 2 and 3). By DIV 14 in culture, fewer prior exposures to elevated 
levels of K+ were required to produce a response of a magnitude similar to that of 
group 1 which had received the greatest number of K+ depolarizations. By DIV 21 
the responses of groups 1 - 4 to K+ - depolarization were not significantiy different 
and therefore the number of prior depolarizations required for each group to "catch 
up" with group 1 decreased as the inherent maturation proceeded. 
The cultures from the experiment shown in Fig. 3.22 were also extracted on DIV 24, 
under basal conditions and the DA content in these cells was measured (Fig. 3.23). 
There was no significant difference in the DA content of the cells in groups 1, 2, 3 or 
4 which had received five, four, three or two stimulations respectively, over the 
investigational period. Only those cells which had been stimulated for the first time 
on DIV 21 (group 5), contained significantiy higher levels of DA than groups 1 - 4 . 
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Fig. 3.22. Depolarization - induced release 
of endogenous DA from hypothalamic 
dopaminergic neurones in primary culture. 
Release studies were performed on a single 
batch of cells divided into 5 groups. Group 
1 ( ^ 1 ) received a 1 hour 56mM K+ -
stimulation on DIV 3 and 7,11, 14, and 21. 
Group 2 ( ^ 1 ) was first stimulated on DIV 
7 and each of the remaining experimental 
days. Group 3 ( ^ 0 ) received an initial 
stimulation on DIV 11, Group 4 ( ^ 3 ) on 
DIV 14 and Group 5 ( g ^ ) on DIV 21. 
Results represents the mean ± s.e.m. n = 4. 
* p < 0.05, * * p < 0.005 compared with the 
corresponding value for DA release in 
Group 1 cells. 
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Fig. 3.23. The effect of prior potassium depolarization on the content of DA in hypothalamic cells in 
primary culture. Group 1 ( ) received five stimulations prior to extraction whereas groups 2 
( ^ 1 ), 3 ( ^ 0 ), 4 ( and 5 ( [%]) received four, three, two or one stimulation(s) respectively. 
There was no significant difference between groups 1 , 2 , 3 and 4. The DA content in group 5 was 
significantly higher than the other four groups. Results represent the mean ± s.e.m. n = 4. * p < 0.05 
for group 5 compared with groups 1 ,2 ,3 and 4. 
5.4 J . DA release vs Conceptional Age. 
Using an alternative approach to investigate the perinatal development of 
hypothalamic DA neuronal systems, we initiated cultures from hypothalami collected 
on embryonic days 18 (El8) and 21 (E21), and postnatal day 1 (PI). Release 
experiments were performed between DIV 7 and DIV 21 (Fig. 3.24.a and b). 
As with our previous developmental studies, the DA output increased with increasing 
culture age throughout the investigational period. Under basal conditions, cultures 
initiated from E18 tissue released markedly less DA than those cultures initiated from 
E l l and PI tissue on all experimental days except DIV 7, when the levels were 
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slightly higher (Fig 3.24.a). DA output induced by a depolarizing stimuli was also 
lower from El8 than E21 and PI cultures at all time points tested. Depolarization -
induced release of DA from the postnatal cultures was dramatically greater on DIV 21 
than from the other two culture types (Fig 3.24.b). 
When the same data were expressed as release v's age relative to conception (CA), 
the pattern for basal release was similar to that seen in the previous figure, with E18 
cultures releasing less DA than E21 and PI cultures (3.25.a). Depolarization induced 
DA release differed slightly, where the rise in output of DA exhibited by the PI 
cultures appeared initially to lag behind the E21 and PI cultures, followed by a sharp 
rise in output by CA +45 (Fig 3.25.b). DA release from the E18 and E21 cultures 
increased steadily over the period of study from CA +25 to +39 and CA +28 to +42, 
respectively. 
When the El8 and PI cultures were observed under light microscope, some 
differences were apparent (Plate 5). Under low power the cells in the E18 cultures 
appeared to form "tight" aggregations and individual neurones were almost 
indistinguishable as the culture proceeded (Plate 5A). In contrast, the typical 
neuronal - type cells within PI cultures remained separated one from another (Plate 
5B). Similar observations were seen under high power and in addition those cells 
from the PI cultures appeared to be larger than their El8 culture counterparts (Plate. 
5C -F). In addition, the PI cultures remained intact for a much longer time period 
than the El8 (and E21) cultures and the monolayer failed to "peel" even after a five 
week period. 
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Fig. 3.24. Release of endogenous DA from hypothalamic dopaminergic neurones in primary culture. 
Cultures were initiated from foetal hypothalamic tissue removed on embryonic days (E) 18 ( • ) and 
21 and postnatal day (P) 1 CM). Basal release (a) and 56mM K+ - stimulated release (b) of DA 
was measured on different days in culture. 
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Fig. 3.25. Release of endogenous DA from foetal rat hypothalamic cells maintained in primary 
culture. Cultures were initiated from foetal hypothalamic tissue removed on embryonic (E) days 18 
(—•—) and 21 (—#—) and postnatal day 1, (—•—). Basal release (a) and 56mM K+ - stimulated 
release (b) of DA was measured on different days relative to conception. Results represent mean ± 
s.e.m, n = 4. 
133 
Description of Plate 5.0. When the E18 and PI cultures were observed under light 
microscope, some differences were apparent Under low power the cells in the El8 
cultures appeared to form "tight" aggregations and individual neurones were almost 
indistinguishable as the cultures proceeded (Fig. A). In contrast, the typical 
neuronal-type cells within PI cultures remained separated one from another (Fig. B). 
Similar observations were seen under high power, and in addition those cells from the 
PI cultures appeared to be larger thantheir El8 culture counterparts (Figs. C-F). In 
addition, the PI cultures remained intact for a much longer time period than the E18 
(and E l l ) cultures and the monolayer failed to "peel" even after a five week period. 
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3.4.6. Discussion. 
Both basal and K+ - induced release of DA from our hypothalamic cultures was 
demonstrable and increased with increasing incubation time. Thus after a 7 min 
incubation in the presence of 56mM K+, DA output was only 20% above that released 
under basal conditions and this percentage difference increased to 50% and 250% 
over a 20 and 60 min incubation period respectively (Fig 3.19). The apparent reduced 
ability of the cells to respond to potassium depolarization over short time periods 
cannot be due to lack of stored DA as DA content is over 500 times greater than that 
released over a 7 min incubation period (Fig 3.21). These results could suggest 
therefore, that the DA held in long term storage sites within the nerve terminal is not 
readily releasable and that a more prolonged stimulus, which activates DA synthesis 
and facilitates the release of the newly sythesized amine, is required before a large 
response to a depolarizing stimulus can be seen. Alternatively, during a short time 
period it is possible that the uptake mechanism for DA is highly effective in 
maintaining low levels of DA around the synaptic cleft, while with prolonged 
stimulation the nerve terminal becomes "swamped" and re-uptake is not sufficient to 
recapture the large amount of DA released, thus accounting for the high levels within 
the release medium. The latter possibility might be investigated by measuring the 
release of endogenous DA in the presence of uptake blockers. 
As the cultures matured, the response to elevated K + increased. Thus during a 1 hour 
incubation period the increase in magnitude of DA output in response to 
depolarization on DIV 3 was 40% above basal but rose to greater than 165% by DIV 
21 (Fig. 3.20). This enhanced responsiveness of the cultures to stimulation with 
advancing culture age suggests a degree of maturation of the synthetic and/or release 
machinery for DA. Much evidence supports a role for synaptogenesis in neuronal 
development in vitro and in vivo using whole brain tissue (Barachovsky & Bradford 
1987). Certain indicators of synapse formation including Ca^+ influx, the 
phosphorylation of the proteins involved in neurotransmitter release and Ca^+ -
dependent release of DA, increase with increased cultivation time in parallel to an 
enhancement of neuronal activity (Zurgil & Zisapel 1984; Barachovsky & Bradford 
1987). Thus, the in vitro development of specific cell -to- cell connectivity may 
account for both the increase in absolute amounts of DA secreted and the increase in 
magnitude of response of these dopaminergic systems to elevated K+. Therefore we 
propose that the development of svnaptic contacts mav plav a role in the maturation 
of hypothalamic dopaminergic neurones in this experimental model, in a manner 
analogous to that proposed for the development of other dopaminergic systems in 
vitro (Barbin 1985) and in vivo (Santana et al 1992). 
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In addition to the inherent maturation of the synthesis/release mechanisms discussed 
above, we were also able to induce a depolarization (56mM K+) - dependent 
acceleration of functional maturation as demonstrated in experiment 3.22. During 
early stages of in vitro development, repeated depolarization enhanced DA output, 
above the inherent pattern of development. At later stages of cultivation this 
depolarization - induced maturation was superseded by the pre-programmed 
development and all cultures, with the exception of those which had not received any 
prior stimulation, behaved in a similar manner by DIV 21. The release of certain 
neuropeptides from our culture model may be similarly modulated (Gillies 1989; 
Hannah et al 1993) and it is likely that the action of exogenous depolarizing stimuli 
in addition to those being generated endogenously, may serve to enhance the activity 
of either the synthesis or secretory apparatus. 
Repeated depolarizations may also change the dynamics of the storage and release of 
endogenous DA at the nerve terminal. A component of neurotransmitter release is 
thought to be mediated via a carrier-dependent process involving the DA transporter 
complex (Raiteri et al 1979). Thus K+ stimulation, like amphetamine, is believed to 
elicit the release of cytoplasmic stores of DA and repeated exposure of the cells to 
such stimuli causes a switch in the route of newly synthesized DA away from 
cytoplasmic degradation by MAO, to the synapse with subsequent release. This is 
exemplified by the observation that repetitive, prolonged exposure of dopaminergic 
neurones to elevated K+ reduces the amount of DOPAC in the extracellular 
compartment, which is generally accepted to be derived from the breakdown of 
cytoplasmic stores of DA (Zetterstrom et al, 1983,1986). 
WhUe there was no significant change in content of naive cells with increasing 
cultivation time, those cultures which were subjected to a single 1 hour incubation in 
the presence of elevated K+ prior to extraction contained significantly higher levels of 
DA than did their untreated counterparts (Fig 3.21). Although we were unable to 
investigate the likely intracellular effects leading to an increase in neurotransmitter 
sy nthesis, it has been reported that membrane depolarization stimulates the 
production of tyrosine hydroxylase in brain regions such as the substantia nigra 
(Knusel et al 1990). Any increase in DA content is likely to return rapidly to basal 
levels as frequent depolarising stimuli did not influence the resting levels of 
neurotransmitter in dopaminergic neurones (Fig 3.23). 
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When primary cultures were initiated from tissue at different stages of embryonic or 
postnatal development, the capacity of the DA - containing neurones to mature and 
survive differed markedly. Those cultures initiated from postnatal tissue ultimately 
displayed a greater maximal response in terms of stimulated DA output than cultures 
initiated from foetal tissue (Fig. 3.24). When expressing DA output in terms of age 
relative to conception, it appeared that the dopaminergic neurones within the PI 
cultures required a longer period of re-adjustment under in vitro conditions before 
they "overtook" those in the E18 or 21 cultures (Fig. 3.25). These results are difficult 
to interpret as we are unable to assess the degree to which initiating hypothalamic 
tissue at different stages of development influences their in vitro behaviour. Yet it is 
believed that during embryogenesis certain aspects of neuronal development, 
including the formation of synaptic contacts, are inhibited (Santana et al 1992). Thus 
when embryonic cells are re-established in culture conditions it is possible that they 
are still exposed to these inhibitory influences and hence their rate of development 
appears to be relatively suppressed and retarded. Therefore we propose, that after 
birth these restraining influences on neuronal development are eventually "lifted" 
allowing processes such as synaptogenesis and other forms of cell -to- cell 
communication to occur. This may account for the dramatic increase in neuronal 
activity displayed by DIV 21 in the PI cultures. The primary source for this 
inhibition is yet to be elucidated but it has been propsed that glial cells are intimately 
involved in neuronal development (Denis - Donini 1984), and if they exerted some 
restraining influence it is likely that they would modulate the rate of development of 
neuronal cells. If these cells and therefore the inhibitory influence they exert, decline 
in postnatal tissue this would account for the more rapid development and enhanced 
activity in the PI culture subtype. It remains to be definitively established whether 
these results are reflecting genuine pre-programmed events in neuronal development 
which are being reflected in vitro , or whether simply taking the tissue at later stages 
of in vivo development is merely increasing the percentage survival of neurones once 
they are removed to an in vitro environment. 
However, a parallel and simultaneous study investigating the activity of SRIH 
containing cells in these hypothalamic cultures yielded markedly different results, 
with the PI cultures releasing the lowest levels of neuropeptide (Davidson & Gillies 
personal communication). Furthermore, in all three culture types (E18, E21,P1), the 
levels of SRIH output decreased as a function with time after DIV 10. The SRIH 
data is more in accord with the view that the survival rate of neurones cultured 
postnatally is significantly less than for those cultured during embryonic development 
(Barbin et al 1985). This is obviously not the case for hypothalamic dopaminergic 
neurones although it does appear to be true for mesencephalic dopaminergic systems 
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(Barbin 1985). These results therefore, further support our view that specific patterns 
of neuronal development in vitro do not solely reflect an artefact of the culture 
condition but mav represent important developmental processes occuring in brain-
specific regions in discrete neuronal populations at different developmental stages, 
manv of which mav be critical to the adequate functioning of the neuroendocrine 
svstem in adult life. 
Our results for endogenous DA are similar in several respects to those for 
The release of both are time dependent and stimulated release increases as the 
cultures mature. The latter is especially significant in that it supports our argument 
that increased [^H]DA output depends more on the development of some component 
of the release mechanism and is not solely a consequence of the increase in [^HjDA 
uptake. It is likely that the maturation of the uptake and release mechanisms may 
proceed independently and at different rates. 
Although the similarities in the release profiles of endogenous and [^HJDA may 
justify our use of radiolabelled neurotransmitter to investigate neuronal activity, some 
apparent differences were also noted. Over a 7 min incubation period endogenous 
DA release was not significantly enhanced by membrane depolarization (Fig. 3.19), 
whereas the magnitude of response of [^HJDA release to a depolarizing stimulus was 
markedly greater than under basal conditions (Fig. 3.8). It is possible that the storage 
site from which [3H]DA is secreted is more responsive to a depolarizing stimulus 
over short intervals, than endogenous DA, with recently re-uptaken amines being 
positioned in intracellular locations which are more readily mobilized than the newly 
sythesized pools from which endogenous transmitter is released. However, as 
[3H]DA release exhibits Ca2+ - dependency, we propose that it is released from 
genuine vesicular bound storage sites and thus mimics endogenous neurotransmitter 
secretion. Over longer durations of incubation endogenous DA release became highly 
responsive to membrane depolarization (Fig. 3.19) and it is therefore likely that 
increasing the incubation period allowed for both the mobilization of newly 
sythesised DA stores and also enabled a degree of neurotransmitter synthesis to occur 
as DA output in one hour under stimulated conditions was greater than the DA 
typically contained in intracellular storage sites (see Fig. 3.21). 
The results from this series of experiments add further support to our proposal, that 
the dopaminergic neurones within this hypothalamic culture model exhibit a 
functional maturation, and show a remarkable capacity for survival under in vitro 
conditions. As perinatal levels (viz content) of DA are relatively high, it has been 
suggested that the neurotransmitter may play some modulatory role in the 
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development of the CNS. DA has been implicated in the adaptation of the newborn 
rat to extrauterine life (Lanier et al 1976). In addition, transient changes in the TH 
activity within the foetal CNS elicits permanent modifications in adult behaviour, 
suggesting that DA is involved in the "laying down" of certain behavioural patterns 
during early development, which are manifested in later life (Arevalo et al 1987). In 
addition, at a structural level, DA can modulate neuronal outgrowth and influence the 
morphological and architectural design of the developing brain (Matteson et al 1988). 
Most of the studies which support a role for DA in organizing CNS development have 
been performed on the brain as a whole. However, DA may play a similar role in the 
hypothalamus to regulate the development of neuroendocrine function in particular. 
Further studies would be required to investigate this proposal and this culture system 
may well aid in the elucidation of the neuronal mechanisms involved in such 
important developmental processes. 
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3.5. Regulation of DA Activity by Gonadal Steroids. 
The role of steroids such as oestrogen and progesterone in the regulation of 
neuroendocrine function is well documented. However, many of the hypothalamic 
neuropeptide systems, notably GnRH neurones and the somatostatin neuronal 
populations of the PeVN appear not to be directly oestrogen responsive because they 
lack oestrogen receptors (Shivers et al 1983, Herbison et al 1993). Hypothalamic 
neurotransmitter systems have more recently been implicated as intermediaries in the 
steroidal regulation of hormone release both from the hypothalamus and the anterior 
pituitary gland (Lookingland & Moore 1984a; Flugge et al 1986; Herbison et al 1989) 
and evidence suggests that the TIDA system and a portion of the ICHDA neurones 
are directly responsive to oestrogens and possess oestrogen receptors (Sar 1984). We 
therefore investigated the effect of the gonadal steroids 17 B-oestradiol (E2) and 
progesterone (Prog) on the functional properties of the dopaminergic neurones, 
employing both measurement of the uptake and release of [^HJDA within our 
experimental model. Further studies were performed to determine the influence of E2 
on endogenous DA release and [^HJGABA uptake and release the results of which 
may be found in Sections 3.5.3 and 3.5.4 respectively. 
3.5.1. 17Ji - oestradiol. 
Uptake experiments were performed on cultures which had been maintained in 
defined medium containing one of a range of concentrations of E2 from 10" to 
10"^ M. Investigations were carried out from DIV 8 to DIV 21 and optimal 
accumulation occurred at a concentration of 10"10M E2 at all time points tested. 
Fig. 3.26 shows the results of uptake studies performed on DIV 8 and DIV 15. 
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Fig. 3.26, Modulation of the uptake of [^H]DA into hypothalamic dopaminergic neurones by E2. 
Uptake experiments were performed as detailed in 2.3.2 on DIV 8 ( # ) and DIV 15 ( -D-) . 
Results represent the mean + s.e.m. n=4. * p < 0.05, ** p.< 0.01 compared with uptake at lO'^^M 
which is the concentration of E2 routinely used in the defined medium. 
The release of [3H]DA,was also modulated by E2. Maximal release of the tritiated 
neurotransmitter was observed in those cells maintained in defined medium 
containing lO'^^M E2, while higher concentrations of the steroid reduced both basal 
and 56mM K+ - stimulated release. Quantitatively similar influences of the steroid 
were observed at all time points tested. Optimal release was not purely a reflection of 
the increased level of uptake as the concentration of E2 at which uptake was maximal, 
differed by two orders of magnitude from the steroid concentration which maximally 
stimulated [3H]DA release. Fig. 3.27 illustrates the results of release experiments 
performed on DIV 12. 
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Fig. 3.27. Modulation of the basal (—•—) and 56 mM K+ - stimulated (—O—) release of [^HjDA 
from foetal rat hypothalamic cells maintained in primary culture, by 5% (DIV 12). Results represent 
the mean ± s.e.m., n = 4. * p < 0.05, ** p < 0.025 compared with release at lO'^^M which is the 
concentration of E2 routinely used in the defined medium. 
5-5.2. Progesterone. 
Cells which were grown and maintained in a range of concentrations of Prog from 
10"12 to lO'^M were subjected to uptake experiments. Fig. 3.28 demonstrates that 
those cells grown in the absence of Prog exhibited the greatest capacity for 
accumulating the radiolabelled neurotransmitter while the higher concentrations of 
the gonadal steroid significantly (p < 0.001) attenuated uptake. 
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Fig. 3.28. Modulation of the uptake of [^ ETIDA into foetal rat hypothalamic cells in culture by the 
gonadal steroid Prog (DIV 10). Results represent the mean ± s.e.m. n=4. * p < 0.001 compared with 
uptake in the absence of the steroid. 
Release experiments performed on the same batch of cells showed that the release 
mechanism for [^HJDA was also modulated by Prog (Fig 3.29). Both basal and 
56mM K+-stimulated release of radiolabelled DA was significantly reduced by 
concentrations of Prog from 10 to 10 "^ M when compared with release from 
cells grown in the absence of the steroid ( * p < 0.05, ** p < 0.005). However, in 
those cells maintained in a high concentration of Prog (lO'^M), both basal and 
depolarization induced release of [^H]DA were raised to levels of output higher than 
that of the control. 
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Fig. 3.29. Modulation of the basal (—•—) and 56 mM K+ - stimulated (—#—) release of [^H]DA 
from foetal rat hypothalamic cells in culture by Prog (DIV 10). Results represent the mean ± s.e.m. 
n=4. * p < 0.05, * * p < 0.005 compared with release in the absence of the steroid. 
3.5.3. Endogenous DA release and E2. 
The influence of E2 on the release of endogenous DA was also investigated 
(Fig. 3.30). Cells were grown in a defined medium containing a range of 
concentrations of the gonadal steroid from lO ^^  to lO'^M and the effect on DA 
release was observed. On DIV 7, both basal and 56mM K+ - stimulated release of 
DA were adversely affected when the cells were grown in the total absence of E2. At 
a concentration of 10" E2 both basal and depolarization-induced release of DA 
were at a maximum, while higher concentrations of the steroid caused a significant 
attenuation of release and also reduced the magnitude of response to 56mM K+, 
although the cells continued to respond significantly to the depolarizing stimuli. 
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Fig. 3 JO. Modulation of the basal (—O—) and 56mM K+ induced (-#—) release of endogenous DA 
from foetal rat hypothalamic cells in primary culture by E2 (DFV 7). Results represent the mean ± 
s.e.m. n = 4. * p < 0.01, * * p < 0.005 release in the presence of E2 compared with release in the 
absence of the steroid. 
On very late ages in vitro (DIV 28, Fig. 3.31) DA release was reduced and the pattern 
of responsiveness to E2 changed. The output of DA from those cultures maintained 
in the absence of the steroid was not significantly different from that of cells grown in 
medium containing the steroid at a concentration of lO'^^M. Optimal depolarization -
induced output of DA was observed from cells grown in lO'^^M E2 and was again 
reduced at higher concentrations. Basal release appeared to be unresponsive to 
changes in E2 levels at this stage in culture. 
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Fig. 3.31. Modulation of basal ( — • — ) and 56mM K+ induced (-#—) release of endogenous DA 
firom foetal rat hypothalamic cells in primary culture by E2 (DIV 28). Results represent the mean ± 
s.e.m. n = 4. * p < 0.05 for depolarization induced release at 10"^ ®M E2 compared with release in the 
absence of the steroid. 
3.5.4. The Effect of E2 on GABA - ergic Neurone Activity. 
As the GABA -ergic systems within the hypothalamus are also considered to be 
linked to neuroendocrine regulation and have been reported to be oestrogen 
responsive (Herbison 1989), a similar experimental design was employed to monitor 
the effect of E2 on the uptake and release of [^H]GABA. 
Unlike the uptake of [^HJDA, [^HJGABA uptake was totally unresponsive to 
steroidal modulation. E2 failed to affect the degree of uptake on any of the days in 
culture investigated from DIV 7 to DIV 17 (3.32, shows the unresponsiveness of 
[^H]GABA uptake to E2 on DIV 7 and 17). 
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Fig. 3.32. Lack of modulation of the uptake of [^H]GABA into foetal rat hypothalamic cells in 
primary culture by E2, on DIV 7 ( -Q—) and DIV 17 (—#—). Results represent the mean ± s.e.m. 
n = 4. 
Investigations to determine the influence of E2 on the release of pre-accumulated 
[^HjGABA showed a different pattern of modulation to that observed for [%]DA. 
The release of [^HJGABA, like that of its uptake, was unresponsive to changes in E2 
concentration during early stages of in vitro development (viz prior to DIV 18). 
However as culture age increased, the release mechanism for tritiated GABA became 
steroid sensitive and 56 mM K+ stimulated release of GABA was modulated by 
altered E2 levels, although basal release remained unaffected. On DIV 18 
depolarization induced release of [^H]GABA was optimal at a concentration of 
10-10ME2(Fig. 3.33). 
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Fig. 3.33. Modulation of the basal ( - * — ) and 56mM K+ induced ( - 0 — ) release of [^HJGABA 
from foetal rat hypothalamic cells in primary culture, by E2, (DIV 18). Results represent the mean ± 
s.e.m. n = 4. * p < 0.05 for 56mM K+ induced release at lO'^^M steroid compared with release at 10' 
which was theconcentrationof E2 routinely used in the defined medium. 
3.5.5. Discussion. 
In this series of experiments we have demonstrated that E2 and Prog significantly, but 
differentially, modulate hypothalamic dopaminergic neuronal function, even at very 
early stages of development. 
In the presence of a constant background level of Prog (lO'^M), both basal and 
potassium - stimulated release, whether of endogenously synthesised (at early time 
points in culture) or pre - accumulated [3H]DA, was optimal at a concentration of 
(Figs 3.27. and 3.30). At lower concentrations of E2 (< 10"^^M), the 
magnitude of the depolarization - induced response (as judged by the percentage 
increase above basal), was reduced to less than one - seventh of that observed at the 
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optimal concentration, while higher concentrations of E2 (viz. lO'^ ® - lO'^M), 
virtually suppressed the response to elevated potassium. In contrast, Prog, in the 
presence of 10" E2, effectively reduced both basal and K+ - stimulated release of 
[3H]DA at all concentrations tested. However, the magnitude of response to 
depolarization, expressed as the percentage above basal, was only moderately reduced 
(by no greater than 40% compared with that observed in the absence of Prog) by any 
concentration of the steroid. 
Prog also profoundly reduced [^H]DA uptake and this effect was maximal even at the 
lowest concentration tested (lO'^^M). In contrast, E2 facilitated uptake maximally at 
a concentration of lO'^^M, although both lower and higher levels of E2 attenuated 
uptake in a concentration - dependent fashion. We do not believe that the effect of E2 
on the release of [%]DA was purely a reflection of the increased level of uptake as 
the concentration of E2, at which uptake was maximal differed by two orders of 
magnitude from the level of E2 which maximally potentiated [^H]DA release. 
Furthermore, other studies involving the investigation of uptake and release 
mechanisms indicate that the two systems do not alter in parallel as discussed in 
Sections 3.2 and 3.3). 
To summarize the effects of these two gonadal steroids on both uptake and release, it 
appears that the actions of E2 on dopaminergic transmission are biphasic while those 
of Prog are universally suppressive. Furthermore, whereas 1 0 " a n d 10"^ ® - lO'^M 
E2 almost totally blunted the DA neurones' ability to respond to a depolarizing 
stimulus. Prog modulated this response only slightly. Thus, while both steroids 
influence dopaminergic transmission, they appear to do so via distinctly different 
mechanisms. 
It is well established that E2 and Prog act in concert in many tissues, including the 
hypothalamus. For example the stimulatory effects of E2 on TH activity in the 
median eminence, as well as the effect of E2 on DA uptake site expression, are 
enhanced in the presence of Prog (Wang & Porter 1986). Such interactions cannot be 
ruled out in our culture system and the actions of each steroid individually may differ 
significantiy from their combined action. Further studies would therefore be required 
to ascertain any possible synergism between E2 and Prog which may be occuring in 
vitro. 
A responsiveness of hypothalamic dopaminergic pathways to gonadal steroids is 
highly relevant to neuroendocrine control, both perinatally and at later time - points in 
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development. During the perinatal period, gonadal steroids exert important 
"organizational" actions in the brain and especially in the hypothalamus, whereas in 
the adult the gonadal steroids influence hypothalamic function by actions which are 
known as "activational" processes. Such actions have profound effects on the HP -
axis, at the onset of puberty and in adult life (Arnold & Gorski 1984). Thus, 
castration of the male rat immediately after birth, results in the emergence of female 
patterns of LH release, including pre - "ovulatory" LH - surges, as well as the 
characteristic female pattern of GH secretion. Although perinatally many of these 
influences are androgen - dependent, they are believed to be mediated via E2 
receptors after the conversion of testosterone to E2 by aromatases which are widely 
distributed within the foetal CNS (Canick et al 1986). Surprisingly therefore, neither 
GnRH neurones (Shivers et al 1983) nor the SRIH containing cells of the PeVN 
(Herbison et al 1993) possess E2 receptors which suggests that an intermediary 
neurotransmitter is involved. Our results provide evidence that intrahypothalamic 
dopaminergic systems may play a role during the organizational period as they 
display distinct responsiveness to E2 and Prog at this critical time point in 
development. As yet we are unable to distinguish which of the several 
intrahypothalamic DA systems are involved. 
The mechanisms via which gonadal steroids influence dopaminergic neurone function 
are not fully understood and most studies have been performed in the adult. The 
effect of E2 alone in regulating TIDA activity is a subject of great controversy and it 
has been ascribed both a stimulatory (Gunnet et al 1986) and an inhibitory (Arita et al 
1990; Tong & Pelletier, 1991; Pasqualini et al 1993) role. The literature largely 
favours the latter and evidence suggests that it is via an inhibitory action on the I'lDA 
system that E2 stimulates the release of prolactin (Reymond et al 1978; Ferland et al 
1979). Levels of DA in the ME and hypophyseal portal blood are significantly 
reduced on the morning of pro - oestrous when E2 levels are high and chronic 
exposure of TIDA to E2 has an intense inhibitory action on TIDA activity. By 
contrast, ovariectomy results in a steroid reversible reduction of TIDA performance in 
the ME (Gunnet et al 1986), which suggests a stimulatory action of E2 on TIDA 
neuronal function. 
Reports suggest that E2 may either attenuate (Michel et al 1987;) or enhance (Engele 
et al 1989 Morrisetti et al 1993) DA uptake. Such discrepancies in the literature may 
arise due to differences in the experimental preparation although, the biphasic nature 
of the actions of E2 on [^HjDA uptake demonstrated in our studies suggest that the 
concentration employed is critical. Both the inhibitory and stimulatory effects of E2 
on DA transport may be mediated via a direct action of the steroid with its 
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intracellular receptor leading to either up or down - regulation of the DA transporter 
protein and hence an increase in uptake site expression. It has also been suggested 
that E2 may act directly in the neuronal membrane causing functional distortions 
which may or may not be physiologically relevant depending on the concentration. It 
has been suggested that significant degeneration of TIDA neurones is caused by 
exposure of the cells to high E2 concentrations during experimentation (Sarkar et al 
1982). It could therefore be argued, that the effect of the higher concentrations of E2 
in inhibiting the uptake and release of DA may be due to general cell death as a result 
of neurotoxicity. We do not however believe that this is the case, as observation of 
the cultures under the light microscope did not reveal any differences, in terms of 
their morphology and size, in the cells grown in high concentrations of the steroid 
compared with those maintained in lower, more physiological levels of the steroid. 
The activity of the TIDA system is regulated by circulating levels of both E2 and 
Prog. The effect is likely to be mediated by a direct action of these steroids at their 
respective receptors which are known to be present on the DA - containing cells of 
this pathway (Sar et al 1984, 1988). Furthermore, some of the TIDA neurones will 
posses both E2 and Prog receptors (90% of them posses progesterone receptors). The 
physiological significance of this, in terms of the regulation of neurohormone release 
is yet to be fully established but evidence suggests that these two steroids have clearly 
distinct actions. Thus, in ovariectomized animals E2 administration results in daily 
LH surges whereas Prog treatment advances and amplifies peak plasma 
gonadotrophin concentrations (De Paola & Barraclough 1979). These effects are 
strongly considered to be mediated via DA and we propose that the different actions 
of E2 and Prog on DA uptake and release demonstrated in our culture model may 
indicate a mechanism whereby these two sex steroids may exert their differential 
effects on gonadotrophin release. 
Endogenous DA was also affected by E2 and it is possible that the steroid exerts its 
influence on DA synthesis as well as release. Chronic administration of E2 has been 
reported to inhibit K+ induced release of DA Aom the median eminenc via an action 
on neurotransmitter synthesis (Wang and Porter 1986). Thus, in our investigation, the 
inhibition of depolarization - induced release of endogenous DA by levels of E2 from 
10 -10 to lO'^M may be reflecting a disruption of its synthetic pathway, whereas the 
lower more physiological concentrations (lO'^^M) may actually increase the 
expression of the synthetic enzymes. 
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The activity of the ICHDA neuronal system is also believed to be steroid responsive 
in vivo (Gunnet et al 1986) and in vitro (Sanghera et al 1991). A number of reports 
have documented a modulatory effect of ICHDA turnover by E2 and these effect are 
considered to be direct actions mediated via E2 receptors located on ICHDA neurones 
(Sar et al 1984). Furthermore, the rostral and caudal portions of the ICHDA tract 
have been shown to be differentially but directly modulated by E2 (Gunnet et al 1986; 
Lookingland and Moore 1984b). Pharmacological studies have also shown that the 
ICHDA tract and more specifically the rostral component of this tract, serves to 
regulate the release of GnRH (MacKenzie et al 1984; 1988; James et al 1987; Leranth 
et al. 1988) and that catecholamine systems in this area may thus be steroid 
responsive (Wilson et al 1991). In support of this view, DA antagonists have been 
shown to abolish ovulation presumably by prevention of the preovulatory luteinizing 
hormone surge (MacKenzie et al 1986). Clearly, in its present form, this model does 
not allow for a differentiation of DA neuronal sub - populations, but microdissection 
of the hypothalamus at a later stage of development may provide additional 
information. 
The physiological relevance of the steroid concentrations achieved in any 
experimental design are difficult to determine, although we would argue that those 
used in the present investigation may well be within the range reported for circulating 
levels found in vivo. For example, plasma concentrations of oestradiol of 2 x lO ^M 
have been reported in the newborn rat (Pang et al 1979), while maternal levels of E2 
are in the order of 1 x lO'^M at day 14 of gestation (Shiverick et al 1983) and are 
known to increase further at parturition. Furthermore, in the adult female rat, during 
the course of the oestrous cycle, levels of circulating E2 range from 2 x 10"! ^  to 1.6 x 
10" 10m (Smith et al 1975). Predictions of CNS steroid levels are however, 
complicated by the actions of aromatase enzymes converting circulating androgens to 
E2 and also by sex hormone binding globulins which regulate circulating levels of 
oestrogens (Ekins 1990). Furthermore, the exact role played by sex steroids and their 
binding globulins in the developing CNS are not fully understood. Despite this, we 
suggest that the very low levels of E2 and Prog (lO'l^ " lO'^^M), which had 
significant effects on dopaminergic neurone function in our culture model, are likely 
to be physiologically appropriate. 
In contrast to the dopaminergic systems in our cultures, we found that both 
[3H]GABA uptake and release demonstrated an insensitivity to changes in E2 levels 
during early and mid - stages of in vitro development. While the lack of 
responsiveness persisted for uptake at later stages of the investigation (DIV 18), the 
K+ - induced release of [^HJGABA was enhanced at IQ-l^M E2. Studies observing 
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GABA release (Herbison et al 1989), turnover (Mansky 1982), and ICC co-
localization of glutamic acid decarboxylase (GAD) with E2 receptors (Tappaz 1983), 
suggest that GABA - ergic systems are E2 responsive in the adult hypothalamus. 
Thus, the appearance of a responsiveness of the GABA - ergic neurones to E2 in our 
culture model may indicate the emergence of a pre - programmed pattern of 
development which merits further investigation. The importance of Prog levels 
should also be investigated as our studies, titrating E2 concentrations in the medium 
have, so far been performed only in the presence of lO'^M Prog. 
In conclusion, we have demonstrated that the activity of at least one sub - population 
of dopaminergic neurones within the foetal cell culture model is responsive to the 
actions of both E2 and Prog but that these actions are different and most likely 
mediated via distinct mechanisms. These studies have also revealed that gonadal 
steroid influences on hypothalamic GABA - ergic neurones occur in a manner which 
is distinctly different from that exerted on dopaminergic neurones. We conclude 
therefore that the gonadal steroids are not merelv influencing neuronal development 
in a non-specific manner (e.g. behaving as a neurotrophic factor) but thev specificallv 
and differentially influence the maturation and/or function of discrete populations of 
hypothalamic neurones involved in the control of endocrine function. We have also 
shown that the nature of response to each steroid depends critically on its 
concentration and it is therefore possible that the contradictory roles ascribed to E2 
concerning its influence on adult dopaminergic function as found in the literature, 
may be due to fundamental differences in the dose and regimen employed for 
individual experiments. 
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3.6. Regulation of DA Activity by GABA-ergic Agents. 
Over 80% of neurones within the hypothalamus possess G A B A A receptors (Purdy et 
al 1991) and there is evidence for an interaction between the dopaminergic and 
GABA-ergic systems of the hypothalamus in the regulation of neuroendocrine 
function. Therefore, we investigated the influence of drugs which influence G A B A -
ergic transmission on the release of endogenous DA from the cultures. Incubation 
periods of 60min in the presence of the drugs were employed and DA release was 
measured using HPLC -EC. 
3.6.1. MUSCIMOL and Endogenous DA Release. 
Fig. 3.34. shows that the release of endogenous DA from the hypothalamic neurones 
was significantly attenuated by the G A B A A receptor agonist, muscimol, when used at 
a range of concentrations from lO'^ to lO'^M (* p < 0.04, ** p < 0.002) 
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Fig. 334. The effect of muscimol on the release of endogenous DA from foetal rat hypothalamic cells 
maintained in primary culture during 1 hour incubations (DIV 8). Results represent the mean ± s.e.m. 
n = 4. * p < 0.05, * * p < 0.002 compared with basal release. 
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3.6.2. BICUCULLINE and Endogenous DA Release. 
The G A B A A receptor antagonist, bicuculline, was stimulatory on the release of 
endogenous DA at concentrations between 10"^  - 10"^M as depicted in Fig. 3.35. 
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Fig. 3.35. The effect of bicuculline on the release of endogenous DA from hypothalamic 
dopaminergic neurones in primary culture during 1 hour incubations (DIV 7). Results represent the 
mean + s.e.m. n=4. * p < 0.005, ** p.< 0.0001 compared with basal release. 
3.6.3. BACLOFEN and Endogenous DA Release. 
The G A B A B receptor agonist, baclofen, like the G A B A A receptor agonist, muscimol, 
inhibited the release of endogenous DA (Fig. 3.36). At concentrations of 10-8,10-7 
and lO'^M, DA release was significantly lower than that of the control (* p < 0.05, ** 
p < 0.02) and at a concentration of lO'^M the amount of DA released was below the 
limits of detection. 
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Fig. 3.36. The effect of baclofen on the release of endogenous DA from hypothalamic dopaminergic 
neurones in primary culture during 1 hour incubations (DIV 10). Results represent the mean + s.e.m. 
n=4. * p < 0.05, * * P < 0.02 compared with basal release. ND = not detectable. 
3.6.4. SKF 89976 A and Endogenous DA Release. 
Fig. 3.37 illustrates the effect of the specific inhibitor of GAB A uptake into neuronal 
cells, SKF 89976 A on endogenous DA release. An increase in the release of DA was 
observed in the presence of 10"^ and lO'^M SKF 89976 A, but the higher 
concentrations of the inhibitor reversed this stimulatory effect. 
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Fig. 337. The effect of SKF 899876 A on the release of endogenous DA from foetal rat hypothalamic 
cells maintained in primary culture during 1 hour incubations (DIV 9). Results represent the mean ± 
s.e.m. n=4. * p < 0.05, ** p.< 0.02 compared with basal release. 
These observations prompted the study of the effect of drugs influencing GABA-ergic 
transmission on the release of pre-accumulated [^H]DA as such an approach required 
fewer hypothalamic cells, could be performed more quickly and could thus 
potentially provide a more economic model for the investigation of GABA-ergic 
influences on DA release. However results were not direcdy comparable as initial 
investigations showed that muscimol failed to modulate [^HJDA release using our 
standard 7 min incubation period. Therefore, the experimental design was modiAed 
to observe the time - course of the effects of these drugs on [%]DA release during a 7 
min incubation period followed by a 20 min incubation period. 
3.6 J. MUSCIMOL and [^H]DA Release. 
Fig. 3.38 demonstrates the response of [^HJDA release to the G A B A A receptor 
agonist, muscimol (10"^ to 10 -^M). Over a 7 min incubation period the drug failed to 
alter the output of [^HJDA with the exception of the highest concentration employed 
(lO'^M), when a slight yet significant stimulatory effect on release was observed 
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(*p < 0.05). In contrast, during the 20 min incubation, a significant (** p < 0.02) 
attenuation of release was achieved by concentrations of muscimol of 10"^ and 
10-5M. 
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Fig. 3.38. The effect of muscimol on the release of [^H]DA from hypothalamic dopaminergic 
neurones during 7 min (—•—) and 20 min ( # ) incubation periods (DIV 18). Results represent 
the mean ± s.e.m. n=4. * p < 0.05, ** p < 0.02 compared with the control. 
3.6.6. BICUCULUNE and [^HJDA Release. 
The G A B A A receptor antagonist, bicuculline was effective in modulating the release 
of [3H]DA during both 7 min and 20 min incubation periods (Fig. 3.39). Low 
concentrations of the drug (10'^ and lO'^M) significantly increased the magnitude of 
[3H]DA release during the 7 min incubation and lO'^M, bicuculline also significantly 
increased [3H]DA release during the 20 min incubation period. In both instances, the 
higher concentrations of the antagonist reduced [^H]DA release, compared with the 
release of [^HJDA observed with lO'^M. During the 7 min incubation, lO'^M 
bicuculline was still higher than the control whereas with 20 min incubation, release 
at this concentration was significantly lower than that of the control. 
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Fig. 3J9. The effect of bicuculline on the release of [^H]DA from foetal rat hypothalamic cells in 
culture, during 7 min ( — • — ) and 20 min (—•—) incubation periods (DIV 18). Results represent the 
mean ± s.e.m. n=4. * p < 0.05, ** p.< 0.02 compared with the control. 
3.6.7. BACLOFEN and l^H]DA Release. 
The G A B A B agonist, baclofen, demonstrated a biphasic modulation of [3H ]DA 
release as illustrated in Fig. 3.40. During a 7 min incubation period lower 
concentrations of the drug (lO'^M), significantly (* p < 0.05), potentiated the release 
of pre-accumulated [^H]DA. During both 7 and 20 min incubation periods, the 
release of [%]DA was slightly but significantly (** p < 0.002) attenuated by baclofen 
at a concentration at lO'^M. In both instances, in the presence of the highest 
concentration of the drug, [^HjDA release was not significantly different to that of the 
control. 
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Fig, 3.40. The effect of baclofen on the release of [^HIDA from foetal rat hypothalamic cells in 
primary culture, during 7 min ( — • — ) and 20 min incubation ( - # — ) periods (DIV 18). Results 
represent the mean + s.e.m. n=4. * p < 0.05, ** p.< 0.002 compared with the control. 
For ease of comparison, the data for this series of experiments is reproduced in 
tabulated form as presented below (Tables 17 and 18). 
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Table. 17.0. Summary of the effects of GABA-ergic agents on the release of 
endogenous DA from hypothalamic cells in primary culture. 
AGENT CONCENTRATION % RELEASE OF STATISTICAL 
(M) BASAL SIGNIFICANCE 
(p value) 
MUSCIMOL 10-9 61.9 ±2.0 <0.05 
10-7 64.8 + 1.6 <0.05 
10-5 40 ±1.57 <0.002 
BICUCULLINE 10-8 80 ±2.3 NS 
10-7 92 ±1.1 NS 
10-6 155 ± 4.49 <0.05 
10-5 323 ±3.12 <0.001 
10-4 279 ±2.9 <0.001 
BACLOFEN 10-8 51.6 ±0.83 <0.05 
10-7 41.6 ±4.29 <0.02 
10-6 33.5 ±2.12 <0.02 
10-5 ND 
SKF 89976 A 10-8 110 ±3.85 NS 
10-7 158 ±2.21 <0.02 
10-6 136 ±1.36 <0.05 
10-5 110.3 ±2.06 NS 
10-4 74 ±2.0 <0.05 
NS = not significantly different from basal release. 
ND = not detectable. 
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Table. 18.0. Summary of the effects of G A B A A and B receptors agonists and a 
G A B A A antagonist on the release of [^HJDA from foetal hypothalamic cells in 
primary culture. 
AGENT CONCENTRATION 
(M) 
% RELEASE OF BASAL 
7 min incubation 20 min incubation 
MUSCIMOL 10-9 108 ± 7.96 107 ± 4.3 
10-7 110 + 2.22 73.2 ±3.27** 
10-5 11611.11* 79 ± 1.71* 
BICUCULLINE 10-9 117 + 1.1** 111 ±1.3** 
10-7 131 ±2.73** 124.7 ± 3.0** 
10-5 106 + 5.6* 87 ±4.17* 
BACLOFEN 10-9 113 ±4.21* 110.6 ±1.41* 
10-7 83.4 ± 4.4** 79.1 ±0.99** 
10-5 93.5 ± 2.6 94.1 ±4.52 
* p < 0.05, **p< 0.02 compared with basal release. 
3.6.8. Discussion. 
The literature provides support for an intimate relationship between the dopaminergic 
and GABA-ergic systems within the hypothalamus. Like DA, G A B A is found in 
relatively high concentrations throughout the hypothalamus and especially in the 
preoptic, anterior and dorsomedial nuclei. Due to the fact that as many as 80% of all 
the neurones within the hypothalamus possess G A B A A receptors it is likely that at 
least one population of DA containing cells within the hypothalamus are G A B A -
responsive. 
In this series of experiments the release of endogenous DA was significantly 
modulated by agents which influence GABA-ergic transmission. The results suggest 
that there may be a complex mixture of G A B A A and G A B A B receptors located both 
on the cell bodies and terminals of the dopaminergic and GABA-ergic cells within 
our culture preparation (Fig. 3.41). BicucuUine elicited a dose - dependent increase in 
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DA output suggesting that the GABA-ergic neurones intrinsic to the cultures exert an 
inhibitory tone on D A secretion, via a G A B A A receptor mediated action. 
Fig. 3.41. Schematic representation of the putative locations of G A B A A and 
G A B A B receptors on the dopaminergic neurones within the hypothalamic culture 
model. 
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This was confirmed by the action of muscimol which effectively attenuated DA 
secretion at all concentrations tested. The G A B A B agonist baclofen also suppressed 
DA release, and was in fact, considerably more effective than muscimol, virtually 
abolishing D A release at the highest concentration. The G A B A B antagonist 
phaclofen however, failed to enhance output at any concentrations tested from 10'^ to 
10"^  (data not shown). This may imply that G A B A B receptors are not involved in the 
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inhibitory tone exerted by endogenous GABA on dopaminergic activity. However, in 
view of the potent effects of baclofen, plus our knowledge that significant amounts of 
GABA are released from these cultures over the incubation time studied (GUlies et al 
1992), it is more likely that the GABAg type receptors influencing DA secretion from 
these perinatal neurones are not effectively blocked by phaclofen. 
G A B A A receptors are classically located post-synaptically, and cause the inhibition 
of neurotransmitter release via an action at chloride channels (Bormann 1988, 
Fig. 3.41). We therefore propose that endogenously produced G A B A continually 
activates G A B A A receptors on the dopaminergic cell body and in this way suppresses 
cell firing and D A secretion. The actions of GABAG receptor agonists/antagonists 
are however, more likely to be pre-synaptic, thus DA release is inhibited via a 
decrease in Ca^+ conductance and an increase in K+ conductance (Bormann 1988, 
Bowery, 1989) at the dopaminergic nerve terminal (Fig. 3.41). 
While the GABA receptor agonists/antagonists demonstrated classical inhibitory/ 
disinhibitory effects on DA secretion, the uptake inhibitor SKF 89976 A modulated 
DA activity in a biphasic manner. Significant stimulation of DA release was elicited 
by low concentrations of the inhibitor while higher concentrations reversed this effect 
and caused a marked decrease in DA output. We propose that this pattern of 
modulation of DA is due to the dual action of the uptake inhibitor at the GABA-ergic 
nerve terminals. It has been reported that a number of neurotransmitter uptake 
inhibitors, whose mechanism of action involves a disruption of the movement of the 
transporter protein, display a secondary action by preventing neurotransmitter release 
(Westemick et al 1985). Furthermore, a component of GABA release is considered to 
be via a carrier - mediated and Ca^+ - independent mechanism (Arias & Tapia 1986). 
Thus, it is feasible that the action of SKF 89976 A may disrupt both the release and 
uptake of GABA at the nerve terminal by nature of its interaction with the transporter 
protein. At lower concentrations SKF 89976 A may thus act predominantly to 
prevent GABA release acting presynaptically via GABAg receptors located on 
GABA-ergic nerve terminals, resulting in a decreased concentration of GABA and a 
subsequent rise in DA release due to disinhibition. This effect is then reversed by the 
higher concentrations of SKF 89976 A where the inhibition of uptake becomes the 
predominant property of the drug and thereby elevates transynaptic GABA levels and 
elicits classical inhibitory actions on DA output. 
Alternatively, SKF 89976 A may have a local action viz. at the nerve terminal and 
thus it is possible that the minor increase in synaptic levels of GABA caused by low 
concentrations of the inhibitor may only be sufficient to act pre-synaptically, causing 
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activation of G A B A G receptors located on their own nerve terminals (autoreceptors 
Anderson & Mitchell 1986). This results in a decrease of G A B A release at this site 
with disinhibition of the dopaminergic neurones as argued above. However, as the 
concentration of SKF 89976 A is increased, the levels of G A B A within the synaptic 
cleft are significantly elevated and act post - synaptically on G A B A A receptors thus 
attenuating D A output. In addition, the G A B A which has failed to be re - uptaken 
may also diffuse to G A B A B receptors located on dopaminergic nerve terminals and 
may also exert an inhibitory influence on DA release at this site (Fig. 3.41). 
When this series of experiments was repeated to investigate the effects of the 
agonists/antagonists on the release of [3H]DA, we were made aware of the 
importance of the time - course over which certain G A B A - ergic agents had their 
effect. Thus, an inhibitory action of muscimol on [3H]DA release was not observed 
during a 7 min incubation period but this does not necessarily imply that the agonist 
was not having an effect. It is possible that over this time period both endogenous 
and [3H] DA are inhibited by muscimol. However, if the G A B A A receptor agonist 
acts preferentially on endogenous DA the inhibition of its output would result in an 
increase in the intraneuronal concentration of the amine which could subsequentiy 
cause the displacement of [%]DA from the nerve terminals. Thus at lower 
concentrations the action of muscimol on [3H]DA may be "cancelled out" by the 
action of endogenous DA causing its displacement, while at the highest concentration 
(lO'^M) the increase in endogenous DA concentrations could be sufficient to cause an 
apparent rise in [3H]DA output. When the cultures were subjected to a further 20 min 
exposure an inhibition of [^HJDA release was noted, suggesting that the agonist was 
now acting equally on the stores of both endogenous and [^H] DA. It was however, 
less potent on [3H]DA release than on endogenous DA release which suggests that 
the store into which the [^HJDA is sequestered is not as susceptible to an inhibitory 
influence as endogenous DA stores. 
The action of bicuculline on [3H]DA release was however evident within the first 7 
min incubation period but the response was markedly different to that shown by 
endogenous DA. First, the antagonist was more potent on [^H] than endogenously 
synthesised DA with concentrations of lO'^M and 10"^M significantly enhancing 
[3H]DA output (these concentrations were ineffective in stimulating endogenous DA 
release). This adds further evidence to our proposal that [3H]DA and possibly 
endogenous re-captured DA, is located in different intracellular pools to those for 
endogenously, newly synthesised amine and that [3H]DA may be more readily 
mobilized for release. Second, while the release of endogenous DA continued to 
increase with higher concentrations of bicuculline, [^HJDA secretion was 
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significantly attenuated by the highest concentration of the antagonist employed. As 
bicuculline is a potent stimulator of endogenous DA release we propose that at the 
higher concentrations the degree of receptor blockade and therefore disinhibition is 
sufficient to cause the release of newly synthesised DA, in preference to the [^HJDA 
held in "older" stores (Cerrito, 1980; Tauc 1982). Thus, while the total amount of 
DA output may have increased with high concentrations of bicuculline (as was seen 
in experiment 3.6.2), the amount of [^H]DA released (and measured) experienced a 
decline. 
While baclofen was very potent on endogenous DA release and reduced output to 
virtually zero, the pattern of its effect on [3H]DA release was significantly different 
and more complex. The apparent and significant stimulation of [%]DA release at 
lO'^M baclofen may again be due to the action of the agonist on the endogenously 
produced transmitter, causing an increase in endogenous DA stores and the 
displacement of [3H]DA from its storage sites. The inhibition of [^HjDA seen with 
higher concentrations of baclofen may be due to direct actions of the agonist acting 
postsynaptically on dopaminergic nerve terminals. 
The differences in the profiles of actions of these various GABA - ergic agents are 
likely to be reflective of the differences in behaviour of [^H] and endogenous DA 
over short periods of incubation. It appears that [^HJDA is in a more readily 
releasable pool than endogenous DA and that the endogenously produced amine is 
more sensitive to inhibition than [^HJDA. Differences in response could also depend 
on whether inhibitory influences operate through post - synaptic (perikarya/dendritic) 
or pre-synaptic (axonal/nerve terminals) receptors. Ideally these experiments should 
be repeated for 7 and 20 min incubations for endogenous DA, but they do however, 
serve to caution against interpreting results from pharmacological studies involving 
[%]DA release alone. The complexity of the interactions between GABA - ergic and 
dopaminergic systems appear to demand that any investigation into their activity is as 
close to the "normal" condition as possible, monitoring changes in the behaviour of 
the naturally occuring neurotransmitter. Furthermore, the time frame in which these 
drugs exert their pharmacological action appears to be crucial and is complicated by 
either short (7 min for [^HJDA), or long (60 min for endogenous DA) incubation 
periods. The discrepancies highlighted in this series of studies mark the major 
differences in these two approaches for studying dopaminergic activity and merit 
further investigation. 
ICC studies reveal that neurones exhibiting immunoreactivity for GAD and TH lie in 
close proximity within the region of the zona incerta (Oertel et al 1982). 
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Furthermore, electron microscopical studies used in conjunction with ICC, provide 
ultrastructural evidence that GAD - immunoreactive neurones form synaptic contacts 
with TH - immunoreactive neurones in the region of the Arc and axoaxonic and 
dend jitic connections between the two neuronal systems are indicated in the Arc, 
periventricular zone and also at the level of the ME. Moreover, co-localization of the 
two neurotransmitters within the Arc has been reported, from which both the 
tuberoinfundibular dopaminergic and GABA-ergic systems are considered to emerge 
(Everitt et al 1984). 
Functional evidence for an interaction between hypothalamic dopamine and G A B A -
ergic tracts stems from their involvement in the regulation of neuropeptide release. 
For example, G A B A , DA and GnRH, nerve terminals are reported to lie in close 
proximity both in the preoptic area and within the Arc/ME complex, as revealed by 
immunocytochemical studies (Van den Pol, 1986; Sakaeu et al 1988). In addition, a 
technique combining anterograde tracing coupled with acute neurodegeneration of 
DA neurones with the neurotoxin 6-OHDA, revealed that DA containing cells 
emerging from the area of the zona incerta impinge upon both GnRH and GABA 
immunoreative neurones. It is widely believed that all three neurochemicals interact 
at the level of the hypothalamus to control the episodic release of LH and also the 
preovulatory LH surge (MacKenzie et al 1988). Interestingly, it appears that DA and 
G A B A display opposing effects on GnRH release depending on the neuronal 
population under investigation i.e. which GABA/dopamine - ergic system is involved, 
and the area of the hypothalamus at which they are acting. Demling et al (1985) 
reported that the release of GnRH at the level of the MPOA is inhibited by G A B A 
whereas by contrast, DA stimulates GnRH release at this site (MacKenzie et al 1988). 
Moreover, DA has an inhibitory influence on GnRH at the level of the Arc/ME 
complex (McCann et al 1986; Jarry et al 1986), while G A B A has a paradoxical effect 
on GnRH neurones at this site, stimulating its secretion. Direct evidence may also be 
found in the literature for a modulatory action of G A B A on dopaminergic activity. 
Thus, i.c.v. injection of muscimol reduces DA turnover in the anterior mediobasal 
hypothalamus (Fuchs et al 1984) and also the release of [^HJDA from synaptosomal 
preparations of median eminence tissue (Anderson & Mitchell 1986). Moreover, a 
tonic inhibition of dopaminergic transmission by G A B A via G A B A A receptor 
activation has been reported for other brain regions including the striatum (Kalivas et 
al 1990). 
To add further complexity to the proposed interactions between DA and GABA, it is 
likely that they may both serve as mediators for steroid feedback processes occuring 
at the level of the hypothalamus. In certain regions of the CNS it is reported that TH -
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immunoreactive neurones do not possess oestrogen receptors. For example, in the 
preoptic area of the hypothalamus, the dopaminergic neurones which were once 
assumed to be the direct target of steroid mediation of neuroendocrine responses, 
appear not to contain E2 receptors (Herbison et al 1992). However, in the same 
region there are GABA - ergic neurones which do possess oestrogen receptors which 
lie in close proximity to these THIP, E2 receptor - negative cells. It is therefore 
possible that the hormonal influences exerted by gonadal steroids on certain sub -
populations of dopaminergic neurones within the hypothalamus are not direct, but 
rather are mediated via steroid responsive intermediates such as the intrahypothalamic 
GABA - ergic systems. 
Thus, although there appear to be some fundamental differences in the behaviour of 
[^H] and endogenous DA in response to drugs affecting GABA-ergic transmission, 
there is still a body of evidence emerging from this series of experiments to support 
an interaction between dopamine and GABA containing systems intrinsic to this 
hypothalamic cell culture model. The close anatomical and functional association of 
the dopaminergic and GABA-ergic neurones in the hypothalamus may be the basis by 
which these two neurotransmitters act in conjunction to regulate certain parameters of 
neuroendocrine function. 
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3.7. Other Modulatory Factors. 
We have previously discussed the role played by DA in the regulation of both PRL 
and GnRH secretion (Section 1.8). We therefore determined to investigate whether 
either of these factors exerted a feedback influence on hypothalamic dopaminergic 
neurones. 
3.7.1. Prolactin. 
We investigated the effect of prolactin on the release of endogenous DA from the 
hypothalamic cultures, at a range of concentrations from lO'l^ to Kh^M but the 
release of endogenous DA from the cultures was not significantly affected. The 
experiment was repeated at a later time-point in culture (DIV 15) where prolactin also 
failed to modulate release. 
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Fig. 3.42. Lack of modulation of the basal release of endogenous DA from rat foetal hypothalamic 
cells in culture, by exogenous prolactin. Cells were incubated in sEBSS containing a range of 
concentrations of prolactin from 10"^^ to lO'^M for 1 hour durations (DIV 7). Results represent the 
mean ± s.e.m. n=4. 
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3.7.2. Gonadotrophin - Releasing Hormone (GnRH). 
We also investigated the action of GnRH at a range of concentrations from lO'l^to 
lO'^M on the release of endogenous DA from the hypothalamic cells in culture. On 
DIVll, GnRH at low concentrations (lO'l^ to lO'^M) significantly elevated 
endogenous DA release while the higher concentrations were without effect. 
However, on DIV16, release was unaffected by the lower concentrations of the 
peptide i.e. and lO'^M, while, in this instance higher concentrations of the 
peptide from 10"^  to lO'^M, were stimulatory on DA output which was optimal at a 
GnRH concentration of 10"^M. Thus, with increasing culture age there was a 
decrease in the sensitivity of the DA neurones to modulation by this neurohormone. 
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Fig. 3.43. Modulation of the basal release of endogenous DA from foetal rat hypothalamic cells in 
culture, by exogenous GnRH. Cells were incubated in sEBSS containing a range of concentrations of 
the neurohormone from 10"^ ® to lO'^M for 1 hour durations on DIV 11 ( B ) and DIV 16 (—•—) . 
Results represent the mean ± s.e.m. n=4. * p < 0.05, ** p.< 0.025. 
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3.7.3. Discussion. 
Prolactin binding sites are present at the level of the ME (Barton et al 1989) and many 
reports suggest that PRL exerts a negative feedback on its own release, via an action 
on the synthesis and secretory mechanisms for DA (Gudelesky et al 1979; Nicholson 
et al 1980; Demarest & Moore 1980; Arita et al 1989). Thus hypoprolactinaemia, 
induced by chronic DA administration, decreases DA synthesis and turnover in I'lDA 
neurones while the regulation of the expression and activation of TH is enhanced by 
hyperprolactinaemia, produced by pituitary implants under the kidney capsule. In our 
investigations however, we were unable to demonstrate any significant effect of PRL 
on the release of endogenous DA. Recently, it has been proposed that an 
uncharacterized cytotropic factor, extracted from the pituitary gland, enhances the 
expression of TH in cultured brain cells (Porter et al 1990). This implies that PRL as 
a pituitary factor, is not solely responsible for regulating DA synthesis/release at 
hypothalamic level and that results from studies where whole pituitary gland/pituitary 
gland extracts have been employed to activate DA synthesis may be misleading. It is 
possible therefore that our negative results are due to the fact that PRL is not the 
major factor which regulates dopaminergic function. 
It is also important to consider the time course of our studies. There is a degree of 
controversy concerning the speed of onset of the action of PRL on ilDA activity. 
The release of [^HJDA from medial basal hypothalamic fragments is reported to be 
augmented by acute exposure to PRL (Foreman & Porter 1981). However, when DA 
turnover is used as the index for TEDA activity, there is a delay in the onset of action 
of PRL of between 10 and 26 hours (Gudelesky et al 1979). The latency in the effect 
of the neurohormone is considered to be reflective of the alterations in dopaminergic 
activity after the induction of transcriptional/translational processes, as a similar time-
course has been proposed for the induction of TH expression. This may account for 
the lack of responsiveness of DA release in our experimental model and longer 
incubation periods in the presence of PRL may result in the emergence of a 
modulatory influence on the dopaminergic activity. 
The action of PRL in the regulation of DA release may also be age - dependent. 
Chronic hyperprolactinaemia induced by haloperidol (a DA antagonist) does not alter 
the expression or amount of TH in the median eminence of young intact female rats, 
although there is a marked increase in TH mass in mature, ovariectomized animals 
(Rossi 1992). As the tissue in our experimental model is derived from a foetal source, 
it is feasible to suggest that at this stage of development the TIDA neurones are not 
equipped to respond to elevated levels of PRL. 
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The effect of PRL on dopaminergic activity is also considered to be tract specific as 
little evidence exists in favour of a modulatory influence on the behaviour of the 
ICHDA tracts. PRL has no effect on TH expression in the A13 group of cells where 
there is a predominance of DA perikarya from which the rostral and caudal portions 
of the ICHDA tract originate. To date, regulation of this system is poorly understood, 
but it is generally accepted that any effect of PRL is negligible compared with its 
marked action on the TIDA pathway. However, the ICHDA pathway constitutes the 
major dopaminergic tract in the hypothalamus, and hence in our culture model, and it 
is therefore possible that the lack of responsiveness of these neurones may conceal 
any modulatory influence being exerted by PRL on I'lDA release. 
An obligatory role for PRL in regulating DA neurone function is exemplified in the 
Ames dwarf mouse which has a marked GH and PRL deficiency and significant 
impairment of TIDA development. It is generally accepted that the deficiency in PRL 
is responsible for the poor development of the TIDA pathway as replacement of the 
hormone restores, in part, the levels of DA synthesis. Furthermore, in female Ames 
dwarf mice, the number of THIP cell bodies within the Arc are significantly lower 
than in any other mouse strains, with fewer THIP nerve terminals innervating the 
external layer of the ME (Morgan & Besch 1990). Yet if PRL is administered to such 
animals there is a marked increase in the number of THIP neurones to a level 
comparable with that observed in phenotypically normal animals. It thus appears that 
it is not an absence of TIDA neurones, but a dormancy of the neurones in the absence 
of PRL, and that the hormone activates DA synthesis in otherwise inactive cells. 
Continued PRL treatment of our cultures might therefore, activate DA neurone 
development further. Alternatively, factors which substitute for this role of PRL may 
either be produced by the cultures themselves or may be present within the defined 
medium. 
Although we were unable to demonstrate an effect of PRL on DA release in our 
hypothalamic culture model, the overall consensus found in the literature suggests 
that PRL is responsible for maintaining the functional integrity of TIDA neurones via 
an action on synthetic/secretory apparatus. Slight modifications to the experimental 
design i.e. isolation of the TIDA tract and increasing the period of incubation, may 
reveal a modulatory effect of the hormone and experiments incorporating these 
changes are planned for future studies. 
In contrast to PRL, GnRH was effective in biphasically modulating the release of 
endogenous DA. On DIV 11, GnRH concentrations of less than lO ^M significantiy 
enhanced the release of DA, while higher concentrations reversed the stimulatory 
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effect. However, by DIV 16, the responsiveness of the dopaminergic neurones to 
GnRH was markedly altered. Thus, concentrations of GnRH, which previously had 
been stimulatory on DA release now failed to increase dopaminergic activity and 100 
- 1000 fold higher concentrations of the hormone were required to elicit a response on 
DA secretion. These results suggest that while GnRH acts as a potent secretasoeue 
for DA at earlv stages of in vitro development, the effect becomes less pronounced as 
the neurones matured. 
There is both anatomical and functional evidence to suggest an association between 
dopaminergic and GnRH - containing systems within the hypothalamus and the role 
played by DA in regulating GnRH secretion is well established. The results of this 
investigation however, suggest a regulatory effect of GnRH on dopaminergic activity 
resulting, presumably, in the modulation of its own release. Other workers have 
proposed a direct effect of this neurohormone on dopaminergic activity. Thus, in 
synaptosomal preparations of the corpus striatum, the biosynthesis of [^HjDA from 
radiolabelled precursors is significantly attenuated by GnRH at a concentration of 5 x 
lO-^M (Wang et al 1982). Furthermore, in the teleost retina, DA containing 
interplexiform cells receive input from GnRH - containing, so called, centrifugal 
fibres, which are reported to stimulate DA release (Umino & Dowling 1991) and 
changes in the acquisition of conditioned avoidance responses (CARS) in adult male 
rats is reduced by injection of GnRH into the hippocampus and nucleus accumbens 
via an inhibitory action on DA release in this brain region (Mora et al 1991). 
Although an autoregulatory negative feedback mechanism for GnRH at hypothalamic 
level has been suggested (Paolo et al 1987; Valencca et al 1987), to our knowledge 
this is the first direct evidence for a modulatory action of the neurohormone on the 
activity of intrahypothalamic dopaminergic systems in vitro. 
It is difficult to determine whether the effect of GnRH is direct, or is exerted via other 
neurotransmitter/neuropeptide systems. For example, endogenous opioidpeptides are 
known to influence the release of GnRH and morphine inhibits LH secretion and 
suppresses the proestrous LH surge and ovulation. Moreover, S - endorphin and long-
acting enkephalin analogues attenuate both the amplitude and frequency of LH 
release via an action which is reversed by nalaxone. The influence of the opioid 
peptides is considered to be mediated via an enhancement on DA biosynthesis and 
release and it is thus feasible to suggest that these peptides may be involved in the 
action of GnRH on DA secretion observed in this study. Furthermore, the close 
association of GnRH - containing neurones to GABA-ergic neurones and the 
functional relationship existing between these two neurochemicals, suggests that 
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GAB A could also be involved in any potential feedback mechanism for the regulation 
of GnRH release. 
The change in the sensitivity of the dopaminergic neurones to GnRH with increasing 
age of culture may be reflective of its involvement in the organizational processes 
which occur prior to and immediately after birth. Hypothalamic GnRH expression 
occurs early in foetal life and the neurohormone demonstrates cytotrophic actions 
well in advance of the commencement of LH biosynthesis (Aubert et al 1985). Thus, 
it is likely that GnRH acts primarily as a trophic factor during early stages of 
development. Moreover, it is possible that one or several of the functional changes 
occurring in the perinatal CNS is mediated via an action on central catecholaroinergic 
systems and thus the shift in responsiveness of DA release to GnRH may represent a 
physiological alteration in the behaviour of dopaminergic neurones at a pre-
programmed point in foetal/postnatal development. A shift in DA responsiveness 
was also observed for E2 on DIV 7 and DIV 28 (Figs. 3.30 and 3.31) and it is thus 
possible that these observations may reflect critical changes in intrahypothalamic 
dopaminergic cell function in response to alterations in the steroid and neuropeptide 
environment which could critically influence organisational events in the 
hypothalamus. 
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3.8. Summary 
Immunocytochemical Studies. 
1. On the basis of TH ICC, perinatal hypothalamic dopaminergic neurones are 
relatively immature at the time of initiating the cultures but continue on a pre-
programmed pattern of morphological development over a period of 2 weeks 
in vitro in a manner similar to that observed in vivo. 
2. We hypothesise that the observed morphological differences may represent 
differences in the original anatomical location of these dopaminergic neuronal 
populations and consequently represent functionally distinct pathways. 
3. THIP neurones with bipolar morphology may represent dopaminergic 
neurones of the TIDA system which are involved in the regulation of PRL and 
GnRH secretion. 
4. Multipolar THIP neurones may derive from the rostral component of the 
ICHDA tract in vivo which may also be involved in the regulation of certain 
aspects of neuroendocrine function. 
5. The functional development of the diencephalic dopaminergic systems 
appears to be retarded in relation to the development of those of the 
mesencephalon. 
6. On the basis of GABA ICC, perinatal GABA-ergic neurones very rapidly (< 3 
days) attain a mature morphology in culture. 
Studies with [%] Neurotransmitters. 
1. Investigations on the uptake and release of [3H]DA provide functional 
evidence in support of the conclusions made in 1-5 above. 
2. Investigations with [^HJGABA provide functional evidence in support of 
conclusion 6 above and, when compared with DA studies, suggest that 
hypothalamic dopaminergic and GABA-ergic systems exhibit pre-
programmed, differential developmental patterns in vitro. 
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3. Studies with [^H] and "cold" DA suggest that a D2-like receptor mediated 
mechanism may influence DA uptake and hence synaptic concentrations of 
DA. 
4. On the basis of the above findings we propose that hypothalamic neurones in 
vitro exhibit developmental patterns which are specific for individual 
neurotransmitter systems and distinct from developmental patterns of similar 
neurotransmitter systems located in other brain regions. Such distinct 
developmental patterns are therefore, unlikely to reflect, solely an artefact of 
the culture conditions, but may represent important developmental processes 
occuring in brain-specific regions in discrete neuronal populations and at 
different developmental stages, many of which may be critical to the adequate 
functioning of the neuroendocrine system in adult life. 
Studies with Endogenous DA. 
Similarities in the responsiveness of endogenous and [^H]DA to non-specific 
and neurochemically evoked release do exist but not in all situations. These 
results emphasize the complex balance between release, uptake, synthesis and 
storage and cautions against conclusions made from studies of [^H]DA release 
alone. 
Studies with Gonadal Steroids. 
Investigations on the uptake and release of [^H]GABA and DA and the release 
of endogenous DA suggest that gonadal steroids may specifically and 
differentially influence the maturation and/or function, during the perinatal 
period, of discrete populations of hypothalamic neurones involved in the 
control of endocrine function. 
DA-GABA Interactions. 
1. Endogenous GABA appears to exert potent inhibitory influences on DA 
release via type A and B receptors. 
2. Differences in [^H] and endogenous DA release in response to 
pharmacological manipulation of GABA-ergic transmission suggest that DA 
may be located in more than one intracellular pool. 
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3. Endogenous DA appears to be more sensitive to inhibitory GABA-ergic 
influences than recently accumulated [^H]DA. 
4. [^H]DA appears to be stored in a pool which is released more readily when 
inhibitory GABA-ergic influences are lifted. 
5. These results support the importance of DA-GAB A interactions in the 
regulation of neuroendocrine function and demonstrate that they are active in 
the perinatal period. 
Prolactin-DA Interactions. 
Prolactin appears to have no influence on hypothalamic dopaminergic 
neurones during the perinatal period. 
GnRH-DA Interactions. 
1. These studies provide evidence for a novel, potent stimulatory effect of GnRH 
on hypothalamic dopaminergic systems during the perinatal period which 
declines as the dopaminergic neurones undergo in vitro development. 
2. This phenomenon could reflect either a developmental stimulus by GnRH to 
the maturation of a population(s) of dopaminergic neurones which will 
ultimately be involved in the control of the reproductive system or, an early 
short-loop feedback system (positive on dopaminergic neurones exerting a 
negative influence of GnRH secreting cells) which is highly active in the 
immature animal in order to repress reproductive function. 
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CHAPTER FOUR: GENERAL DISCUSSION 
AND FUTURE DIRECTIONS. 
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The major purpose of this project was to investigate the development of the various 
dopaminergic neuronal populations of the hypothalamus, employing a primary cell 
culture model and monitoring changes in both the morphology and function of this 
neurotransmitter system. To a great extent, these aims have been realized and, in 
addition, the results have raised a number of further questions which we would hope 
to address in future studies. 
It is widely accepted that the development of individual neurones and indeed of whole 
neuronal populations in vivo, are dependent on cell -to- cell associations, with various 
soluble trophic, inhibitory and migratory factors determining the exact phenotype that 
each cell adopts. Thus, the very identity of a neurone is believed to be exacted by its 
environment. Even with the use of defined media and increasingly more complex 
systems for supporting neuronal growth, cells maintained in such culture are unlikely 
to be exposed to the same developmental signals and inputs that they experience in 
the 3-dimensional, in situ situation. In the absence of extrahypothalamic regulatory 
factors it might therefore be expected that neurones would have very Umited capacity 
to survive and develop in culture. However, we have demonstrated that the 
dopaminergic neurones within our culture model pursue distinct processes of both 
morphological and functional development, the patterns of which closely resemble 
that reported for in vivo development. We propose, therefore, that a degree of 
programming of neuronal hypothalamic cells occurs during foetal development, at 
least prior to El8 in the rat strain employed, and that this pre - programming resulted 
in the well defined pattern of morphogenesis demonstrated by THIP neurones 
(Section 3.1.1.3) and also the obvious pattern of functional development as indicated 
by the biochemical studies (Section 3.2). Furthermore, the in vitro behaviour of 
dopaminergic neurones derived from animals at different ages relative to conception, 
emphasised important changes in neuronal activity occurring over the perinatal 
period. As argued in 3.4.6, it is likely that at term certain processes of neuronal 
development are suppressed and this inhibition is re-exerted within the culture 
system. In contrast, postnatally such restraining influences are lifted, permitting the 
completion of neuronal development and allowing the neurones to perform at their 
optimal level. If our hypothesis is correct it suggests that even the different patterns 
of neuronal development may to some extent be reproduced in culture. 
This is further evidenced by the GABA-ergic system studies. While the 
dopaminergic neurones within the culture model displayed a degree of morphological 
and functional immaturity at early time points in cultivation, from as early as DIV 3 
intrahypothalamic GABA-ergic neurones were both morphologically developed and 
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functionally competent. This was especially apparent if one compares the values 
obtained for Km in our uptake studies, where those for GAB A were of the same order 
of magnitude as those found in adult brain, but those for DA suggested immaturity of 
the DA system. It is thus interesting to speculate that much of the developmental 
process for GABA-ergic systems occurs prior to birth and that under culture 
conditions they rapidy re-attain their advanced state of development viz. rapid 
regrowth of neurites and the expression of transporter proteins. In contrast, the 
dopaminergic neurones are reported to be only partially developed at birth (Olson & 
Seiger 1973), and this neuronal retardation (in comparison to the GABA - ergic 
systems) is carried over into the in vitro situation. Thus, although we are aware of the 
limitations of the tissue culture approach, it appears that, at least for 
intrahypothalamic dopaminergic and GABA-ergic systems, many of the 
characteristics of in vivo neuronal development are sustained and that culture models 
are likely to be more reflective of the in vivo situation than was once thought 
It would be interesting to cultivate foetal hypothalamic tissue at earlier gestational 
periods (viz. prior to El8), in an attempt to pin-point the time at which this pre-
programming occurs. Repetition of the biochemical studies may reveal that the rate 
and degree of development of intrahypothalamic cultures is impaired the earlier the 
tissue is taken, indicating that the development of these neuronal populations is highly 
dependent on their exposure to certain signals which may only occur at a distinct time 
- point in the ontogeny of the hypothalamus. Parallel investigations involving the 
mesencephalic dopaminergic cell system would indicate whether the phenomenon 
was region specific or general to all central dopaminergic pathways. Following this, 
an attempt to isolate the factors involved in regulating the development of these 
dopaminergic systems would be beneficial. We believe that the identification of the 
substances which inhibit/facilitate the growth and survival of dopaminergic neurones, 
would be more readily achieved within a culture model system and will greatly 
improve our understanding of the development of the brain, the factors controlling its 
function and also the aetiology of age-related CNS and neuroendocrine abnormalities. 
Although far off, such an approach has potential for the development of new types of 
therapy for the treatment of endocrine, neurological and neurodegenerative diseases 
in a manner similar to that of the recently identified glial cell line - derived 
neurotrophic factor which has already been targeted for possible use in the treatment 
of Parkinsons' Disease (Lin et al 1993). 
Further investigation into the ontogeny of the uptake and release mechanisms in play 
in the foetal hypothalamus is also important in order to shed light on the transition of 
neurotransmitter systems from their inactive to functional states. As a pronounced 
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change in Km values for both the dopaminergic and GABA-ergic systems was 
demonstrable in this study, it is likely that physiological and therefore relevant 
changes in intrahypothalamic transmitter function occur around the perinatal period. 
The use of molecular biological techniques may allow further investigation into the 
ontogeny of the expression of the dopamine transporter on nerve terminals. 
Furthermore, a similar approach may be used to study the proposed D2-like 
autoreceptor which may play a more important role in regulating dopaminergic 
activity in the foetal than in the adult CNS. The apparently transient nature of the 
Na+ dependency of GABA uptake and also the loss of effectiveness of SKF 89976 A 
with increasing age may also be further explored employing molecular biological 
techniques to identify structural changes in the GABA transporter protein. As GABA 
is the major inhibitory neurotransmitter in the CNS and the major route for the 
termination of its transmission is via re-uptake, any perinatal changes in the nature of 
the uptake protein may have important implications in the development of the CNS. 
One of the major limitations in this experimental model is the fact that we are dealing 
with a heterogeneous population of dopaminergic neurones which display very 
different profiles in terms of their functional capabilities and their responsiveness to 
peripheral steroids, neurohormones, drugs etc. In general, the activity of ICHDA 
systems is more readily modulated by pharmacological manipulation of 
neurotransmitter systems whereas, in the adult the TIDA neuronal system is more 
responsive to gonadal steroids and hormones such as prolactin (Lookingland & 
Moore 1984a, 1984b, 1985). Furthermore, adult TIDA neurones are highly resistant 
to the actions of 6 - OHDA, the neurotoxic effect of which is dependent on it gaining 
access to the nerve terminals via the uptake mechanism. By contrast, the ICHDA 
tract, like other dopaminergic neuronal systems, is susceptible to 6 - OHDA and it has 
been suggested that the differences in effectiveness of this toxic agent on these two 
hypothalamic tracts is reflective of the absence of a high affinity uptake mechanism 
on TIDA nerve terminals (Demarest & Moore 1979) although a possible difference in 
the ligand specificity of the TIDA transporter molecule ought also to be considered. 
Such contrariety makes absolute interpretation of our results difficult as we are unable 
to discriminate between actions exerted on TIDA neurones from those being exerted 
on ICHDA populations. Neither are we able to definitively identify those actions 
which are influencing the activity of both systems and to what extent each pathway 
contributes to the observed effect. In future studies, we would hope to refine the 
culture model used by further dissection of the hypothalamic tissue to isolate the 
arcuate nucleus - median eminence (Arc - ME) complex fi-om the remainder of the 
structure. Thus, by culturing each portion separately we will be able to monitor the 
activity of the TIDA and ICHDA neuronal systems more effectively. It must be 
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remembered however, that some THDA neurones are known to innervate the median 
eminence and other, as yet uncharacterized, dopaminergic populations are present 
within the hypothalamus and thus, obtaining a culture model containing a totally 
homogeneous population of DA - containing cells would be difficult to achieve. 
Therefore, we would hope in the future to adopt an additional culture system in order 
to further investigate some of the findings reported here. A culture model has been 
described whereby slices of hypothalamic tissue derived from newborn animals may 
be maintained for up to 6 weeks (Bertini et al 1993). In such a system the structural 
integrity of the hypothalamic tissue is retained including the various 
intrahypothalamic neuronal systems and their functional connections with each other. 
Thus, by taking slices from the appropriate region of the hypothalamus, this model 
allows the investigation of discrete neuronal populations both in terms of their 
topography (ICC studies revealing their site of origin and termination) and also their 
relationship to other neuropeptide and neurotransmitter systems (release studies in the 
presence of different physiological factors and pharmacological agents). 
The modulatory influence of E2 and Prog on dopaminergic function allows us to 
speculate on the role played by the peripheral sex steroids in the developing CNS. 
The specific actions of E2 on the functioning of both the perinatal and adult HP-axis 
have already been discussed, but it is believed that such hormones also have a non-
specific influence on neuronal development. E2 appears to promote neurite growth in 
mesencephalic THIP neurones in vitro and has also been shown to increase neuronal 
survival in a number of brain regions including the hypothalamus (Reisert et al 1987). 
In vivo such actions may play a critical role in establishing the anatomical and 
functional sexual dimorphism demonstrated in several brain regions. Thus, 
androgens, after their conversion to oestrogens by aromatases, are believed to regulate 
synaptogenesis and the phenotypic nature of cells which form synaptic connections. 
This is exemplified in the mPOA where neonatal castration of the male animal leads 
to a permanent alteration in the morphology and presumably the neuronal circuitry 
because gender - specific patterns of LH secretion become disrupted (Arnold & 
Gorski 1984). It is however, yet to be elucidated exactly how the structural changes 
elicit the functional changes exhibited in the adult. In future studies it would be 
valuable to investigate the effect of neonatal androgen exposure on the development/ 
differentiation and activity of the intrahypothalamic dopaminergic neurones. 
Morphometric studies employing ICC coupled to image analysis would allow 
determination of the effects of E2/Prog and aromatizable androgens on THIP neuronal 
growth and survival in vitro and any changes in neuropeptide output which coincided 
with changes in dopaminergic activity could simultaneously be investigated. Again, 
the use of slice cultures may prove useful in such a study as it would be possible to 
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relate steroid induced changes in the neuroendocrine system with alterations in 
intrahypothalamic neurotransmitter activity. Such changes are widely believed to 
have implications in the activity of the HP-axis both at puberty and in the adult. In 
addition, the individual action of E2 and Prog on either ICHDA or TTDA neurones 
could be studied more discretely, as could the synergism existing between the two 
hormones. Such a model would also allow us to investigate gender related 
differences in the development of the dopaminergic and GABA-ergic populations by 
using hypothalamic tissue from both sexes in isolation. As sexual dimorphism has 
been reported for the distribution of dopaminergic neurones in the hypothalamus 
(Simerly & Swanson 1987) and the activity of TIDA neurones in the adult male is 
lower than in the female, such differences may well be responsible for the gender -
specific differences in the release of neuropeptides such as prolactin and LH in the 
adult intact animal. 
The hypothalamus, like all other regions of the CNS, exhibits a considerable degree 
of diversity in its morphological, biochemical and physiological properties and this 
diversity literally demands a cellular approach, such as tissue culture technology, for 
the investigation and correlation of these properties. We have demonstrated that the 
morphological and functional development of intrahypothalamic dopaminergic and 
GABA-ergic systems, in addition to their anatomical and functional interactions and 
their responsiveness to neuropeptides and gonadal steroids, may be readily studied 
using a dissociated cell culture model. We propose that such an approach to the 
investigation of the development of the hypothalamus will continue to enhance our 
understanding of the neuroendocrine system and the myriad of factors involved in the 
regulation of its ontogeny and function. 
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APPENDIX I 
Addresses of Suppliers. 
i. Consumbles and small equipment: 
SUPPLIER 
Amersham Life Science 
Amersham Place, 
Little Chalfont, 
Buckinghamshire, HP7 9NA 
AMS Biotechnology 
Unit 6, Tannery Yard, 
Whiney Street, 
Burford, OX8 SDN 
Anderman and Co Ltd 
145 London Road, 
Kings-Upon-Thames, 
Surrey, KT2 6NH 
Arterial Medical Services 
313 Chase Road, 
Southgate, 
London, N14 6JH 
BDH/MERCKLtd 
Freshwater Road, 
Dagenham, 
Essex 
PRODUCT 
[^H] gamma aminobutyric acid 
tyrosine hydroxylase antibody 
Sterile Pipette Tips 
1ml syringes 
acetonitrile 
7ml Bijou bottles 
citric acid 
calcium chloride 
diethylether 
D-Glucose 
EDTA 
Hamilton syringes (HPLC Type) 
hydrochloric acid 
di-sodium hydrogen phosphate 
potassium chloride 
magnesium sulphate 
paraformaldehyde 
perchloric acid 
picric acid 
methanol 
"Ralmount" (mountant) 
sodium chloride 
sodium dihydrogen orthophosphate 
sodium hydrogen carbonate 
sodium hydroxide 
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Bibby Sterilin 
Tilling Drive, 
Stone, 
Staffs ST15 OSA 
Boeringher Manheim U.K. 
Bell Lane 
East Sussex, BN7 ILG 
Chance Propper 
Spon Lane, 
Smethwich, 
Warley 
Charing Cross Hospital (Pharmacy) 
Fulham Palace Road 
Hammersmith 
W6 8RF 
Citifluor Ltd 
Connaught Building (Room 303) 
Northampton Square, 
London, EClV OHB 
Dako Ltd 
16 Manor Court, 
Hughenden Avenue, 
Highwycombe, 
Bucks, HP 13 5RE 
DuPont Ltd 
Wedgewood Way, 
Stevenage, 
Hertfordshire, SGI 4QN 
Gelman Sciences 
10 Hanover Road, 
Brackmills, 
Northampton, NN4 OE2 
Gibco Life Technologies 
3 Fountain Drive 
Inchinan Business Park, 
Inchinan, PA4 9RF 
Hoechst UK Ltd 
Pharmaceutical division, 
Hoechst House 
Salisbury Road, 
Hounslow, 
Middx, TW4 6JH 
Sterile 10ml pipettes 
dispase (Grade I) 
glass coverslips (15mm) 
microscope slides 
sterile water 
sterile saline 
aprotinin 
Citifluor (mountant) 
normal goat serum 
[^H]dihydroxyphenylamine 
hydrochloride ([^HJDA) 
Acrodisc 0.2|i filters 
Dulbecco's Modified Eagles Medium 
foetal calf serum 
fungizone 
Ham's F-12 Nutrient Mixture 
horse serum 
Nunc 4x4 multiwell plates (15mm) 
Nunc 6 well culture plates (35mm) 
benztropine 
nomifensine 
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A.R. Horwell Ltd 
73 Haygrove Road, 
West Hampstead, NW6 2BP 
Hughes and Hughes Ltd 
Elms Industrial Estate, 
Church Road, 
Harold Wood, 
Romford Essex 
ICN Biomedicals 
Pereguine Business Park, 
High Wycombe, 
Bucks, HP 13 7DL 
Lab Impex Research 
111-113 Walde grave Road, 
Teddington, 
MiddlesexTWll 8LL 
Labsystems 
Unit 5, 
The Ringway Centre, 
Edison Road, 
Basingstoke 
Lancaster Synthetic Ltd 
Eastgate, 
White Lund, 
Morcambe, 
Lanes, LA3 30H 
National Institue of Diabetes and 
Digestive and Kidney Diesease. 
Suite 505 
210 West Fayette Street, 
Baltimore, 
Maryland, 21201-3472 
Nova Pharmaceutical Corporation 
6200 Freeport Centre 
Baltimore, 
Maryland, 21224-2788 
Nuclear Enterprise 
Sight Hill, 
Edinburgh, 
Scotland, EHl 1 4BH 
Phillip Harris Scientific 
618 Western Avenue, 
Park Royal, 
London W3 OTE 
Sterilin petridishes 
scintillation vial inserts and caps 
HEPES 
Speed-Cat Cartridges 
Finpipettes 
sodium-n-octylsulphate 
prolactin 
SKF-89976A (GABA uptake inhibitor) 
scintillation cocktail 
1ml disposable syringes 
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Penninsula Laboratories Ltd 
Box 62,17K Westdale Industrial Estate, 
Jackson Street, 
St Helens, 
Merseyside, WA9 3AJ 
Sigma Chemical Company 
Fancy Road, 
Poole, 
Dorset BHM 7NH 
gonadotrophin hormone-releasing 
hormone 
Stratech Scientific 
61-63 Dudley Street, 
Luton, 
Bedfordshire 
UniPath Ltd 
Wade Road, 
Basingstoke, Hants, RG OPW 
Vector Laboratoies 
16 Wulfric Square, 
Bretton, 
Peterborough, PES 8RF 
Walter Starstedt 
68 Boston Road, 
Leicester, LE4 lAW 
aminooxyacetic acid 
ascorbic acid 
bacitracin 
baclofen hydrochloride 
bicuculline 
bovine serum albumin 
DNA-ase 
dopamine 
diaminobenzedine (free base) 
3,4,- dihydroxybenzylamine 
3, 4, -dihydroxyphenylacetic acid 
epinephrine 
Hanks balanced salt solution 
insulin 
muscimol 
pargyline 
poly-L-lysine 
trizma base 
trizma hydrochloride 
tri-iodthyronine 
Texas Red conjugated goat anti-mouse 
IgG 
Fluoroscein conjugated goat anti mouse 
IgG 
Fluoroscein conjugated goat anti rabbit 
IgG 
Phosphate buffered saline (tablets) 
Unconjugated horse anti-mouse I ^ 
peroxidase anti peroxidase conjugated 
antibody 
5ml tubes 
3.5ml tubes 
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ii. Large Equipment. 
SUPPLIER 
Biotech Instrument Ltd 
183 Camford Way, 
Luton, 
Beds, LU3 3AN 
Decon Ultrasonics Ltd 
Conway Street, 
Hove, 
Sussex 
Envair 
York Avenue 
Haskingden, 
Rosendale, 
Lane, BB4 4HX 
Fison's Instruments 
Sussex Manor Park, 
Gatwick Road, 
Crawley, 
Sussex 
Heraeus Equipment Ltd 
9 Wales Way, 
Brentwood, 
Essex, CM 15 9TB 
Lab Impex Research 
111-113 Waldegrave Road, 
Teddington, 
Middlesex TWll 8LL 
PRODUCT 
HPLC-EC Equipment 
Water sonicator for cleaning glassware 
Class n biological safety cabinet 
MSE "coolair" benchtop centrifuge 
MSE "soniprep" 150 sonicator 
CO2 incubator 
"Speed-mate" vacuum pump 
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